None(e1,e2)	0	1	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
None(e1,e2)	27	35	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	62	126	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	26	28	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
effect(e1,e2)	4	21	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	27	30	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	24	36	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	16	20	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
None(e1,e2)	13	33	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	19	63	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	20	24	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine_oxidase_(_mao_)_inhibitors , tricyclic antidepressants or some antihistamines .
None(e1,e2)	9	14	however , in clinical studies the consequences of concomitant irbesartan on the pharmacodynamics of warfarin were negligible .
None(e1,e2)	0	2	prednisolone : ethinyl_estradiol may inhibit the metabolism of prednisolone , leading to increased plasma concentrations .
None(e1,e2)	22	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	37	51	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	45	63	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
effect(e1,e2)	5	23	these pharmacokinetic effects seen during diltiazem coadministration can result in increased clinical effects ( e.g. , prolonged sodation ) of both midazolam and triazolam .
None(e1,e2)	65	84	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	5	25	effects of felbatol on low-dose combination_oral_contraceptives a group of 24 nonsmoking , healthy white female volunteers established on an oral contraceptive regimen containing 30 mg ethinyl_estradiol and 75 mg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle ( day 15 ) to midcycle ( day 14 ) of two consecutive oral contraceptive cycles .
None(e1,e2)	6	13	ethoxzolamide may increase the action of tricyclics , amphetamines , procainamide , and quinidine .
None(e1,e2)	39	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	58	60	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	3	5	the effect of keppra on probenecid was not studied .
None(e1,e2)	74	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	43	45	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta_blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	21	34	iron supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron ( as feso4 ) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80 % and 31 % , respectively .
None(e1,e2)	1	5	- procainamide ( e.g. , pronestyl ) or
None(e1,e2)	3	17	the auc of ciprofloxacin was decreased an average of 15-fold in 12 healthy subjects given ciprofloxacin and didanosine -placebo tablets concurrently .
None(e1,e2)	39	41	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	26	71	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	44	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	102	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	71	99	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	16	43	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/ hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	10	12	co-medications that induce cyp 3a4 ( e.g. , rifampicin , phenytoin , carbamazepine , phenobarbital , or st. john s wort ) may significantly decrease exposure to exemestane .
None(e1,e2)	33	36	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	16	28	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium_channel_blocking_drugs , and isoniazid .
None(e1,e2)	0	2	diphenoxylate_hcl and atropine_sulfate may interact with mao inhibitors in studies with male rats , diphenoxylate hydrochloride was found to inhibit the hepatic microsomal enzyme system at a dose of 2 mg/kg/day .
None(e1,e2)	119	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	65	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	8	however , co-administration of duloxetine with aluminum- and magnesium -containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
None(e1,e2)	5	30	in addition , oxcarbazepine and mhd induce a subgroup of the cytochrome p450 3a family ( cyp3a4 and cyp3a5 ) responsible for the metabolism of dihydropyridine calcium antagonists and oral contraceptives , resulting in a lower plasma concentration of these drugs .
None(e1,e2)	5	15	there have been reports of theophylline -related side effects in patients on concomitant therapy with norfloxacin and theophylline .
None(e1,e2)	36	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	21	27	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	6	8	prolonged recovery time may occur if barbiturates and/or narcotics are used concurrently with ketamine .
None(e1,e2)	8	11	chloramphenicol has been shown to be antagonistic to beta-lactam_antibiotics , including ceftazidime , based on in vitro studies and time kill curves with enteric gram-negative bacilli .
None(e1,e2)	76	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	73	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	39	46	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	59	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	6	dimenhydrinate may decrease emetic response to apomorphine .
None(e1,e2)	28	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	13	30	although increased plasma concentrations ( c max and auc 0-24 hrs ) of desloratadine and 3-hydroxydesloratadine were observed , there were no clinically relevant changes in the safety profile of desloratadine , as assessed by electrocardiographic parameters ( including the corrected qt interval ) , clinical laboratory tests , vital signs , and adverse events .
None(e1,e2)	14	18	the use of codeine may result in additive cns depressant effects when coadministered with alcohol , antihistamines , psychotropics or other drugs that produce cns depression .
None(e1,e2)	26	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	26	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	0	17	heparin : since heparin is contraindicated in patients with heparin-induced thrombocytopenia , the co-administration of argatroban and heparin is unlikely for this indication .
None(e1,e2)	0	4	hmg-coa_reductase_inhibitors : simvastatin ( cyp3a4 substrate ) in combination with amiodarone has been associated with reports of myopathy/rhabdomyolysis .
None(e1,e2)	35	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	38	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	55	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	14	other : there appears to be no pharmacokinetic interaction between acitretin and cimetidine , digoxin , or glyburide .
int(e1,e2)	61	66	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	15	24	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type 1c antiarrhythrnics propatenone and flecainide ) .
None(e1,e2)	17	21	potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( phenytoin , valproate , oral contraceptive , digoxin , warfarin , probenecid ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .
None(e1,e2)	24	26	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	3	11	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic drugs .
None(e1,e2)	45	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	66	70	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	46	56	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
mechanism(e1,e2)	0	33	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin_g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	10	40	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	3	ketoconazole /itraconazole , macrolides , including erythromycin
None(e1,e2)	15	35	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	9	11	fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole .
None(e1,e2)	59	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	16	22	a similar association , though less marked , has been suggested with barbiturates , phenyl-butazone , phenytoin_sodium , carbamazepine and possibly with griseofulvin , ampicillin , and tetracyclines ( 72 )
None(e1,e2)	0	20	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	18	29	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns_depressants , causing increased cns depression .
None(e1,e2)	4	16	elevated serum levels of cyclosporine have been reported with the concomitant use of some quinolones and cyclosporine .
mechanism(e1,e2)	7	9	in a study involving healthy subjects receiving tambocor and propranolol concurrently , plasma flecainide levels were increased about 20 % and propranolol levels were increased about 30 % compared to control values .
effect(e1,e2)	0	7	narcotic_analgesics may potentiate the hypotensive effects of clonidine .
None(e1,e2)	6	19	curariform muscle relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
None(e1,e2)	11	32	reported examples of this interaction include the following : immunosuppressives : cyclosporine ( cyp3a4 substrate ) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine , despite reduction in dose of cyclosporine .
None(e1,e2)	31	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
mechanism(e1,e2)	14	28	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
None(e1,e2)	30	39	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic_acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	8	60	agents with increased levels in the presence of carbamazepine : equetrotm increases the plasma levels of the following agents : clomipramine hcl , phenytoin ( 6 ) , and primidone thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with equetrotm , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .
effect(e1,e2)	0	6	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
None(e1,e2)	24	28	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	10	24	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	24	29	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline_salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	117	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	9	42	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	59	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	34	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type_anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic_antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
mechanism(e1,e2)	16	28	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
mechanism(e1,e2)	16	28	when ertapenem is co-administered with probenecid ( 500 mg p.o . every 6 hours ) , probenecid competes for active tubular secretion and reduces the renal clearance of ertapenem .
None(e1,e2)	8	29	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	7	22	because cholestyramine binds bile acids , cholestyramine resin may interfere with normal fat digestion and absorption and thus may prevent absorption of fat_soluble_vitamins such as a , d , e , and k .
None(e1,e2)	0	21	rifampin : when a single 375-mg dose of aprepitant was administered on day9 of a 14-day regimen of 600 mg/day of rifampin , a strong cyp3a4 inducer , the auc of aprepitant decreased approximately 11-fold and the mean terminal half-life decreased approximately 3-fold .
None(e1,e2)	0	9	hydrochlorothiazide ( hctz ) alone or in combination with triamterene : concomitant use of hctz alone or in combination with triamterene is contraindicated .
None(e1,e2)	0	14	cholestyramine and colestipol resins : absorption of hydrochlorothiazide is impaired in the presence of anionic_exchange_resins .
None(e1,e2)	42	44	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium_chloride , folic acid , and acetaminophen .
None(e1,e2)	0	12	diltiazem : in patients with mild to moderate hypertension , administration of aprepitant once daily , as a tablet formulation comparable to 230 mg of the capsule formulation , with diltiazem 120 mg 3 times daily for 5 days , resulted in a 2-fold increase of aprepitant auc and a simultaneous 1.7-fold increase of diltiazem auc .
None(e1,e2)	79	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	54	70	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide_antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	17	27	since the concomitant administration of these two drugs can lead to phenytoin intoxication , prior to administering disulfiram to a patient on phenytoin therapy , a baseline phenytoin serum level should be obtained .
None(e1,e2)	56	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	44	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	0	2	ritonavir and indinavir : upon concomitant administration of 5 mg of vardenafil with 600 mg bid ritonavir , the cmax and auc of ritonavir were reduced by approximately 20 % .
None(e1,e2)	71	124	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	39	41	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	2	5	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	29	35	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	0	2	warfarin : atorvastatin had no clinically significant effect on prothrombin time when administered to patients receiving chronic warfarin treatment .
None(e1,e2)	19	23	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	75	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	15	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	0	43	carbamazepine : coadministration of carbamazepine ( 200 mg bid ) , a potent cyp3a4 inducer , with aripiprazole ( 30 mg qd ) resulted in an approximate 70 % decrease in cmax and auc values of both aripiprazole and its active metabolite , dehydro-aripiprazole .
None(e1,e2)	24	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	38	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	21	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	10	12	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	3	12	infusion requirements of nimbex in patients administered succinylcholine prior to infusions of nimbex were comparable to or slightly greater than when succinylcholine was not administered .
effect(e1,e2)	5	45	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	17	20	such individuals are referred to as poor metabolizers of drugs such as debrisoquin , dextromethorphan , the tricyclic_antidepressants , and clozapine .
None(e1,e2)	13	15	although increased plasma concentrations ( c max and auc 0-24 hrs ) of desloratadine and 3-hydroxydesloratadine were observed , there were no clinically relevant changes in the safety profile of desloratadine , as assessed by electrocardiographic parameters ( including the corrected qt interval ) , clinical laboratory tests , vital signs , and adverse events .
None(e1,e2)	31	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	35	37	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	4	24	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns-depressive effect of alcohol , barbiturates or other sedating drugs .
None(e1,e2)	13	22	patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other cns_depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
None(e1,e2)	36	86	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	2	42	coadministration of valdecoxib ( 40 mg bid ( day 1 ) and 40 mg qd ( days 2-7 ) ) with glyburide ( 10 mg glyburide bid ) resulted in 21 % increase in glyburide auc0-12 and a 16 % increase in glyburide cmax leading to a 16 % decrease in glucose auc0-24 .
None(e1,e2)	20	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	22	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	44	62	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	18	35	the results of a study of coadministration of ethambutol ( 50 mg/kg ) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20 % and 13 % , respectively , suggesting that the oral absorption of ethambutol may be reduced by these antacid products .
None(e1,e2)	3	9	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	36	43	in vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce , inhibit , or are metabolized by cytochrome p450 3a4 , such as cyclosporine , terfenadine , ketoconazole , erythromycin , and troleandomycin .
None(e1,e2)	2	20	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	66	136	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	35	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	31	76	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	58	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	3	22	concomitant use of tricyclic_antidepressants with drugs that can inhibit cytochrome p450 2d6 may require lower doses than usually prescribed for either the tricyclic_antidepressant or the other drug .
None(e1,e2)	6	14	platelet inhibitors : drugs such as acetylsalicylic_acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	24	26	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	17	30	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal_anti-inflammatory_agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	0	36	phenytoin : in a single ( 400 mg ) and multiple dose ( 400 mg tid ) study of neurontin in epileptic patients ( n=8 ) maintained on phenytoin monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics .
None(e1,e2)	8	12	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	3	46	when atropine and pralidoxime are used together , the signs of atropinization ( flushing , mydriasis , tachycardia , dryness of the mouth and nose ) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine .
None(e1,e2)	13	15	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic_antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	31	86	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	13	23	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	15	17	approximately 2/3 of the patients in the phase 3 study received either prophylactic low dose heparin ( unfractionated_heparin up to 15,000 units/day ) or prophylactic doses of low molecular weight heparins as indicated in the prescribing information for the specific products .
None(e1,e2)	22	24	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	16	27	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	15	31	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
effect(e1,e2)	10	13	concomitant treatment of four patients in the united kingdom with foscavir and intravenous pentamidine may have caused hypocalcemia ;
None(e1,e2)	51	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	22	43	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	9	11	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	24	37	because busulfan is eliminated from the body via conjugation with glutathione , use of acetaminophen prior to ( 72 hours ) or concurrent with busulfex may result in reduced busulfan clearance based upon the known property of acetaminophen to decrease glutathione levels in the blood and tissues .
None(e1,e2)	1	41	if desipramine_hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	119	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	33	37	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin_analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	0	6	theophylline : the effect of steady-state fluvoxamine l50 mg bid on the pharmacokinetics of a single dose of theophylline ( 375 mg ) as 442 mg aminophylline was evaluated in 12 healthy non-smoking , male volunteers .
int(e1,e2)	0	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	16	the use of codeine may result in additive cns depressant effects when coadministered with alcohol , antihistamines , psychotropics or other drugs that produce cns depression .
advise(e1,e2)	0	24	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	0	7	digoxin : studies of concomitant administration of flurbiprofen and digoxin to healthy men ( n= 14 ) did not show a change in the steady state serum levels of either drug .
None(e1,e2)	6	11	phenobarbital : coadministration of felbamate with phenobarbital causes an increase in phenobarbital plasma concentrations , in 12 otherwise healthy male volunteers ingesting phenobarbital , the steady-state trough ( cmin ) phenobarbital concentration was 14.2 micrograms/ml .
mechanism(e1,e2)	4	21	furthermore , rifampin , phenytoin , phenobarbital , and other inducers of cytochrome p450 3a4 may cause a reduction in plasma bexarotene concentrations .
mechanism(e1,e2)	2	13	absorption of tetracyclines is impaired by antacids containing aluminum , calcium , or magnesium , and iron-containing preparations .
advise(e1,e2)	16	26	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
effect(e1,e2)	4	17	the antihypertensive effects of methyldopa , mecamylamine , reserpine , and veratrum alkaloids may be reduced by sympathomimetics .
None(e1,e2)	15	25	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	24	42	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
mechanism(e1,e2)	7	12	calcium antagonists : after repeated co-administration of trileptal , the auc of felodipine was lowered by 28 % [ 90 % ci : 20-33 ] .
None(e1,e2)	14	19	probenecid : concomitant administration of toradol oral and probenecid resulted in decreased clearance of ketorolac and significant increases in ketorolac plasma levels ( total auc increased approximately threefold from 5.4 to 17.8 m g/h/ml ) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours .
None(e1,e2)	1	26	oral hypoglycemics : bepridil has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for insulin or oral hypoglycemic_agents .
None(e1,e2)	7	9	albuterol , antihistamines , antidiabetic drugs , diuretics , digitalis .
None(e1,e2)	5	17	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet_inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	31	59	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	18	toxicology studies of heroin-related deaths reveal frequent involvement of other central_nervous_system_depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
None(e1,e2)	10	12	similarly , patients receiving the drug and a hydantoin , sulfonamide or sulfonylurea should be observed for signs of toxicity to these drugs .
None(e1,e2)	19	26	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	11	27	since the concomitant administration of these two drugs can lead to phenytoin intoxication , prior to administering disulfiram to a patient on phenytoin therapy , a baseline phenytoin serum level should be obtained .
None(e1,e2)	51	68	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	26	32	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin_hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	25	56	tolbutamide : aprepitant , when given as 125 mg on day 1 and 80 mg/day on days 2 and 3 , decreased the auc of tolbutamide ( a cyp2c9 substrate ) by 23 % on day 4 , 28 % on day 8 , and 15 % on day 15 , when a single dose of tolbutamide 500 mg was admini , stered orally prior to the administration of the 3-day regimen of aprepitant and on days 4,8 , and 15 .
None(e1,e2)	3	48	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
None(e1,e2)	2	7	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	4	37	the similarity of the tysabri -associated adverse event profile between study 1 ( without co-administered avonex ) and study 2 ( with co-administered avonex ) indicates that this alteration in clearance does not necessitate reduction of the tysabri dose to maintain safety , general ) .
None(e1,e2)	14	16	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease_inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
None(e1,e2)	0	16	haloperidol : haloperidol blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of amphetamines .
None(e1,e2)	11	17	the effect of foods highly fortified with elemental iron ( primarily iron -fortified breakfast cereals ) on cefdinir absorption has not been studied .
None(e1,e2)	66	145	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	46	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	12	14	oral contraceptives : the effect of oral contraceptives on the pharmacokinetics of d.h.e_._45 ( dihydroergotamine_mesylate ) injection , usp has not been studied .
None(e1,e2)	40	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	15	17	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	0	6	macrolide_antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e . 45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	9	28	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel_blocking_drugs , and isoniazid .
None(e1,e2)	9	29	benzthiazide may interact with alcohol , blood thinners , decongestant_drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	14	28	ketoconazole at 400 mg daily ( the maximum approved prescription dose ) co-administered with tikosyn ( 500 mcg bid ) for 7 days has been shown to increase dofetilide cmax by 53 % in males and 97 % in females , and auc by 41 % in males and 69 % in females .
None(e1,e2)	2	10	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	26	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	2	16	chlorpromazine : chlorpromazine blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of amphetamines , and can be used to treat amphetamine poisoning .
None(e1,e2)	10	19	in addition , studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics or pharmacodynamics of warfarin , or the pharmacokinetics of propranolol ( 40 mg twice daily ) , phenytoin , theophylline , or oral contraceptives .
None(e1,e2)	0	21	calcium_channel_blockers : isolated cases of conduction disturbance ( rarely with hemodynamic compromise ) have been observed when coreg is co-administered with diltiazem .
None(e1,e2)	4	32	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	42	62	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	41	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	9	concurrent use of butorphanol with central_nervous_system_depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central nervous system depressant effects .
None(e1,e2)	22	24	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	21	23	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	105	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	12	caution should be observed when anileridine is coadministered with other opioids , sedatives , phenothiazines , or anesthetics , as these agents may increase respiratory and circulatory depression .
None(e1,e2)	4	9	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv protease inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
None(e1,e2)	18	22	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium_hydroxide s ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	6	16	absorption of tetracyclines is impaired by antacids containing aluminum , calcium , or magnesium , and iron -containing preparations .
None(e1,e2)	0	7	tambocor has been administered to patients receiving digitalis_preparations or beta-adrenergic blocking agents without adverse effects .
None(e1,e2)	14	50	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
effect(e1,e2)	0	11	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
None(e1,e2)	9	29	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
mechanism(e1,e2)	2	10	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
None(e1,e2)	13	27	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	36	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
effect(e1,e2)	0	8	beta_blockers may exacerbate the hypertensive response seen with clonidine withdrawl .
None(e1,e2)	2	62	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	14	34	the following agents may increase certain actions or side effects of anticholinergic drugs . amantadine antiarrhythmic agents of class ( e.g . quinidine ) , antihistamines antipsychotic agents ( e.g . phenothiazines ) , benzodiazepines .
None(e1,e2)	11	23	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	7	9	increased toxicity ( cns depression ) : cns_depressants , mao_inhibitors , tricyclic antidepressants , phenothiazines .
None(e1,e2)	10	18	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
effect(e1,e2)	2	7	patients taking revia may not benefit from opioid containing medicines , such as cough and cold preparations , antidiarrheal preparations , and opioid analgesics .
None(e1,e2)	16	21	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	28	70	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	8	15	because lithium may enhance the serotonergic effects of escitalopram , caution should be exercised when lexapro and lithium are coadministered .
None(e1,e2)	9	31	medications can interfere with folate utilization , including : anticonvulsant_medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	46	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	6	theophylline : as with some other quinolones , concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life .
None(e1,e2)	0	12	methotrexate : caution should be used if diflunisal is administered concomitantly with methotrexate .
effect(e1,e2)	6	9	glyburide : the concomitant administration of ciprofloxacin with the sulfonylurea glyburide has , on rare occasions , resulted in severe hypoglycemia .
None(e1,e2)	6	8	administration of epinephrine to patients receiving cyclopropane or halogenated_hydrocarbon_general_anesthetics such as halothane which sensitize the myocardium , may induce cardiac arrhythmia..
None(e1,e2)	4	19	it is recommended that buspirone_hydrochloride not be used concomitantly with mao inhibitors because the effects of concomitant administration of buspirone_hcl with most other psychotropic drugs have not been studied , the concomitant use of buspirone hcl with other cns-active drugs should be approached with caution .
None(e1,e2)	14	41	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	39	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	21	alcohol : it should be borne in mind that alcohol ingestion may increase the danger inherent in any intentional or unintentional sinequan overdosage .
None(e1,e2)	12	40	concomitant administration of fenofibrate ( equivalent to 145 mg tricor ) with atorvastatin ( 20 mg ) once daily for 10 days resulted in approximately 17 % decrease ( range from 67 % decrease to 44 % increase ) in atorvastatin auc values in 22 healthy males .
None(e1,e2)	75	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	16	phenytoin : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenytoin with or without other enzyme- inducing aeds .
mechanism(e1,e2)	10	21	inhibitors or substrates of cyp2d6 ( i.e. , quinidine , selective_serotonin_reuptake_inhibitors [ ssris ] ) may increase the plasma concentration of doxepin when administered concomitantly .
None(e1,e2)	3	15	antimycobacterial agents : rifampin contraindicated since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of saquinavir .
None(e1,e2)	0	12	ace_inhibitors : reports suggest that nsaids may diminish the antihypertensive effect of angiotensin_converting_enzyme_(_ace_)_inhibitors .
None(e1,e2)	26	34	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	1	5	- carbamazepine ( e.g. , tegretol ) or
None(e1,e2)	19	20	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	3	28	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	24	26	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	1	13	although metoclopramide may increase the bioavailability of levodopa by increasing gastric emptying , metoclopramide may also adversely affect disease control by its dopamine receptor antagonistic properties .
None(e1,e2)	21	50	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	15	ethanol : clinical evidence has shown that etretinate can be formed with concurrent ingestion of acitretin and ethanol .
None(e1,e2)	15	27	in view of the potential risk of dehydration secondary to vomiting and/or diarrhea induced by camptosar , the physician may wish to withhold diuretics during dosing with camptosar and , certainly , during periods of active vomiting or diarrhea .
effect(e1,e2)	3	17	toxicology studies of heroin -related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
effect(e1,e2)	9	25	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	13	17	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	44	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	71	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	23	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type_anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
mechanism(e1,e2)	0	40	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
advise(e1,e2)	3	9	the use of fludara for injection in combination with pentostatin is not recommended due to the risk of severe pulmonary toxicity .
None(e1,e2)	0	11	acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16 % ( 90 % confidence interval : 8-23 % ) , decrease mean c max digoxin by 26 % ( 90 % confidence interval : 16-34 % ) and decrease mean trough concentrations of digoxin by 9 % ( 90 % confidence limit : 19 % decrease to 2 % increase ) .
None(e1,e2)	1	26	oral hypoglycemic_agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	43	45	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	26	37	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	6	8	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	31	42	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	59	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	9	clinical studies of pegasys alone or in combination with copegus did not include sufficient numbers of subjects aged 65 or over to determine whether they respond differently from younger subjects .
None(e1,e2)	21	31	antibiotics : in vitro and/or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	42	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	36	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	32	34	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	19	44	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
advise(e1,e2)	2	14	patients on warfarin-type_anticoagulant therapy may require dosage adjustment of the anticoagulant during and after griseofulvin therapy .
effect(e1,e2)	13	48	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin_sodium .
mechanism(e1,e2)	2	7	midazolam : aprepitant increased the auc of midazolam , a sensitive cyp3a4 substrate , by 2.3-fold on day 1 and 3.3-fold on day 5 , when a single oral dose of midazolam 2 mg was coadministered on day 1 and day 5 of a regimen of aprepitant 125 mg on day 1 and 80 mg/day on days 2 through 5 .
None(e1,e2)	10	44	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	44	52	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	5	16	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	11	15	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic_antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	27	29	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	0	2	barbiturates , carbamazepine , and phenytoin decrease the half-life of doxycycline .
None(e1,e2)	12	23	human pharmacokinetic data indicate that oral ketoconazole markedly inhibits the metabolism of cisapride , resulting in a mean eight-fold increase in auc of cisapride .
None(e1,e2)	13	33	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central_nervous_system_(_cns_)_depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	0	4	nitroglycerin : dynacirc ( isradipine ) has been safely coadministered with nitroglycerin .
None(e1,e2)	36	40	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
None(e1,e2)	10	15	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	23	27	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	0	17	warfarin : in a study in healthy volunteers , no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin ( 0.7 mg/kg body weight ) were administered during 11 days of multipledose treatment with 5 mg b.i.d . isradipine .
None(e1,e2)	7	25	studies in healthy volunteers have shown that acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin , nifedipine , propranolol , or ranitidine .
None(e1,e2)	46	66	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	41	126	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	12	17	caution should be observed when anileridine is coadministered with other opioids , sedatives , phenothiazines , or anesthetics , as these agents may increase respiratory and circulatory depression .
None(e1,e2)	15	24	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type 1c antiarrhythmics propafenone and flecainide ) .
None(e1,e2)	11	13	concomitant administration of mefloquine and other related compounds ( eg , quinine , quinidine and chloroquine ) may produce electrocardiographic abnormalities and increase the risk of convulsions .
None(e1,e2)	19	23	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	3	7	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
None(e1,e2)	43	50	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	17	22	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns_depressants such as anesthetics , opiates , and alcohol .
None(e1,e2)	4	70	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	28	32	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	33	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	32	37	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline_salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	69	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	39	46	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	2	26	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	17	31	the risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric acid derivatives , niacin ( nicotinic acid ) , erythromycin , azole_antifungals .
mechanism(e1,e2)	10	35	in renal and cardiac transplant recipients , a reduction of cyclosporine dose ranging from 15 % to 48 % was necessary to maintain cyclosporine trough concentrations similar to those seen prior to the addition of diltiazem .
None(e1,e2)	0	11	colestipol : plasma concentrations of atorvastatin decreased approximately 25 % when colestipol and atorvastatin were coadministered .
None(e1,e2)	15	17	the effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis drug rifampin .
None(e1,e2)	5	15	use in conjunction with other antiepileptic_drugs : the addition of felbatol to antiepileptic drugs ( aeds ) affects the steady-state plasma concentrations of aeds .
None(e1,e2)	0	5	aspirin /nonsteroidal antiinflammatory drugs ( nsaids )
None(e1,e2)	23	26	both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when alfenta is administered in combination with other cns_depressants such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .
None(e1,e2)	33	51	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	16	23	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	51	55	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	8	26	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	2	20	increasing the indinavir dose to 1000 mg every 8 hours does not compensate for the increased indinavir metabolism due to efavirenz .
None(e1,e2)	0	2	warfarin : eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of ( r ) - or ( s ) -warfarin , nor were there any changes in the pharmacodynamic profile ( prothrombin time ) following a single 25 mg oral dose of warfarin
None(e1,e2)	15	43	a pharmacokinetic study evaluating the administration of a single dose of inspra 100 mg with ketoconazole 200 mg bid , a potent inhibitor of the cyp3a4 pathway , showed a 1.7-fold increase in cmax of eplerenone and a 5.4-fold increase in auc of eplerenone .
None(e1,e2)	21	36	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	35	54	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	48	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	7	isoflurane or enflurane administered with nitrous_oxide / oxygen to achieve 1.25 mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
None(e1,e2)	14	36	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	65	116	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	2	7	erythromycin and clarithromycin ( and possibly other macrolide_antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
None(e1,e2)	33	42	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	50	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	14	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	5	27	clinical trials have indicated that pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral , inhaled and/or parenteral antibiotics , bronchodilators , enzyme supplements , vitamins , oral or inhaled corticosteroids , and analgesics .
None(e1,e2)	48	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	18	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	7	diuretic : hydrochlorothiazide , given concomitantly with ketoprofen , produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone .
None(e1,e2)	27	31	may interact with the following : beta-adrenergic blocking agents ( these medicines may make your condition worse and prevent the adrenergic bronchodilators from working properly ) and disopyramide , quinidine , phenothiazines , and procainamide ( these medicines may increase the risk of heart problems ) .
None(e1,e2)	26	28	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	26	31	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	33	20	drugs that inhibit cyp3a4 cyp3a4 is a minor metabolic pathway for the elimination of zaleplon because the sum of desethyl zaleplon ( formed via cyp3a4 in vitro ) and its metabolites , 5-oxo-desethylzaleplon and 5-oxo-desethylzaleplon glucuronide , account for only 9 % of the urinary recovery of a zaleplon dose .
None(e1,e2)	0	15	h2_blockers /proton pump inhibitors : long-term suppression of gastric acid secretion by h2 blockers or proton_pump_inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
None(e1,e2)	29	52	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic_hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	24	39	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta_adrenergic_blocking_agents .
None(e1,e2)	16	25	other drug interactions : no pharmacokinetic interactions were observed between vardenafil and the following drugs : glyburide , warfarin , digoxin , maalox , and ranitidine .
None(e1,e2)	4	15	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	14	46	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	14	25	however , other published reports describe modest elevations ( less than two-fold ) of clozapine and metabolite concentrations when clozapine was taken with paroxetine , fluoxetine , and sertraline .
None(e1,e2)	4	29	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	9	12	population pharmacokinetic analyses revealed that mtx , nsaids , corticosteroids , and tnf_blocking_agents did not influence abatacept clearance .
None(e1,e2)	11	17	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine -containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	17	22	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
None(e1,e2)	124	153	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	62	70	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
advise(e1,e2)	2	12	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
None(e1,e2)	2	18	although other hormonal_contraceptives are highly effective , there have been reports of pregnancy from women who have used combined_oral_contraceptives , as well as topical/injectable/implantable/insertable hormonal birth control products .
None(e1,e2)	51	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	5	barbiturates , carbamazepine , and phenytoin decrease the half-life of doxycycline .
None(e1,e2)	19	26	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
advise(e1,e2)	15	33	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
None(e1,e2)	23	27	the daily dose of enablex should not exceed 7.5 mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
effect(e1,e2)	6	19	tablets : the benzodiazepines , including lorazepam , produce cns-depressant effects when administered with such medications as barbiturates or alcohol .
None(e1,e2)	12	14	stavudine and zidovudine ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against hiv .
None(e1,e2)	33	43	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic_antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	31	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	14	33	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin_d .
int(e1,e2)	26	28	digitalis : immediate release capsules : since there have been isolated reports of patients with elevated digoxin levels , and there is a possible interaction between digoxin and nifedipine , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over- or under-digitalization .
None(e1,e2)	36	40	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	35	41	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	14	24	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
int(e1,e2)	7	21	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	6	14	other reported interactions with amiodarone : fentanyl ( cyp3a4 substrate ) in combination with amiodarone may cause hypotension , bradycardia , and decreased cardiac output .
None(e1,e2)	35	43	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	2	26	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	2	15	results with warfarin wshow no evidence of interaction with either single or repeated doses of trileptal .
None(e1,e2)	29	49	may interact with addictive medications , especially central nervous system ( cns ) depressants with habituating potential ( prolonged concurrent use may increase the risk of habituation ) , alcohol or cns depression producing medications ( concurrent use may increase the cns depressant effects of either these medications or ethinamate ) .
None(e1,e2)	33	35	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
effect(e1,e2)	8	77	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	1	5	analgesic/ anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	26	38	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing_compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	109	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	13	22	inhibitors of cyp3a4 ( eg , ketoconazole ) or cyp2d6 ( eg , quinidine , fluoxetine , or paroxetine ) can inhibit aripiprazole elimination and cause increased blood levels .
None(e1,e2)	18	31	neuropathy has occurred more frequently in patients with a history of neuropathy or neurotoxic drug therapy , including stavudine , and these patients may be at increased risk of neuropathy during videx therapy ( see adverse reactions ) .
None(e1,e2)	35	69	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	81	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	13	immunosuppressive_drugs , fibric acid derivatives , niacin ( nicotinic acid , erythromycin , azole_antifungals : skeletal muscle .
None(e1,e2)	0	4	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ace inhibitor therapy .
None(e1,e2)	30	43	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium_salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	11	13	these would include a variety of preparations which contain androgens , estrogens , progestins , or glucocorticoids .
effect(e1,e2)	8	25	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	12	40	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
mechanism(e1,e2)	16	22	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium_hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
advise(e1,e2)	3	5	thus , when ibuprofen and lithium are administered concurrently , subjects should be observed carefully for signs of lithium toxicity .
None(e1,e2)	9	16	specific studies have confirmed these effects with sevoflurane , isoflurane , propofol , alfentanil , and midazolam .
mechanism(e1,e2)	5	15	tricyclic antidepressants ( amitriptyline , imipramine , nortriptyline ) : metabolism may be inhibited by combination_hormonal_contraceptives , increasing plasma levels of antidepressant ;
effect(e1,e2)	16	39	epidemiological studies of the case-control and cohort design that have demonstrated an association between use of psychotropic_drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an nsaid or aspirin potentiated the risk of bleeding .
None(e1,e2)	18	20	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
mechanism(e1,e2)	3	21	concurrent use with probenecid or other drugs significantly eliminated by active renal tubular secretion may result in increased plasma concentrations of penciclovir .
None(e1,e2)	38	50	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
effect(e1,e2)	2	10	if a diuretic is also used , the risk of lithium toxicity may be increased .
None(e1,e2)	2	24	chlorpromazine : chlorpromazine blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of amphetamines , and can be used to treat amphetamine poisoning .
None(e1,e2)	56	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	31	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
advise(e1,e2)	4	12	therefore , patients under methotrexate therapy should be carefully monitored when concomitant ciprofloxacin therapy is indicated .
None(e1,e2)	14	32	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	6	15	drug interaction studies have shown that esomeprazole does not have any clinically significant interactions with phenytoin , warfarin , quinidine , clarithromycin or amoxicillin .
advise(e1,e2)	14	16	since acetaminophen in high doses has been associated with hepatotoxicity , concomitant administration of diflunisal and acetaminophen should be used cautiously , with careful monitoring of patients .
None(e1,e2)	3	18	digoxin : when starlix 120 mg before meals was administered in combination with a single 1-mg dose of digoxin to healthy volunteers , there were no clinically relevant changes in the pharmacokinetics of either agent .
None(e1,e2)	12	28	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal_anti-inflammatory_agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	102	116	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	0	16	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
None(e1,e2)	0	20	anticonvulsants : in a pharmacokinetic study , maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy ( eg , phenytoin , carbamazepine , or phenobarbital ) than in healthy volunteers .
None(e1,e2)	8	13	netilmicin should not be administered concomitantly with potent loop_diuretics such as furosemide and ethacrynic_acid as the potential for ototoxicity is enhanced by the combination .
None(e1,e2)	42	66	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	26	33	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	2	10	coadministration of viracept and drugs that induce cyp3a may decrease nelfinavir plasma concentrations and reduce its therapeutic effect .
None(e1,e2)	9	27	- methotrexate ( e.g. , mexate ) use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate
None(e1,e2)	20	33	discontinuing colestipol hydrochloride could pose a hazard to health if a potentially toxic drug that is significantly bound to the resin has been titrated to a maintenance level while the patient was taking colestipol_hydrochloride .
None(e1,e2)	28	44	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	18	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	9	16	oral contraceptives : coadministration of atorvastatin and an oral contraceptive increased auc values for norethindrone and ethinyl_estradiol by approximately 30 % and 20 % .
None(e1,e2)	15	20	the potential for drug interactions with emtriva has been studied in combination with indinavir , stavudine , famciclovir , and tenofovir_disoproxil_fumarate .
None(e1,e2)	59	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	14	furosemide : when aliskiren was co-administered with furosemide , the auc and cmax of furosemide were reduced by about 30 % and 50 % , respectively .
None(e1,e2)	57	73	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	23	furosemide : clinical studies , as well as random observations , have shown that ibuprofen can reduce the natriuretic effect of furosemide and thiazides in some patients .
None(e1,e2)	45	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	17	however , no deleterious interactions were seen when romazicon was administered after narcotics , inhalational anesthetics , muscle_relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia .
None(e1,e2)	9	11	poor metabolizers have higher than expected lasma concentrations of tricyclic_antidepressants ( tcas ) when given usual doses .
None(e1,e2)	57	69	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	5	17	protein binding in vitro , diclofenac interferes minimally or not at all with the protein binding of salicylic_acid ( 20 % decrease in binding ) , tolbutamide , prednisolone ( 10 % decrease in binding ) , or warfarin .
None(e1,e2)	5	10	coadministration of oral contraceptives , diazepam , phenytoin , or quinidine did not seem to change the pharmacokinetic profile of esomeprazole .
None(e1,e2)	7	48	although glucocorticoids have been shown to reduce proleukin -induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
None(e1,e2)	16	46	duloxetine may have a clinically important interaction with the following other drugs : alcohol : when duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide , duloxetine did not increase the impairment of mental and motor skills caused by alcohol .
None(e1,e2)	85	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	26	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	26	32	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	9	13	antihistamines may have additive effects with alcohol and other cns_depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
int(e1,e2)	0	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	32	48	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	3	5	ergot derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine
None(e1,e2)	6	8	drugs with a narrow therapeutic index digoxin : sonata ( 10 mg ) did not affect the pharmacokinetic or pharmacodynamic profile of digoxin ( 0.375 mg q24h for 8 days ) .
None(e1,e2)	11	13	caution should also be applied for other sympathomimetics , and for aminophylline and theophylline and tricyclic antidepressants , which may also precipitate arrhythmias .
None(e1,e2)	53	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	100	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	55	65	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	29	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	24	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	9	13	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	59	69	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	23	27	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium_channel-blocking_drugs , and isoniazid .
None(e1,e2)	12	19	in addition , under the influence of sympatholytic medicinal products such as beta-blockers , clonidine , guanethidine , and reserpine , the signs of hypoglycemia may be reduced or absent .
None(e1,e2)	79	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	12	methotrexate : humira has been studied in rheumatoid arthritis patients taking concomitant mtx .
None(e1,e2)	76	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	29	32	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
effect(e1,e2)	14	36	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	18	46	duloxetine may have a clinically important interaction with the following other drugs : alcohol : when duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide , duloxetine did not increase the impairment of mental and motor skills caused by alcohol .
None(e1,e2)	51	56	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	19	nonetheless , the range of individual simulect clearance values in the presence of azathioprine ( 12-57 ml/h ) or mycophenolate_mofetil ( 7-54 ml/h ) did not extend outside the range observed with dual therapy ( 10-78 ml/h ) .
None(e1,e2)	59	71	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	13	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	0	29	h2_blockers /proton pump inhibitors : long-term suppression of gastric acid secretion by h2 blockers or proton pump inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
None(e1,e2)	1	3	- antihypertensives : bumetanide may potentiate the effect of various antihypertensive drugs , necessitating a reduction in the dosage of these drugs .
None(e1,e2)	71	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	21	in a study involving healthy subjects receiving tambocor and propranolol concurrently , plasma flecainide levels were increased about 20 % and propranolol levels were increased about 30 % compared to control values .
None(e1,e2)	38	56	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing_compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	102	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	11	patients receiving other narcotic_analgesic s , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	0	15	valproic_acid : the mean steady-state trough serum valproic acid concentrations prior to and during concomitant gabapentin administration ( 400 mg tid ;
None(e1,e2)	29	36	hiv protease inhibitors : indinavir ( 800 mg t.i.d . ) co-administered with vardenafil 10 mg resulted in a 16-fold increase in vardenafil auc , a 7-fold increase in vardenafil cmax and a 2-fold increase in vardenafil half-life .
None(e1,e2)	16	18	toxicology studies of heroin-related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
None(e1,e2)	0	4	albuterol , antihistamines , antidiabetic_drugs , diuretics , digitalis .
None(e1,e2)	59	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
effect(e1,e2)	14	22	other cns depressant drugs ( e.g . barbiturates , tranquilizers , opioids and general anesthetics ) have additive or potentiating effects with inapsine .
effect(e1,e2)	2	9	furosemide : toradol iv/im reduced the diuretic response to furosemide in normovolemic healthy subjects by approximately 20 % ( mean sodium and urinary output decreased 17 % ) .
mechanism(e1,e2)	10	16	protease inhibitors : in vitro data indicate that indinavir and ritonavir markedly inhibit the metabolism of cisapride which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	9	24	phase ii clinical trial data , where iressa and vinorelbine have been used concomitantly , indicate that iressa may exacerbate the neutropenic effect of vinorelbine .
None(e1,e2)	0	5	selegiline - l-phenylalanine and the selective_mao_inhibitor selegiline may have synergistic antidepressant activity if used concomitantly .
mechanism(e1,e2)	5	7	pre-treatment with the cyp3a4 inducer rifampicin decreased erlotinib auc by about 2/3 .
None(e1,e2)	10	14	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease_inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
None(e1,e2)	28	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	5	25	clinical trials have indicated that pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral , inhaled and/or parenteral antibiotics , bronchodilators , enzyme supplements , vitamins , oral or inhaled corticosteroids , and analgesics .
None(e1,e2)	131	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	30	in another drug interaction study , co-administration of orally inhaled ciclesonide and oral ketoconazole , a potent inhibitor of cytochrome p450 3a4 , increased the exposure ( auc ) of des-ciclesonide by approximately 3.6-fold at steady state , while levels of ciclesonide remained unchanged .
None(e1,e2)	44	116	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	5	warfarin : the effect of celecoxib on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2-5 mg of warfarin .
None(e1,e2)	48	54	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	2	14	cimetidine : atorvastatin plasma concentrations and ldl-c reduction were not altered by coadministration of cimetidine .
None(e1,e2)	8	12	similarly , patients receiving the drug and a hydantoin , sulfonamide or sulfonylurea should be observed for signs of toxicity to these drugs .
None(e1,e2)	3	14	hypotension patients on diuretic therapy : patients on diuretics and especially those in whom diuretic therapy was recently instituted , as well as those on severe dietary salt restriction or dialysis , may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril .
None(e1,e2)	16	31	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin_sodium was used concomitantly with angiotensin- converting enzyme ( ace ) inhibitors , betablockers , calcium-channel_blockers , diuretics , and nonsteroidal anti-inflammatory drugs ( nsaids ) without evidence of clinically significant adverse interactions .
None(e1,e2)	7	13	co-administration : concomitant use of argatroban with antiplatelet_agents , thrombolytics , and other anticoagulants may increase the risk of bleeding .
None(e1,e2)	25	28	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin_b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	20	31	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic_antidepressants or some antihistamines .
advise(e1,e2)	25	27	although a causal mechanism and a cause-and-effect relationship have not been established , current evidence suggests that renal function should be monitored in patients on thiazide_diuretics and allopurinol even in the absence of renal failure , and dosage levels should be even more conservatively adjusted in those patients on such combined therapy if diminished renal function is detected..
None(e1,e2)	11	35	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	2	6	antacids and kaolin : antacids and kaolin can reduce absorption of chloroquine ;
None(e1,e2)	7	23	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	12	27	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium_channel_antagonists , angiotensin converting enzyme inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	16	50	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	16	30	aspirin/acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
None(e1,e2)	98	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	81	114	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	13	45	the principal drugs given ( number of patients in parentheses ) were : cardiac_glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	38	40	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	18	33	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	0	4	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	2	9	- oral contraceptives ( birth control pills ) containing estrogen or
None(e1,e2)	22	33	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	14	20	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	52	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	22	concomitant single dose administration of valdecoxib 20 mg with multiple doses of ketoconazole and fluconazole produced a significant increase in exposure of valdecoxib .
None(e1,e2)	33	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	5	aspirin : as with other nsaids , concomitant administration of ponstel and aspirin is not generally recommended because of the potential of increased adverse effects .
None(e1,e2)	2	10	antiarrhythmics : amiodarone , bepridil , flecainide , propafenone , quinidine contraindicated due to potential for serious and/or life-threatening reactions .
advise(e1,e2)	10	12	should it be decided to discontinue therapy in patients receiving beta-blockers and clonidine concurrently , the beta-blocker should be discontinued slowly over several days before the gradual withdrawal of clonidine .
None(e1,e2)	28	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	2	pyrazolone_derivatives ( phenylbutazone , oxyphenbutazone , and possibly dipyrone ) : concomitant administration with aspirin may increase the risk of gastrointestinal ulceration .
None(e1,e2)	5	15	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid-associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	0	29	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	2	26	ephedrine : ephedrine may enhance the metabolic clearance of corticosteroids , resulting in decreased blood levels and lessened physiologic activity , thus requiring an increase in corticosteroid dosage .
None(e1,e2)	3	14	cholestyramine and colestipol resins : absorption of hydrochlorothiazide is impaired in the presence of anionic_exchange_resins .
None(e1,e2)	21	50	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	69	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	18	antidepressants ( tricyclic ) , atropine or other anticholinergic agents , or digitalis glycosides : concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects .
None(e1,e2)	6	28	since amiodarone is a substrate for cyp3a4 , there is the potential that the use of st. john s wort in patients receiving amiodarone could result in reduced amiodarone levels .
None(e1,e2)	21	32	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	47	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	93	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	28	because of the potential for arava levels to continue to increase with multiple dosing , caution should be used if patients are to be receiving both arava and rifampin .
effect(e1,e2)	4	15	when other potent parental antihypertensive_drugs , such as diazoxide , are used in combination with hydralazine , patients should be continuously observed for several hours for any excessive fall in blood pressure .
advise(e1,e2)	5	22	brovana , as with other beta2-agonists , should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors , tricyclic_antidepressants , or drugs known to prolong the qtc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	3	16	metformin : when starlix 120 mg three times daily before meals was administered in combination with metformin 500 mg three times daily to patients with type 2 diabetes , there were no clinically relevant changes in the pharmacokinetics of either agent .
None(e1,e2)	57	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	2	propantheline and diphenoxylate , by decreasing gut motility , may increase digoxin absorption .
None(e1,e2)	12	21	antihypertensives : amiodarone should be used with caution in patients receiving - receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	68	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	38	42	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	14	16	consequently , it is recommended that fluvoxamine not be used in combination with either terbinafine , astemizole , or cisapride .
mechanism(e1,e2)	18	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	15	because nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of nalfon , the concomitant use of nalfon and salicylates is not recommended .
None(e1,e2)	21	25	coadministration of valdecoxib ( 40 mg bid ( day 1 ) and 40 mg qd ( days 2-7 ) ) with glyburide ( 10 mg glyburide bid ) resulted in 21 % increase in glyburide auc0-12 and a 16 % increase in glyburide cmax leading to a 16 % decrease in glucose auc0-24 .
mechanism(e1,e2)	3	11	drugs such as troleandomycin and ketoconazole may inhibit the metabolism of corticosteroids and thus decrease their clearance .
None(e1,e2)	0	9	probenecid or cimetidine : concomitant administration of probenecid or cimetidine decreases the elimination of zalcitabine , most likely by inhibition of renal tubular secretion of zalcitabine .
None(e1,e2)	0	13	methotrexate renal tubular transport of methotrexate may be inhibited by concomitant administration of ciprofloxacin , potentially leading to increased plasma levels of methotrexate .
None(e1,e2)	30	32	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	52	56	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2_antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
effect(e1,e2)	5	9	hyperpyrexia has been reported when amitriptyline_hcl is administered with anticholinergic agents or with neuroleptic drugs , particularly during hot weather .
None(e1,e2)	36	44	although glucocorticoids have been shown to reduce proleukin-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
None(e1,e2)	0	4	catecholamine-depleting_drugs , such as reserpine , may have an additive effect when given with beta-blocking agents .
None(e1,e2)	18	31	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	1	3	- alcohol , barbiturates , or narcotics : potentiation of otthostatic hypotension may occur
None(e1,e2)	20	59	agents with increased levels in the presence of carbamazepine : equetrotm increases the plasma levels of the following agents : clomipramine_hcl , phenytoin ( 6 ) , and primidone thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with equetrotm , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .
None(e1,e2)	39	55	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	5	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	8	11	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	71	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	26	36	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	0	2	amiodarone inhibits cyp2d6 .
None(e1,e2)	22	31	although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic antiretroviral agents , including protease inhibitors , macrolide_antibiotics , and azole antifungals , the effect of panretin gel on the steady-state concentrations of these drugs is not known .
None(e1,e2)	11	33	concomitant administration of fenofibrate ( equivalent to 145mg tricor ) with pravastatin ( 40 mg ) once daily for 10 days has been shown to increase the mean cmax and auc values for pravastatin by 36 % ( range from 69 % decrease to 321 % increase ) and 28 % ( range from 54 % decrease to 128 % increase ) , respectively , and for 3 -hydroxy-iso-pravastatin by 55 % ( range from 32 % decrease to 314 % increase ) and 39 % ( range from 24 % decrease to 261 % increase ) , respectively in 23 healthy adults .
None(e1,e2)	9	11	in rheumatoid arthritis , concomitant medications besides mtx were nonsteroidal_anti-inflammatory_agents , folic_acid , corticosteroids and/or narcotics .
mechanism(e1,e2)	2	41	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
advise(e1,e2)	2	11	subutex and suboxone should be prescribed with caution to patients on benzodiazepines or other drugs that act on the central nervous system , regardless of whether these drugs are taken on the advice of a physician or are taken as drugs of abuse .
None(e1,e2)	0	10	clofibric_acid : combination hormonal contraceptives may increase the clearance of clofibric_acid .
None(e1,e2)	1	25	plasma tca concentrations may need to be monitored and the dose of the tca may need to be reduced if a tca is co-administered with duloxetine .
None(e1,e2)	8	20	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	12	14	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	38	42	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	76	102	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	11	13	combinations of these drugs have not been studied and coadministration of crixivan and atazanavir is not recommended .
effect(e1,e2)	9	39	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
None(e1,e2)	8	16	no drug interaction studies have been conducted for colazal , however the use of orally administered antibiotics could , theoretically , interfere with the release of mesalamine in the colon .
None(e1,e2)	6	8	further , in clinical studies with proscar ( finasteride , 5 mg ) when used in older men who have benign prostatic hyperplasia ( bph ) , psa levels are decreased by approximately 50 % .
None(e1,e2)	126	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	16	metformin : in healthy subjects given single 500 mg doses of cephalexin and metformin , plasma metformin mean cmax and auc increased by an average of 34 % and 24 % , respectively , and metformin mean renal clearance decreased by 14 % .
advise(e1,e2)	20	39	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
mechanism(e1,e2)	16	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	24	54	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	14	22	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	36	43	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	26	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	25	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	19	35	in addition , studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics or pharmacodynamics of warfarin , or the pharmacokinetics of propranolol ( 40 mg twice daily ) , phenytoin , theophylline , or oral contraceptives .
None(e1,e2)	47	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	49	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	28	40	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	3	5	however , neither phenobarbital nor diazepam appears to affect dantrium metabolism .
None(e1,e2)	4	13	these data indicate that levetiracetam does not influence the plasma concentration of other aeds and that these aeds do not influence the pharmacokinetics of levetiracetam .
None(e1,e2)	11	19	other cyp3a4 inducers include , but are not limited to , rifabutin , rifapentine , phenytoin , carbamazepine , phenobarbital and st. johns wort .
effect(e1,e2)	31	33	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	2	6	antiarrhythmics : amiodarone , bepridil , flecainide , propafenone , quinidine contraindicated due to potential for serious and/or life-threatening reactions .
None(e1,e2)	25	54	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	30	37	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	2	18	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	13	15	concomitant administration of mefloquine and other related compounds ( eg , quinine , quinidine and chloroquine ) may produce electrocardiographic abnormalities and increase the risk of convulsions .
None(e1,e2)	41	51	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	41	48	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin_analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	21	27	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	0	10	antibiotics ( e.g. , erythromycin , trimethoprim and sulfamethoxazole , amoxicillin ) .
None(e1,e2)	7	19	the pharmacokinetics of a 1-mg dose of butorphanol administered as stadol ns were not affected by the coadministration of cimetidine ( 300 mg qid ) .
None(e1,e2)	87	126	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	10	23	agents with increased levels in the presence of carbamazepine : equetrotm increases the plasma levels of the following agents : clomipramine hcl , phenytoin ( 6 ) , and primidone thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with equetrotm , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .
None(e1,e2)	1	18	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
None(e1,e2)	0	11	anticholinesterases ( neostgmine , physostigmine ) , lignocaine , quinine , procainamide can enhance toxicity and cause cardio respiratory depression .
None(e1,e2)	4	18	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
mechanism(e1,e2)	32	64	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	93	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	10	12	there was no effect on the 3 major metabolites ( 5-dfur , 5-fu and fbal ) .
None(e1,e2)	2	8	monitoring of cyclosporine levels and possible adjustment of cyclosporine dosage should be considered when these drugs are co-administered .
None(e1,e2)	0	10	azopt ( brinzolamide ophthalmic suspension ) 1 % contains a carbonic_anhydrase_inhibitor .
None(e1,e2)	0	5	non-selective_mao_inhibitors including tranylcypromine sulfate , phenelzine_sulfate , and pargyline hc1 : concomitant use of l-tyrosine and non-selective mao inhibitors may cause hypertension .
None(e1,e2)	24	26	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	28	37	the following drug interactions have been identified involving nizoral tablets and other drugs metabolized by the cytochrome p450 3a4 enzyme system : ketoconazole tablets inhibit the metabolism of terfenadine , resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite .
None(e1,e2)	59	102	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	12	18	pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine , antipyrine , ketoconazole , erythromycin and azithromycin .
None(e1,e2)	66	109	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	35	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	73	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	4	30	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	19	23	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	40	50	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot_derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	4	6	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	12	18	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
None(e1,e2)	4	28	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel-blocking_drugs , and isoniazid .
None(e1,e2)	3	15	the auc of ciprofloxacin was decreased an average of 15-fold in 12 healthy subjects given ciprofloxacin and didanosine-placebo tablets concurrently .
None(e1,e2)	4	23	experience with co-administration of hmg-coa_reductase_inhibitors and fentanyl in patients is limited , therefore , consideration should be given to temporarily suspending use of hmg-coa_reductase_inhibitors in patients receiving fentanyl .
None(e1,e2)	0	14	flurbiprofen pretreatment attenuated the hypotensive effect of a single dose of propranolol but not atenolol .
None(e1,e2)	57	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	20	although this interaction has not been reported with cinoxacin , caution should be exercised when cinoxacin is given concomitantly with caffeine -containing products .
None(e1,e2)	39	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	17	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	85	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	11	13	amphotericin b or potassium-depleting diuretics ( benzothiadiazines and related drugs , ethacrynic_acid and furosemide ) enhanced hypokalemia .
None(e1,e2)	13	15	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	65	92	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	10	analgesic/anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	13	55	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex_sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
effect(e1,e2)	9	17	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central_nervous_system_depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
effect(e1,e2)	39	50	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	28	55	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	98	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	2	probenecid : probenecid slows the renal elimination of lome-floxacin .
None(e1,e2)	0	7	inomax has been administered with tolazoline , dopamine , dobutamine , steroids , surfactant , and high-frequency ventilation .
None(e1,e2)	5	12	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	0	9	non-selective_mao_inhibitors including tranylcypromine sulfate , phenelzine sulfate , and pargyline hc1 : concomitant use of l-tyrosine and non-selective mao inhibitors may cause hypertension .
None(e1,e2)	0	6	fluconazole and ketoconazole : ketoconazole and fluconazole are predominantly cyp 3a4 and 2c9 inhibitors , respectively .
mechanism(e1,e2)	9	11	acetaminophen : in normal volunteers , concomitant administration of diflunisal and acetaminophen resulted in an approximate 50 % increase in plasma levels of acetaminophen .
None(e1,e2)	39	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	15	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	4	43	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	40	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	16	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	43	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	33	caffeine : two hundred mg of caffeine ( equivalent to 1 to 3 cups of american coffee ) was administered to 16 normal , healthy volunteers who had achieved steady-state blood concentrations of lomefloxacin after being dosed at 400 mg qd .
None(e1,e2)	20	36	in a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline ( an anticholinergic_agent with multiple effects on the gi tract ) to healthy volunteers , the auc of clonazepam was 10 % lower and the cmax of clonazepam was 20 % lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .
effect(e1,e2)	4	6	concurrent administration of a tnf_antagonist with orencia has been associated with an increased risk of serious infections and no significant additional efficacy over use of the tnf antagonists alone .
None(e1,e2)	6	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	17	37	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	10	16	carbamazepine : isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels carbamazepine levels should be determined prior to concurrent administration with isoniazid , signs and symptoms of carbamazepine toxicity should be monitored closely , and appropriate dosage adjustment of the anticonvulsant should be made .
mechanism(e1,e2)	2	11	antacids containing aluminum_hydroxide and magnesium hydroxide reduce the oral absorption of enoxacin by 75 % .
None(e1,e2)	16	36	insulin : a clinical study in 6 insulin-dependent diabetic patients demonstrated no effect of extraneal on insulin absorption from the peritoneal cavity or on insulins ability to control blood glucose when insulin was administered intraperitoneally with extraneal .
None(e1,e2)	6	8	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
effect(e1,e2)	21	39	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan_kerastick for topical solution .
None(e1,e2)	1	5	if antacids are required during omnicef therapy , omnicef should be taken at least 2 hours before or after the antacid .
None(e1,e2)	10	13	antiarrhythmic agents , class i ( such as flecainide , lidocaine , or quinidine ) : concurrent use with arbutamine may have a proarrhythmic effect .
mechanism(e1,e2)	0	8	phenytoin , nicotine , and rifampin may decrease clozapine plasma levels , resulting in a decrease in effectiveness of a previously effective clozapine dose .
int(e1,e2)	9	25	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
None(e1,e2)	7	45	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	97	103	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	27	55	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic_acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2_antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	22	29	in a controlled clinical trial , a 20 % reduction of the phenytoin dose at the initiation of felbatol therapy resulted in phenytoin levels comparable to those prior to felbatol administration .
None(e1,e2)	1	21	when amiodarone is added to flecainide therapy , plasma flecainide levels may increase two-fold or more in some patients , if flecainide dosage is not reduced .
None(e1,e2)	26	30	the following agents may increase certain actions or side effects of anticholinergic drugs . amantadine antiarrhythmic agents of class ( e.g . quinidine ) , antihistamines antipsychotic_agents ( e.g . phenothiazines ) , benzodiazepines .
None(e1,e2)	3	14	and disulfiram when amitriptyline_hcl is given with anticholinergic agents or sympathomimetic drugs , including epinephrine combined with local anesthetics , close supervision and careful adjustment of dosages are required .
None(e1,e2)	15	27	inhibitors of cyp2d6 : because cyp2d6 is involved in duloxetine metabolism , concomitant use of duloxetine with potent inhibitors of cyp2d6 may result in higher concentrations of duloxetine .
mechanism(e1,e2)	11	25	acidifying agents : gastrointestinal acidifying agents ( guanethidine , reserpine , glutamic_acid_hcl , ascorbic acid , fruit juices , etc . ) lower absorption of amphetamines .
None(e1,e2)	24	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	18	21	potential interactions between taxol , a substrate of cyp3a4 , and protease inhibitors ( ritonavir , saquinavir , indinavir , and nelfinavir ) , which are substrates and/or inhibitors of cyp3a4 , have not been evaluated in clinical trials .
None(e1,e2)	18	30	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	15	65	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood_thinner s ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	5	7	the absorption of tetracycline , furosemide , penicillin_g , hydrochlorothiazide , and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride ;
None(e1,e2)	6	20	data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following : sertraline and paroxetine .
None(e1,e2)	63	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	32	theophylline : following co-administration of two 250-mg dirithromycin tablets administered once daily with 200-mg theophylline tablets administered twice daily for 10 days to 14 healthy subjects , the steady-state plasma concentration of theophylline was not significantly altered .
effect(e1,e2)	7	15	however , it has been established that acitretin interferes with the contraceptive effect of microdosed progestin minipill preparations .
None(e1,e2)	17	19	- perhexiline hydrogen maleate or mao-inhibitors ( with hepatotoxic potential ) must not be administered together with bezalip or bezalip_retard .
None(e1,e2)	87	117	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	0	14	auranofin should be avoided by patients with a history of serious reaction to any gold_medication , including solganal and myochrysine .
None(e1,e2)	4	14	pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine , antipyrine , ketoconazole , erythromycin and azithromycin .
None(e1,e2)	3	15	while all the selective_serotonin_reuptake_inhibitors ( ssris ) , e.g. , fluoxetine , seriraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	30	32	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	34	38	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	23	91	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	16	in vitro , buspirone does not displace tightly bound drugs like phenytoin , propranolol , and warfarin from serum proteins .
None(e1,e2)	10	23	although these results do not indicate a significant interaction between toradol and warfarin or heparin , the administration of toradol to patients taking anticoagulants should be done extremely cautiously , and patients should be closely monitored .
None(e1,e2)	14	30	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	18	20	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
mechanism(e1,e2)	6	21	plasma exposure ( auc ) to valdecoxib was increased 62 % when coadministered with fluconazole and 38 % when coadministered with ketoconazole .
None(e1,e2)	3	33	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic_acid has been reported to both increase and decrease ethosuximide levels ) .
None(e1,e2)	0	46	praziquantel : in the fed state , praziquantel ( 40 mg/kg ) increased mean maximum plasma concentration and area under the curve of albendazole sulfoxide by about 50 % in healthy subjects ( n=10 ) compared with a separate group of subjects ( n=6 ) given albendazole alone .
None(e1,e2)	24	34	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide_antibiotics .
None(e1,e2)	39	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	46	50	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth_subsalicylate ( pepto-bismol ) ;
None(e1,e2)	0	12	nonsteroidal_antiinflammatory agents : aspirin is contraindicated in patients who are hypersensitive to nonsteroidal_anti-inflammatory agents .
None(e1,e2)	15	24	because there is a theoretical basis that these effects may be additive , use of ergotamine -containing or ergot-type medications ( like dihydroergotamine or methysergide ) and naratriptan within 24 hours is contraindicated .
None(e1,e2)	13	19	the gonadotropin levels may be transiently elevated by spironolactone , minimally elevated by levodopa , and suppressed by oral contraceptives and digoxin .
None(e1,e2)	61	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	9	concomitant use with other calcium -containing medicines ( including antacids ) may cause too much calcium in the blood or urine , which may increase the chance of side effects .
effect(e1,e2)	0	21	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta_blockers .
None(e1,e2)	6	18	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
mechanism(e1,e2)	7	18	urinary alkalinizing agents ( acetazolamide , some thiazides ) increase the concentration of the non-ionized species of the amphetamine molecule , thereby decreasing urinary excretion .
None(e1,e2)	14	27	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	21	33	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central_nervous_system_(_cns_)_depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	30	38	isoflurane or enflurane administered with nitrous oxide/oxygen to achieve 1.25 mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
None(e1,e2)	2	18	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	29	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	22	antimycobacterial agents : rifampin contraindicated since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of saquinavir .
None(e1,e2)	7	9	pharmacokinetic interactions between nisoldipine and beta-blockers ( atenolol , propranolol ) were variable and not significant .
None(e1,e2)	20	30	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	10	38	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
effect(e1,e2)	5	49	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	2	14	probenecid or cimetidine : concomitant administration of probenecid or cimetidine decreases the elimination of zalcitabine , most likely by inhibition of renal tubular secretion of zalcitabine .
None(e1,e2)	15	20	because both of these drugs have negative inotropic properties and the effects of coadministration with tambocor are unknown , neither disopyramide nor verapamil should be administered concurrently with tambocor unless , in the judgment of the physician , the benefits of this combination outweigh the risks .
None(e1,e2)	42	58	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	67	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	5	the conversion of 6-deoxy_penciclovir to penciclovir is catalyzed by aldehyde oxidase .
None(e1,e2)	33	63	however , there are limited in vivo data suggesting a modest cyp2d6 inhibitory effect for escitalopram , i.e. , coadministration of escitalopram ( 20 mg/day for 21 days ) with the tricyclic antidepressant desipramine ( single dose of 50 mg ) , a substrate for cyp2d6 , resulted in a 40 % increase in cmax and a 100 % increase in auc of desipramine .
None(e1,e2)	13	18	in vitro studies indicate cyp3a4 isoform and cyp1a2 isoform mediate the metabolism of levobupivacaine to desbutyl levobupivacaine and 3-hydroxy_levobupivacaine , respectively .
None(e1,e2)	0	6	adrenergic_blockers adrenergic blockers are inhibited by amphetamines .
None(e1,e2)	83	102	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	34	43	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	22	41	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	19	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	15	18	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	11	41	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	49	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	11	inomax has been administered with tolazoline , dopamine , dobutamine , steroids , surfactant , and high-frequency ventilation .
None(e1,e2)	35	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	14	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
mechanism(e1,e2)	15	19	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	3	5	the use of mao_inhibitors or tricyclic_antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone .
None(e1,e2)	6	8	no significant interactions were found between nisoldipine and warfarin or digoxin .
None(e1,e2)	2	17	the effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide , ketoconazole , methotrexate , phenytoin , tolbutamide , and warfarin have been studied in vivo and clinically important interactions have not been found .
None(e1,e2)	17	20	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
None(e1,e2)	34	36	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
None(e1,e2)	17	68	although there was no effect of aprepitant on the plasma auc of r ( + ) or s_(_-_)_warfarin determined on day 3 , there was a 34 % decrease in s ( - ) warfarin ( a cyp2c9 substrate ) trough concentration accompanied by a 14 % decrease in the prothrombin time ( reported as international normalized ratio or inr ) 5 days after completion of dosing with aprepitant .
None(e1,e2)	21	27	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	1	31	aspirin/ acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
effect(e1,e2)	8	21	psychoactive drugs : hallucinations have been reported when toradol was used in patients taking psychoactive drugs ( fluoxetine , thiothixene , alprazolam ) .
None(e1,e2)	77	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	83	112	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	33	45	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
int(e1,e2)	0	44	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	9	12	this information should be considered when changing from intravenous amiodarone to oral amiodarone .
None(e1,e2)	34	49	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	25	31	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	13	26	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	0	17	warfarin - administration of 40 mg/day racemic citalopram for 21 days did not affect the pharmacokinetics of warfarin , a cyp3a4 substrate .
None(e1,e2)	7	10	rifampin : rifampin increases the metabolism of ethinyl_estradiol and some progestins ( norethindrone ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
None(e1,e2)	1	14	analgesic/ anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	11	40	drug interactions : flupenthixol may interact with some drugs , like monoamine_oxidase_inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
mechanism(e1,e2)	28	64	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	8	20	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot_derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	28	42	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	21	54	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	5	7	uricosuric drugs , such as probenecid and sulfinpyrazone , can inhibit renal tubular secretion of nitrofurantoin .
None(e1,e2)	78	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	63	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	22	phenytoin , nicotine , and rifampin may decrease clozapine plasma levels , resulting in a decrease in effectiveness of a previously effective clozapine dose .
None(e1,e2)	6	10	the patient was also chronically receiving phenytoin , phenobarbital , digoxin , and levothyroxine sodium .
None(e1,e2)	0	10	terfenadine : in a prospective study involving six-healthy-male volunteers , dirithromycin did not affect the metabolism of terfenadine .
None(e1,e2)	49	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	51	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	27	35	therefore , it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( e.g . ketoconazole , ampicillin esters , iron salts , digoxin ) .
None(e1,e2)	8	31	experience with co-administration of hmg-coa reductase inhibitors and fentanyl in patients is limited , therefore , consideration should be given to temporarily suspending use of hmg-coa reductase inhibitors in patients receiving fentanyl .
None(e1,e2)	8	10	specific effects of felbatol on other antiepileptic drugs phenytoin : felbatol causes an increase in steady-state phenytoin plasma concentrations .
None(e1,e2)	4	22	ketoconazole : co-administration of bosentan 125 mg b.i.d . and ketoconazole , a potent cyp3a4 inhibitor , increased the plasma concentrations of bosentan by approximately 2-fold .
None(e1,e2)	4	21	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
mechanism(e1,e2)	0	2	phenothiazine-related_compounds and beta-adrenergic_blocking_agents may have additive hypotensite effects due to the inhibition of each other s metabolism .
None(e1,e2)	8	23	the concurrent use of robinul injection with other anticholinergics or medications with anticholinergic activity , such as phenothiazines , antiparkinson drugs , or tricyclic_antidepressants , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
mechanism(e1,e2)	6	27	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	7	17	phase ii clinical trial data , where iressa and vinorelbine have been used concomitantly , indicate that iressa may exacerbate the neutropenic effect of vinorelbine .
None(e1,e2)	20	33	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	9	26	until further data are developed regarding drug interactions when azithromycin and these drugs are used concomitantly , careful monitoring of patients is advised : digoxin elevated digoxin concentrations .
None(e1,e2)	42	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	33	43	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide_dinitrate , morphine , atropine , heparin , protamine , potassium_chloride , folic acid , and acetaminophen .
mechanism(e1,e2)	13	19	steroids enhance the renal toxicity of edetate calcium disodium in animals . 7 edetate_calcium_disodium interferes with the action of zinc_insulin preparations by chelating the zinc . 7
None(e1,e2)	59	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	26	32	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	26	42	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	38	66	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	28	may interact anticoagulants ( altered hypo-prothrombinemic effect ) , barbiturates , rifampin and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of diethylstilbestrol ) , corticosteroids ( increased effect of corticosteroids ) .
None(e1,e2)	10	17	other : there appears to be no pharmacokinetic interaction between acitretin and cimetidine , digoxin , or glyburide .
None(e1,e2)	6	22	administration of diltiazem hydrochloride concomitantly with propranolol in five normal volunteers resulted in increased propranolol levels in all subjects and bioavailability of propranolol was increased approximately 50 % .
None(e1,e2)	6	13	patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other cns_depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
mechanism(e1,e2)	2	25	treatment with pegasys once weekly for 4 weeks in healthy subjects was associated with an inhibition of p450 1a2 and a 25 % increase in theophylline auc .
None(e1,e2)	57	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	5	sedative /hypnotics : midazolam , triazolam
None(e1,e2)	48	51	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel_blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	76	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	85	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	11	example inhibitors include azole_antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	18	27	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic_products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
mechanism(e1,e2)	13	40	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot_alkaloid_class , of which d.h.e . 45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide_class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	12	20	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic_analgesic s , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
mechanism(e1,e2)	2	13	co-administration with efavirenz or fluconazole had a modest effect on the pharmacokinetics of azithromycin .
None(e1,e2)	0	2	cimetidine , ranitidine : in normal volunteers ( n=9 ) , pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small ( 13 % ) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine .
None(e1,e2)	0	30	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	4	19	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	6	13	no dose adjustment is necessary when simulect is added to triple-immunosuppression regimens including cyclosporine , corticosteroids , and either azathioprine or mycophenolate mofetil .
None(e1,e2)	7	11	the combination of therapeutic doses of intravenous dantrolene_sodium and verapamil in halothane a-chloralose anesthetized swine has resulted in ventricular fibrillation and cardiovascular collapse in association with marked hyperkalemia .
None(e1,e2)	34	49	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting_enzyme_(_ace_)_inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
effect(e1,e2)	0	7	beta-adrenergic_blocking_drugs add some further antihypertensive effect to captopril , but the overall response is less than additive .
None(e1,e2)	92	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	18	24	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide_mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	20	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	32	36	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	35	41	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	33	43	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	30	46	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	0	13	rifampin : rifampin increases the metabolism of ethinyl estradiol and some progestins ( norethindrone ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
None(e1,e2)	11	16	therefore , when meclofenamate sodium is given to a patient receiving warfarin , the dosage of warfarin should be reduced to prevent excessive prolongation of the prothrombin time .
None(e1,e2)	17	43	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	41	63	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	26	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	10	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	14	21	animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl_alcohol , increases the inhibitory effects of chlorpromazine , but does not exhibit monoamine oxidase inhibition .
None(e1,e2)	11	35	results of studies in multiple sclerosis patients taking tysabri and concomitant interferon_beta-1a ( avonex 30 mcg im once weekly ) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate .
effect(e1,e2)	3	10	naproxen and other nsaids can reduce the antihypertensive effect of propranolol and other beta-blockers .
None(e1,e2)	16	19	oral anticoagulants : in some normal volunteers , the concomitant administration of diflunisal and warfarin , acenocoumarol , or phenprocoumon resulted in prolongation of prothrombin time .
None(e1,e2)	2	18	- a diuretic ( water pill ) such as hydrochlorothiazide ( hctz , hydrodiuril ) , chlorothiazide ( diuril ) , and others ;
None(e1,e2)	39	41	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic_antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	9	40	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	69	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	0	11	corticosteroids may also potentiate the replication of some organisms contained in live_attenuated_vaccines .
None(e1,e2)	12	18	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
effect(e1,e2)	10	18	concomitant use of prostaglandin synthase inhibiting drugs , eg , indomethacin , may decrease the hypotensive effects of beta_blockers .
None(e1,e2)	6	10	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	2	11	antipyrine : antipyrine pharmacokinetics were not significantly different before and after tiagabine multiple-dose regimens .
None(e1,e2)	35	56	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	30	51	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	8	25	however , since aspirin , nsaids , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or nsaids with ibandronate .
None(e1,e2)	5	10	concomitant administration of naproxen and aspirin is not recommended because naproxen is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations and peak plasma levels .
None(e1,e2)	12	21	table 1 effects on plasma concentrations ( auc 0-24 hrs ) of loratadine and descarboethoxyloratadine after 10 days of coadministration ( loratadine 10 mg ) in normal volunteers
advise(e1,e2)	0	31	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
advise(e1,e2)	8	28	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	105	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	78	113	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	2	9	carbamazepine : felbatol causes a decrease in the steady-state carbamazepine plasma concentrations and an increase in the steady-state carbamazepine epoxide plasma concentration .
None(e1,e2)	3	15	heparin : since heparin is contraindicated in patients with heparin-induced thrombocytopenia , the co-administration of argatroban and heparin is unlikely for this indication .
None(e1,e2)	31	36	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	7	20	these agents include medications such as : anticoagulants , platelet inhibitors including acetylsalicylic acid , sali-cylates , nsaids ( including ketorolac_tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	19	25	although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic antiretroviral agents , including protease_inhibitors , macrolide antibiotics , and azole_antifungals , the effect of panretin gel on the steady-state concentrations of these drugs is not known .
None(e1,e2)	0	24	chlorpromazine : chlorpromazine blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of amphetamines , and can be used to treat amphetamine poisoning .
None(e1,e2)	26	43	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	28	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	12	trough plasma enoxacin levels were also 20 % higher when caffeine and enoxacin were administered concomitantly .
None(e1,e2)	15	25	although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic antiretroviral_agents , including protease inhibitors , macrolide antibiotics , and azole_antifungals , the effect of panretin gel on the steady-state concentrations of these drugs is not known .
None(e1,e2)	19	33	in addition , studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics or pharmacodynamics of warfarin , or the pharmacokinetics of propranolol ( 40 mg twice daily ) , phenytoin , theophylline , or oral contraceptives .
None(e1,e2)	12	18	and calcium channel antagonists e.g. , verapamil ) , cyp1a2 inducers ( omeprazole ) and cyp1a2 inhibitors ( furafylline and clarithromycin ) .
effect(e1,e2)	10	15	there is one report suggesting that the concomitant use of trazodone_hydrochloride ( desyrel ) and buspirone_hcl may have caused 3- to 6-fold elevations on sgpt ( alt ) in a few patients .
None(e1,e2)	6	12	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
mechanism(e1,e2)	10	14	in the first study , concomitant administration of 0.2 mg cerivastatin_sodium and 12 g cholestyramine resulted in decreases of more than 22 % for auc and 40 % for cmax when compared to dosing cerivastatin sodium alone .
None(e1,e2)	34	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	7	22	tissue culture and animal studies indicate that elspar can diminish or abolish the effect of methotrexate on malignant cells.14 this effect on methotrexate activity persists as long as plasma asparagine levels are suppressed .
advise(e1,e2)	8	30	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
mechanism(e1,e2)	0	6	mineral_oil interferes with the absorption of fat-soluble_vitamins , including vitamin d preparations .
None(e1,e2)	8	34	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	71	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	29	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	67	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	13	19	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine_sodium from the gastrointestinal tract : aluminum_hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	16	37	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	21	27	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	19	27	the daily dose of enablex should not exceed 7.5 mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
None(e1,e2)	0	17	caffeine : enoxacin is a potent inhibitor of the cytochrome p-450 isozymes responsible for the metabolism of methylxanthines .
None(e1,e2)	15	26	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	14	32	theophylline : following co-administration of two 250-mg dirithromycin tablets administered once daily with 200-mg theophylline tablets administered twice daily for 10 days to 14 healthy subjects , the steady-state plasma concentration of theophylline was not significantly altered .
None(e1,e2)	21	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	14	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	69	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	0	32	uricosuric_agents : since the excretion of oxipurinol is similar to that of urate , uricosuric agents , which increase the excretion of urate , are also likely to increase the excretion of oxipurinol and thus lower the degree of inhibition of xanthine oxidase .
None(e1,e2)	1	12	certain antibiotic , cisplatin , cyclosporine , diuretic , foscarnet , and vaccines .
None(e1,e2)	4	6	increased plasma concentrations of terfenadine , astemizole , and cisapride cause qt prolongation and have been associated with torsades de pointes-type ventricular tachycardia , sometimes fatal .
None(e1,e2)	0	8	potassium-sparing_diuretics such as spironolactone , triamterene , or amiloride , or potassium supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
None(e1,e2)	2	9	to avoid phenytoin intoxication , appropriate adjustment of the anticonvulsant should be made .
None(e1,e2)	27	35	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	129	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	56	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
effect(e1,e2)	0	15	cytosine_arabinoside , a cytostatic agent , has been reported to inactivate the antifungal activity of flucytosine by competitive inhibition .
None(e1,e2)	2	46	videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because these products may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
effect(e1,e2)	0	8	antihistamines may partially counteract the anticoagulation effects of heparin or warfarin .
None(e1,e2)	31	36	in two combined 12-week placebo controlled trials that included brovana doses of 15 mcg twice daily , 25 mcg twice daily , and 50 mcg once daily , 54 of 873 brovana -treated subjects received concomitant theophylline at study entry .
None(e1,e2)	28	31	a drug-drug interaction study evaluated the effect of the use of aczone gel , 5 % , in combination with double strength ( 160 mg/800 mg ) trimethoprim/ sulfamethoxazole ( tmp/ smx ) .
None(e1,e2)	7	38	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	4	25	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	0	7	digitalis_glycosides : amphotericin b-induced hypokalemia may potentiate digitalis toxicity .
None(e1,e2)	17	25	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns_depressants such as anesthetics , opiates , and alcohol .
None(e1,e2)	1	15	using calcium_acetate with digitalis glycosides ( heart medicine ) may cause hypercalcemia ( too much calcium in the blood ) , which could increase the chance of developing an irregular heartbeat .
None(e1,e2)	31	44	plasma exposure of diazepam ( 10 mg bid ) was increased by 28 % following administration of valdecoxib ( 40 mg bid ) for 12 days , while plasma exposure of valdecoxib ( 40 mg bid ) was not substantially increased following administration of diazepam ( 10 mg bid ) for 12 days .
effect(e1,e2)	17	21	hypotension , av conduction disturbances , and left ventricular failure have been reported in some patients receiving beta-adrenergic_blocking_agents when an oral calcium_antagonist was added to the treatment regimen .
None(e1,e2)	3	11	mao inhibitors : maoi_antidepressants , as well as a metabolite of furazolidone , slow amphetamine metabolism .
None(e1,e2)	0	19	glyburide : in a randomized , multiple-dose crossover study , patients with type 2 diabetes were administered 120 mg starlix three times a day before meals for 1 day in combination with glyburide 10 mg daily .
None(e1,e2)	27	29	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	14	28	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	31	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	9	11	therefore , agents affecting sympathetic activity ( e.g. , ganglionic_blocking_agents or adrenergic_neuron_blocking_agents ) should be used with caution .
None(e1,e2)	26	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	32	40	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic_blocking_agents , calcium channel blockers , antihistamines or h1-blocking_agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	6	10	beta-blocking agents a pharmacokinetic study of felodipine in conjunction with metoprolol demonstrated no significant effects on the pharmacokinetics of felodipine .
None(e1,e2)	22	32	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin-_converting_enzyme_(_ace_)_inhibitors , betablockers , calcium-channel blockers , diuretics , and nonsteroidal_anti-inflammatory_drugs ( nsaids ) without evidence of clinically significant adverse interactions .
None(e1,e2)	8	19	antiarrhythmic agents , class i ( such as flecainide , lidocaine , or quinidine ) : concurrent use with arbutamine may have a proarrhythmic effect .
None(e1,e2)	21	44	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	12	aspirin : concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations , peak plasma levels , and auc values .
None(e1,e2)	33	52	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	38	42	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	0	18	carbamazepine : steady-state trough plasma carbamazepine and carbamazepine 10 , 11 epoxide concentrations were not affected by concomitant gabapentin ( 400 mg tid ;
None(e1,e2)	61	67	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	118	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	43	there have been postmarketing reports of drug interactions when erythromycin is coadministered with cisapride , resulting in qt prolongation , cardiac arrythmias , ventricular tachycardia , ventricular fibrulation , and torsades de pointes , most like due to inhibition of hepatic metabolism of cisapride by erythromycin .
None(e1,e2)	12	22	antimycobacterial agents : rifampin contraindicated since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of saquinavir .
None(e1,e2)	0	2	hydrochlorothiazide ( hctz ) alone or in combination with triamterene : concomitant use of hctz alone or in combination with triamterene is contraindicated .
None(e1,e2)	0	11	digoxin : digoxin concentrations are increased by about 15 % when digoxin and carvedilol are administered concomitantly .
mechanism(e1,e2)	18	31	interactions with other antiretroviral drugs : significant decreases in the auc of delavirdine ( 20 % ) and indinavir ( 84 % ) occurred following simultaneous administration of these agents with videx .
None(e1,e2)	11	17	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	11	13	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	16	19	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
mechanism(e1,e2)	2	8	phenytoin : amphetamines may delay intestinal absorption of phenytoin ;
None(e1,e2)	26	33	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	25	73	tolbutamide : aprepitant , when given as 125 mg on day 1 and 80 mg/day on days 2 and 3 , decreased the auc of tolbutamide ( a cyp2c9 substrate ) by 23 % on day 4 , 28 % on day 8 , and 15 % on day 15 , when a single dose of tolbutamide 500 mg was admini , stered orally prior to the administration of the 3-day regimen of aprepitant and on days 4,8 , and 15 .
None(e1,e2)	1	29	since cholestyramine resin may bind other drugs given concurrently , it is recommended that patients take other drugs at least 1 hour before or 4 to 6 hours after cholestyramine resin ( or at as great an interval as possible ) to avoid impeding their absorption .
None(e1,e2)	0	23	ritonavir and indinavir : upon concomitant administration of 5 mg of vardenafil with 600 mg bid ritonavir , the cmax and auc of ritonavir were reduced by approximately 20 % .
None(e1,e2)	15	18	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic_antidepressants or other cns_depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	25	39	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	76	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	14	22	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
None(e1,e2)	13	20	digoxin : in a study in 12 patients with congestive heart failure where ketoprofen and digoxin were concomitantly administered , ketoprofen did not alter the serum levels of digoxin .
None(e1,e2)	20	35	it is recommended that buspirone hydrochloride not be used concomitantly with mao inhibitors because the effects of concomitant administration of buspirone_hcl with most other psychotropic drugs have not been studied , the concomitant use of buspirone_hcl with other cns-active drugs should be approached with caution .
None(e1,e2)	5	10	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	2	23	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	21	33	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	12	32	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	6	8	the steady state plasma concentrations of imipramine and desipramine have been reported to be increased an average of 31 % and 20 % , respectively , by the concomitant administration of alprazolam tablets in doses up to 4 mg/day .
None(e1,e2)	44	51	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	83	106	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	12	25	amiodarone or verapamil : the risk of myopathy/rhabdomyolysis is increased when either amiodarone or verapamil is used concomitantly with a closely related member of the hmg-coa_reductase_inhibitor_class ( see warnings , myopathy/rhabdomyolysis ) .
None(e1,e2)	44	57	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	19	27	monoamine oxidase inhibitors and tricyclic antidepressants : foradil should be administered with extreme caution in patients being treated with monoamine_oxidase_inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .
advise(e1,e2)	10	33	although specific drug interaction studies have not been conducted with alphagan_p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	10	12	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
None(e1,e2)	32	45	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	0	25	exemestane is extensively metabolized by cyp 3a4 , but coadministration of ketoconazole , a potent inhibitor of cyp 3a4 , has no significant effect on exemestane pharmacokinetics .
None(e1,e2)	2	4	fluoxetine , ocs , sertraline , diltiazem , macrolide antibiotics ( exercise caution ) .
None(e1,e2)	2	4	interaction between lomefloxacin and cyclosporine has not been studied .
None(e1,e2)	18	20	patients should be warned of the potential danger of the intravenous self-administration of benzodiazepines while under treatment with suboxone or subutex .
None(e1,e2)	32	56	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	44	51	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	10	12	there has been too little experience with the coadministration of tambocor with nifedipine or diltiazem to recommend concomitant use .
None(e1,e2)	0	30	quinidine : coadministration of a 10-mg single dose of aripiprazole with quinidine ( 166 mg/day for 13 days ) , a potent inhibitor of cyp2d6 , increased the auc of aripiprazole by 112 % but decreased the auc of its active metabolite , dehydroaripiprazole , by 35 % .
None(e1,e2)	38	47	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	4	6	antacids , kaolin-pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
None(e1,e2)	21	23	nabilone should be administered with caution to patients who are taking other psychoactive drugs or cns depressants , including alcohol , barbiturates and narcotic_analgesics , or to those with a history of psychiatric disorder ( including manic-depressive illness and schizophrenia ) .
None(e1,e2)	8	41	ketoconazole : when a single 125-mg dose of aprepitant was administered on day5 of a 10-day regimen of 400 mg/day of ketoconazole , a strong cyp3a4 inhibitor , the auc of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold .
None(e1,e2)	7	13	in a study involving healthy subjects receiving tambocor and propranolol concurrently , plasma flecainide levels were increased about 20 % and propranolol levels were increased about 30 % compared to control values .
mechanism(e1,e2)	2	8	methotrexate : piperacillin_sodium may reduce the excretion of methotrexate .
None(e1,e2)	15	27	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	46	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	11	diuretics : diclofenac and other nsaids can inhibit the activity of diuretics .
None(e1,e2)	2	4	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	26	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	41	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	7	9	in some patients the combined use of indomethacin and diflunisal has been associated with fatal gastrointestinal hemorrhage .
None(e1,e2)	60	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	31	66	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	0	2	digitalis_glycosides : amphotericin_b -induced hypokalemia may potentiate digitalis toxicity .
None(e1,e2)	0	41	central_nervous_system_depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	29	38	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	42	54	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
effect(e1,e2)	22	36	brovana , as with other beta2-agonists , should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors , tricyclic_antidepressants , or drugs known to prolong the qtc interval because the action of adrenergic_agonists on the cardiovascular system may be potentiated by these agents .
mechanism(e1,e2)	2	4	co-administration of tacrolimus and bosentan resulted in markedly increased plasma concentrations of bosentan in animals .
None(e1,e2)	7	28	zebeta should be used with care when myocardial_depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	1	17	like isoflurane , desflurane does not predispose to premature ventricular arrhythmias in the presence of exogenously infused epinephrine in swine .
advise(e1,e2)	7	29	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	19	86	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	38	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	4	15	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	95	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	27	33	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	20	35	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	92	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	56	70	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2_antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	6	10	- valproic acid ( e.g. , depakene ) use of sulfapyridine with these medicines may increase the chance of side effects affecting the liver
None(e1,e2)	30	32	lithium - coadministration of racemic citalopram ( 40 mg/day for 10 days ) and lithium ( 30 mmol/day for 5 days ) had no significant effect on the pharmacokinetics of citalopram or lithium .
None(e1,e2)	46	51	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	29	50	this interaction , which has not been investigated using higher doses of fluvoxamine , may be more pronounced if a 300 mg daily dose is co-administered , particularly since fluvoxamine exhibits non-linear pharmacokinetics over the dosage range 100-300 mg . if alprazolam is co-administered with fluvoxamine tablets , the initial alprazolam dosage should be at least halved and titration to the lowest effective dose is recommended .
None(e1,e2)	0	15	methotrexate - there is one report that methotrexate may decrease the possible effectiveness of supplemental l-glutamine for chemotherapy-induced mucositis .
None(e1,e2)	3	5	do not mix toradol and morphine in the same syringe .
None(e1,e2)	8	16	this effect is small with occasional doses of antacids , but may be clinically significant when antacids are used on a continuous schedule .
None(e1,e2)	0	2	sedatives and tranquilizers ( e.g. , diazepam ) .
None(e1,e2)	8	26	no drug interaction studies have been conducted for colazal , however the use of orally administered antibiotics could , theoretically , interfere with the release of mesalamine in the colon .
None(e1,e2)	8	14	results of studies in multiple sclerosis patients taking tysabri and concomitant interferon beta-1a ( avonex 30 mcg im once weekly ) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate .
None(e1,e2)	17	29	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	33	35	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
effect(e1,e2)	18	25	certain drugs , including nonsteroidal anti-inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non-selective_beta-adrenergic-blocking_agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
None(e1,e2)	24	28	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	70	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	76	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	63	67	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	42	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	15	18	because there is a theoretical basis that these effects may be additive , use of ergotamine -containing or ergot-type_medications ( like dihydroergotamine or methysergide ) and axert within 24 hours of each other should be avoided .
None(e1,e2)	33	85	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	18	20	spontaneous reports of serotonin syndrome associated with co-administration of zyvox and serotonergic agents , including antidepressants such as selective_serotonin_reuptake_inhibitors ( ssris ) , have been reported .
None(e1,e2)	76	114	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	12	29	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
None(e1,e2)	4	22	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac_tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	96	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	0	5	acetazolamide decreases urinary excretion of amphetamine and may enhance the magnitude and duration of their effect .
None(e1,e2)	29	31	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	16	23	no significant drug-drug pharmacokinetic ( or pharmacodynamic ) interactions have been found in interaction studies with hydrochlorothiazide , digoxin , warfarin , and nifedipine .
None(e1,e2)	5	14	aspirin : concurrent administration of aspirin and flurbiprofen resulted in 50 % lower serum flurbiprofen concentrations .
None(e1,e2)	0	12	leukocyte_transfusions : acute pulmonary toxicity has been reported in patients receiving intravenous amphotericin_b and leukocyte transfusions .
None(e1,e2)	0	21	magnesium : magnesium-containing preparations ( eg , antacids ) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin_d by patients on chronic renal dialysis .
None(e1,e2)	40	42	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal_muscle_relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	9	30	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	9	13	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	9	23	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	33	80	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central_nervous_system_(_cns_)_depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	30	53	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	0	18	ketamine : marked hypertension and tachycardia have been reported in association with concomitant administration of levothyroxine sodium and ketamine .
effect(e1,e2)	3	14	concomitant use of antihistamines with alcohol , tricyclic antidepressants , barbiturates , or other central_nervous_system_depressants may have an additive effect .
None(e1,e2)	12	19	these agents include medications such as : anticoagulants , platelet inhibitors including acetylsalicylic_acid , sali-cylates , nsaids ( including ketorolac_tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	4	16	tablets simultaneous administration of sucralfate and furosemide tablets may reduce the natriuretic and antihypertensive effects of furosemide .
None(e1,e2)	11	13	- a diuretic ( water pill ) such as hydrochlorothiazide ( hctz , hydrodiuril ) , chlorothiazide ( diuril ) , and others ;
None(e1,e2)	11	23	ritonavir and indinavir : upon concomitant administration of 5 mg of vardenafil with 600 mg bid ritonavir , the cmax and auc of ritonavir were reduced by approximately 20 % .
None(e1,e2)	26	49	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	0	8	tolbutamide : in diabetic patients receiving diflunisal and tolbutamide , no significant effects were seen on tolbutamide plasma levels or fasting blood glucose .
None(e1,e2)	5	23	in a multiple-dose study , enoxacin caused a dose-related increase in the mean elimination half-life of caffeine , thereby decreasing the clearance of caffeine by up to 80 % and leading to a five-fold increase in the auc and the half-life of caffeine .
None(e1,e2)	38	40	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal_muscle_relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	35	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	25	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	48	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	40	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	9	21	when amiodarone is added to flecainide therapy , plasma flecainide levels may increase two-fold or more in some patients , if flecainide dosage is not reduced .
None(e1,e2)	4	9	known drug interactions include barbiturates , tranquilizers , and alcohol .
None(e1,e2)	4	14	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine_antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
effect(e1,e2)	18	29	certain drugs , including nonsteroidal anti-inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non-selective_beta-adrenergic-blocking_agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic_drugs .
None(e1,e2)	40	44	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot_derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	27	31	certain drugs , including nonsteroidal anti-inflammatory agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic_drugs .
None(e1,e2)	4	16	non-selective mao inhibitors including tranylcypromine_sulfate , phenelzine sulfate , and pargyline hc1 : concomitant use of l-tyrosine and non-selective mao inhibitors may cause hypertension .
None(e1,e2)	80	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	13	29	certain drugs , including nonsteroidal anti-inflammatory agents ( nsaids ) , salicylates , monoamine_oxidase_inhibitors , and non-selective beta-adrenergic-blocking agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic_drugs .
None(e1,e2)	15	24	in order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with taxol should be premedicated with corticosteroids ( such as dexamethasone ) , diphen-hydramine and h2 antagonists ( such as cimetidine or ranitidine ) .
None(e1,e2)	35	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	8	aspirin : concomitant administration of low-dose aspirin with vioxx may result in an increased rate of gi ulceration or other complications , compared to use of vioxx alone .
None(e1,e2)	49	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	10	29	agents with increased levels in the presence of carbamazepine : equetrotm increases the plasma levels of the following agents : clomipramine hcl , phenytoin ( 6 ) , and primidone thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with equetrotm , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .
None(e1,e2)	24	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	0	11	furosemide may add to or potentiate the therapeutic effect of other antihypertensive_drugs .
None(e1,e2)	19	33	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central_nervous_system_(_cns_)_depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	94	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	19	warfarin : quinolones , including enoxacin , decrease the clearance of r-warfarin , the less active isomer of racemic warfarin .
None(e1,e2)	45	82	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	75	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	2	phenytoin , nicotine , and rifampin may decrease clozapine plasma levels , resulting in a decrease in effectiveness of a previously effective clozapine dose .
effect(e1,e2)	4	6	methadone : coadministration of amprenavir and methadone can decrease plasma levels of methadone .
None(e1,e2)	12	33	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	20	22	in some patients , this may lead to reduced clearance , prolongation of plasma half-life , and enhanced effects of caffeine and theobromine .
advise(e1,e2)	7	21	magnesium : magnesium-containing preparations ( eg , antacids ) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin_d by patients on chronic renal dialysis .
None(e1,e2)	69	76	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	2	15	adenosine : dipyridamole has been reported to increase the plasma levels and cardiovascular effects of adenosine .
None(e1,e2)	94	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	53	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	9	11	compounds tested in man include warfarin , theophylline , phenytoin , diazepam , aminopyrine and antipyrine .
advise(e1,e2)	10	18	of particular importance , sufficient time must elapse before initiating tca treatment in a patient being withdrawn from fluoxetine , given the long half-life of the parent and active metabolite ( at least 5 weeks may be necessary ) .
None(e1,e2)	35	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	18	concurrent use of rifampin increases the metabolic clearance of zebeta , resulting in a shortened elimination half-life of zebeta .
effect(e1,e2)	11	44	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	8	27	however , since aspirin , nsaids , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or nsaids with ibandronate .
None(e1,e2)	10	28	since there have been conflicting results regarding the effect of digoxin levels , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing diltiazem_hydrochloride therapy to avoid possible over- or under-digitalization .
None(e1,e2)	6	8	other antiarrhythmic drugs ( eg , quinidine , procainamide , lidocaine , propranolol ) have occasionally been used concurrently with norpace .
None(e1,e2)	0	7	erythromycin : in hypercholesterolemic patients , steady-state cerivastatin auc and cmax increased approximately 50 % and 24 % respectively after 10 days with co-administration of erythromycin , a known inhibitor of cytochrome p450 3a4 .
None(e1,e2)	35	41	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
int(e1,e2)	0	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	20	47	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	38	51	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	21	23	beta blockers : although the results of a clinical study did not indicate a safe problem associated with the administration of d.h.e_._45 ( dihydroergotamine_mesylate ) injection , usp to subjects already receiving propranolol , there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine .
None(e1,e2)	37	59	in a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline ( an anticholinergic agent with multiple effects on the gi tract ) to healthy volunteers , the auc of clonazepam was 10 % lower and the cmax of clonazepam was 20 % lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .
None(e1,e2)	34	38	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	2	18	these include probenecid , cholestyramine , and some antibiotics ( e.g . erythromycin , rifamipicin , ampicillin and chloramphenicol ) .
effect(e1,e2)	9	18	corticosteroids : a relationship of functional antagonism exists between vitamin_d analogues , which promote calcium absorption , and corticosteroids , which inhibit calcium absorption .
None(e1,e2)	18	29	other concomitant therapies : in clinical trials , the safety profile in subjects treated with acamprosate concomitantly with anxiolytics , hypnotics and sedatives ( including benzodiazepines ) , or non-opioid_analgesics was similar to that of subjects taking placebo with these concomitant medications .
None(e1,e2)	12	25	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
effect(e1,e2)	7	15	tissue culture and animal studies indicate that elspar can diminish or abolish the effect of methotrexate on malignant cells.14 this effect on methotrexate activity persists as long as plasma asparagine levels are suppressed .
advise(e1,e2)	18	22	however , due to possible pharmacodynamic interactions , when co-administered with precedex , a reduction in dosage of precedex on the concomitant anesthetic , sedative , hypnotic or opioid may be required .
None(e1,e2)	0	2	amiodarone , disopyramide , lidocaine
None(e1,e2)	25	27	use lowest possible dose of atorvastatin with careful monitoring , or consider hmg-coa reductase inhibitors that are not primarily metabolized by cyp3a4 , such as pravastatin , fluvastatin , or rosuvastatin in combination with crixivan .
None(e1,e2)	35	42	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
mechanism(e1,e2)	14	27	coadministration with compounds that are potent inducers of cyp3a4 ( eg , phenobarbital , phenytoin , dexamethasone , carbamazepine ) may result in decreased plasma levels of saquinavir .
None(e1,e2)	14	21	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta_blockers .
None(e1,e2)	12	43	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	3	14	symptoms resolved when clonidine was withdrawn and recurred when the patient was rechallenged with clonidine .
None(e1,e2)	38	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	2	17	interactions with mixed_agonist/antagonist_opioid_analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	16	40	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
mechanism(e1,e2)	0	2	diamox modifies phenytoin metabolism with increased serum levels of phenytoin .
mechanism(e1,e2)	2	20	coadministration of aprepitant with these drugs or other drugs that are known to be metabolized by cyp2c9 , such as phenytoin , may result in lower plasma concentrations of these drugs .
None(e1,e2)	17	21	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	2	5	products containing calcium and other multivalent_cations likely will interfere with absorption of alendronate .
effect(e1,e2)	7	11	interactions attributed to the combined use of baclofen injection and epidural morphine include hypotension and dyspnea .
mechanism(e1,e2)	2	13	mao inhibitors maoi_antidepressants , as well as a metabolite of furazolidone , slow amphetamine metabolism .
None(e1,e2)	77	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	19	ace inhibitors and angiotensin_ii_receptor_antagonists ( hypertension ) - in clinical studies of patients with hypertension , the addition of inspra 50 to 100 mg to ace inhibitors and angiotensin ii receptor antagonists increased mean serum potassium slightly ( about 0.09-0.13 meq/l ) .
mechanism(e1,e2)	16	24	lithium reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ace inhibitors , and with some angiotensin_ii_receptor_antagonists .
None(e1,e2)	1	5	certain antipsychotic_medications ( such as sertindole ) ;
None(e1,e2)	0	14	cyclosporine : elevated serum levels of cyclosporine have been reported with concomitant use of cyclosporine with other members of the quinolone class .
None(e1,e2)	5	7	bacteriostatic antibiotics : chloramphenicol , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .
None(e1,e2)	11	14	spontaneous reports of serotonin syndrome associated with co-administration of zyvox and serotonergic_agents , including antidepressants such as selective serotonin reuptake inhibitors ( ssris ) , have been reported .
None(e1,e2)	7	9	additive depressant effect when used with general anesthetics , sedatives , antianxiety drugs , hypnotics , alcohol , and other opiate analgesics .
None(e1,e2)	25	29	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	71	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	22	26	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease_inhibitors , quinidine , and verapamil .
None(e1,e2)	1	2	oral contraceptives rofecoxib did not have any clinically important effect on the pharmacokinetics of ethinyl estradiol and norethindrone .
None(e1,e2)	11	12	drug-drug interactions between keppra and other antiepileptic drugs ( aeds ) phenytoin keppra ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy .
None(e1,e2)	69	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	31	this antagonistic effect of probenecid on bumetanide natriuresis is not due to a direct action on sodium excretion but is probably secondary to its inhibitory effect on renal tubular secretion of bumetanide .
mechanism(e1,e2)	5	26	in vitro data suggest that itraconazole , when compared to ketoconazole , has a less pronounced effect on the biotransformation system responsible for the metabolism of astemizole .
None(e1,e2)	4	17	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	50	52	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	102	109	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	28	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	24	34	in order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with taxol should be premedicated with corticosteroids ( such as dexamethasone ) , diphen-hydramine and h2 antagonists ( such as cimetidine or ranitidine ) .
None(e1,e2)	18	36	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin /flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	21	45	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	22	27	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	11	13	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine oxidase inhibitors or other antidepressants .
None(e1,e2)	16	22	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	110	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	5	the use of nuromax before succinylcholine to attenuate some of the side effects of succinylcholine has not been studied .
None(e1,e2)	11	16	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium_channel_blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
effect(e1,e2)	0	6	antithyroid_agents may decrease thyroidal uptake of sodium_iodide_i131 , a rebound in uptake may occur up to 5 days after sudden withdrawal of carbimazole .
None(e1,e2)	0	12	carbamazepine : tiagabine had no effect on the steady-state plasma concentrations of carbamazepine or its epoxide metabolite in patients with epilepsy .
None(e1,e2)	15	18	interactions for vitamin d analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	5	16	concomitant administration of diltiazem with carbamazepine has been reported to result in elevated serum levels of carbamazepine ( 40 % to 72 % increase ) , resulting in toxicity in some cases .
None(e1,e2)	15	26	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	1	5	when ertapenem is co-administered with probenecid ( 500 mg p.o . every 6 hours ) , probenecid competes for active tubular secretion and reduces the renal clearance of ertapenem .
None(e1,e2)	0	2	h2_blockers / proton_pump_inhibitors : long-term suppression of gastric acid secretion by h2 blockers or proton pump inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
None(e1,e2)	9	14	other cns depressant drugs ( e.g . barbiturates , tranquilizers , opioids and general anesthetics ) have additive or potentiating effects with inapsine .
None(e1,e2)	44	57	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	4	antacids containing magnesium , aluminum , or calcium ;
None(e1,e2)	32	49	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	3	17	mao inhibitors , narcotic_analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic_antidepressants , and other drugs having anticholinergic activity .
mechanism(e1,e2)	4	15	the mean clearances of dofetilide were 16 % and 15 % lower in patients on thiazide_diuretics and inhibitors of tubular organic cation transport , respectively .
None(e1,e2)	10	14	other drugs : drugs such as quinidine , disopyramide , procainamide , phenothiazines , antihistamines , and tricyclic antidepressants may be associated with qt-interval prolongation and an increased risk of ventricular arrhythmia .
None(e1,e2)	19	156	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	23	h1 and h2_blockers - although not reported , l-histidine , via its metabolism to histamine , might decrease the efficacy of h1 and h2_blockers .
None(e1,e2)	95	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	15	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
advise(e1,e2)	0	7	lithium generally should not be given with diuretics because they reduce lithiums renal clearance and add a high risk of lithium toxicity .
None(e1,e2)	7	41	zebeta should be used with care when myocardial_depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	0	6	hmg-coa_reductase_inhibitors : the combined use of tricor and hmg-coa reductase inhibitors should be avoided unless the benefit of further alterations in lipid levels is likely to outweigh the increased risk of this drug combination .
None(e1,e2)	22	40	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
effect(e1,e2)	14	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
mechanism(e1,e2)	6	43	plasma levels of several closely related tricyclic_antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
None(e1,e2)	0	7	insulin : a clinical study in 6 insulin -dependent diabetic patients demonstrated no effect of extraneal on insulin absorption from the peritoneal cavity or on insulins ability to control blood glucose when insulin was administered intraperitoneally with extraneal .
None(e1,e2)	21	25	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis_preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	0	19	anticoagulants : flurbiprofen like other nonsteroidal anti-inflammatory drugs , has been shown to affect bleeding parameters in patients receiving anti-coagulants , and serious clinical bleeding has been reported .
None(e1,e2)	1	12	cephalosporins- cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
None(e1,e2)	14	17	drug/ laboratory test interactions certain endocrine and liver function tests may be affected by estrogen -containing oral contraceptives .
None(e1,e2)	105	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	9	standard therapy includes antibiotics , such as penicillin and gentamicin ;
None(e1,e2)	30	34	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	19	60	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	22	40	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	16	18	duloxetine may have a clinically important interaction with the following other drugs : alcohol : when duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide , duloxetine did not increase the impairment of mental and motor skills caused by alcohol .
None(e1,e2)	19	27	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	55	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
mechanism(e1,e2)	19	21	in one man , the c max of terfenadine was 8.1 ng/ml with terfenadine alone and 7.2 ng/ml with terfenadine plus dirithromycin .
None(e1,e2)	3	28	oral contraceptives : valdecoxib ( 40 mg bid ) did not induce the metabolism of the combination oral contraceptive norethindrone/ethinyl estradiol ( 1 mg /35 mcg combination , ortho-novum 1/35 ) .
None(e1,e2)	23	38	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
effect(e1,e2)	5	15	1- adrenergic receptor antagonism , aripiprazole has the potential to enhance the effect of certain antihypertensive_agents .
None(e1,e2)	26	30	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	151	153	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	30	32	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao_inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	23	29	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	2	6	fluoxetine , ocs , sertraline , diltiazem , macrolide antibiotics ( exercise caution ) .
advise(e1,e2)	27	38	because changes in glucose concentrations with valdecoxib coadministration were within the normal variability and individual glucose concentrations were above or near 70 mg/dl , dose adjustment for glyburide ( 5 mg qd and 10 mg bid ) with valdecoxib coadministration ( up to 40 mg qd ) is not indicated .
advise(e1,e2)	15	24	nicardipine hcl usually does not alter the plasma levels of digoxin , however , serum digoxin levels should be evaluated after concomitant therapy with nicardipine_hcl is initiated .
None(e1,e2)	33	43	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns_depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
mechanism(e1,e2)	17	41	on the basis of the metabolism of bexarotene by cytochrome p450 3a4 , ketoconazole , itraconazole , erythromycin , gemfibrozil , grapefruit juice , and other inhibitors of cytochrome p450 3a4 would be expected to lead to an increase in plasma bexarotene concentrations .
None(e1,e2)	17	20	because there is a theoretical basis that these effects may be additive , use of ergotamine-containing or ergot-type_medications ( like dihydroergotamine or methysergide ) and axert within 24 hours of each other should be avoided .
None(e1,e2)	0	11	exemestane is extensively metabolized by cyp 3a4 , but coadministration of ketoconazole , a potent inhibitor of cyp 3a4 , has no significant effect on exemestane pharmacokinetics .
None(e1,e2)	57	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	23	65	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	37	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	56	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	7	21	ketoconazole : co-administration of 200 mg twice-daily ketoconazole with aliskiren resulted in an approximate 80 % increase in plasma levels of aliskiren .
None(e1,e2)	12	29	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
mechanism(e1,e2)	12	23	products containing calcium and other multivalent cations ( such as aluminum , magnesium , iron ) are likely to interfere with absorption of ibandronate .
None(e1,e2)	16	18	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
None(e1,e2)	0	18	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium_hydroxide with 500-mg of mefenamic acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	19	21	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	6	8	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	9	13	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac_glycosides , calcium channel blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
mechanism(e1,e2)	2	15	naproxen , naproxen_sodium and other nsaids have been reported to reduce the tubular secretion of methotrexate in an animal model , possibly increasing the toxicity of methotrexate .
mechanism(e1,e2)	18	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	22	29	in 2 separate studies , fexofenadine hydrochloride 120 mg twice daily ( 240 mg total daily dose ) was co-administered with either erythromycin 500 mg every 8 hours or ketoconazole 400 mg once daily under steady-state conditions to healthy volunteers ( n=24 , each study ) .
None(e1,e2)	29	49	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	4	tricyclic_antidepressants ( amitriptyline , imipramine , nortriptyline ) : metabolism may be inhibited by combination hormonal contraceptives , increasing plasma levels of antidepressant ;
None(e1,e2)	17	19	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine oxidase inhibitors , tricyclic_antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
None(e1,e2)	4	6	coadministration of entecavir with lamivudine , adefovir_dipivoxil , or tenofovir disoproxil fumarate did not result in significant drug interactions .
None(e1,e2)	59	74	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	18	22	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	17	28	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
effect(e1,e2)	1	10	oral contraceptives may be less effective while you are taking lymecycline .
None(e1,e2)	0	7	digoxin : concomitant administration of erythromycin and digoxin has been reported to result in elevated digoxin serum levels .
None(e1,e2)	30	45	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type_1c_antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	4	10	non-selective mao inhibitors including tranylcypromine_sulfate , phenelzine sulfate , and pargyline hc1 : concomitant use of l-tyrosine and non-selective mao inhibitors may cause hypertension .
None(e1,e2)	7	29	inhibitors of this isoenzyme ( e.g. , macrolide_antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
effect(e1,e2)	3	15	cardiac effects of dopamine are antagonized by beta-adrenergic blocking agents , such as propranolol and metoprolol .
None(e1,e2)	30	44	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	21	26	steroids enhance the renal toxicity of edetate calcium disodium in animals . 7 edetate calcium disodium interferes with the action of zinc_insulin preparations by chelating the zinc . 7
None(e1,e2)	10	23	when administered concurrently , the following drugs may interact with beta-adrenergic_receptor_blocking_agents : anesthetics , general : exaggeration of the hypotension induced by general anesthetics .
None(e1,e2)	2	10	trough plasma enoxacin levels were also 20 % higher when caffeine and enoxacin were administered concomitantly .
None(e1,e2)	0	16	fentanyl anesthesia : severe hypotension has been reported during fentanyl anesthesia with concomitant use of a beta_blocker and a calcium channel blocker .
None(e1,e2)	65	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	18	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	26	48	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	12	22	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	8	10	antihistamines may partially counteract the anticoagulation effects of heparin or warfarin .
None(e1,e2)	22	26	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
int(e1,e2)	61	68	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
advise(e1,e2)	24	29	mao inhibitors : duragesic is not recommended for use in patients who have received maoi within 14 days because severe and unpredictable potentiation by mao_inhibitors has been reported with opioid_analgesics
None(e1,e2)	40	42	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
None(e1,e2)	19	95	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	39	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	26	38	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	18	20	drugs whose absorption can be affected by the level of acidity in the stomach : drugs such as ketoconazole and itraconazole should be administered at least 2 hours prior to dosing with videx .
None(e1,e2)	4	26	corresponding values for free valproate cmin concentrations were 7 3 , 9 4 , and 11 6 micrograms/ml for 0 , 1200 , and 2400 mg/day felbatol , respectively .
None(e1,e2)	40	44	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium_chloride , folic acid , and acetaminophen .
None(e1,e2)	12	14	it is desirable to monitor tcaplasma levels whenever an agent of the tricyclic_antidepressant_class including anafranil is going to be co-administered with another drug known to be an inhibitor of p450 2d6 ( and/or p450 1a2 ) .
None(e1,e2)	78	80	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	12	probenecid : as with other b-lactam antibiotics , co-administration of probenecid with cefditoren_pivoxil resulted in an increase in the plasma exposure of cefditoren , with a 49 % increase in mean cmax , a 122 % increase in mean auc , and a 53 % increase in half-life .
None(e1,e2)	28	34	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	0	5	inomax has been administered with tolazoline , dopamine , dobutamine , steroids , surfactant , and high-frequency ventilation .
None(e1,e2)	4	16	certain drugs , including nonsteroidal_anti-inflammatory_agents ( nsaids ) , salicylates , monoamine oxidase inhibitors , and non-selective_beta-adrenergic-blocking_agents may potentiate the hypoglycemic action of starlix and other oral antidiabetic drugs .
None(e1,e2)	28	34	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	4	13	since blood level of calcitriol /ergocalcitriol will be reduced , higher doses of rocaltrol may be necessary if these drugs are administered simultaneously .
None(e1,e2)	19	145	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	13	rifampicin : in a study in healthy volunteers , a six-day course of rifampicin at 600 mg/day followed by a single 5 mg dose of isradipine resulted in a reduction in isradipine levels to below detectable limits .
mechanism(e1,e2)	0	26	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	25	32	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	69	76	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	36	quinolone_antibiotic s : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
effect(e1,e2)	2	19	anticoagulants : flurbiprofen like other nonsteroidal anti-inflammatory drugs , has been shown to affect bleeding parameters in patients receiving anti-coagulants , and serious clinical bleeding has been reported .
mechanism(e1,e2)	0	10	mineral_oil interferes with the absorption of fat-soluble vitamins , including vitamin_d_preparations .
None(e1,e2)	0	5	barbiturates , phenytoin , or rifampin increased metabolic clearance of fludrocortisone acetate because of the induction of hepatic enzymes .
None(e1,e2)	36	46	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	14	23	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	0	2	gemfibrozil other fibrates niacin ( nicotinic acid ) ( =1 g/day )
None(e1,e2)	19	26	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary_vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	8	51	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	1	49	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	2	cytokines ( interferon , interleukin ) : cytokines have been reported to induce both hyperthyroidism and hypothyroidism .
None(e1,e2)	9	19	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	40	70	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	85	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	7	14	additive depressant effect when used with general anesthetics , sedatives , antianxiety drugs , hypnotics , alcohol , and other opiate analgesics .
None(e1,e2)	49	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	16	drugs metabolized by cytochrome p450 enzymes the drug interaction study evaluating the effect of grepafloxacin on theophylline indicates that grepafloxacin inhibits theophylline metabolism , which is mediated by cyp1a2 .
None(e1,e2)	15	20	other concomitant therapies : in clinical trials , the safety profile in subjects treated with acamprosate concomitantly with anxiolytics , hypnotics and sedatives ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .
None(e1,e2)	6	24	cytochrome p-450 inducers , such as phenytoin , carbamazepine and phenobarbital , induce clonazepam metabolism , causing an approximately 30 % decrease in plasma clonazepam levels .
None(e1,e2)	21	37	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	3	15	therefore , when meclofenamate_sodium is given to a patient receiving warfarin , the dosage of warfarin should be reduced to prevent excessive prolongation of the prothrombin time .
None(e1,e2)	3	7	include terfenadine , astemizole , cisapride , midazolam , and triazolam .
None(e1,e2)	7	19	erythromycin and clarithromycin ( and possibly other macrolide_antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
effect(e1,e2)	6	9	aspirin : animal studies wshow that aspirin given with nonsteroidal_anti-inflammatory_agents , including ibuprofen , yields a net decrease in anti-inflammatory activity with lowered blood levels of the non-aspirin drug .
None(e1,e2)	2	8	magnesium : magnesium -containing preparations ( eg , antacids ) may cause hypermagnesemia and should therefore not be taken during therapy with vitamin d by patients on chronic renal dialysis .
effect(e1,e2)	6	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	12	mercaptopurine/azathioprine : allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric_acid .
None(e1,e2)	0	14	coumarin_anticoagulants : there have been rare reports of increased prothrombin time in patients taking coumarin_anticoagulants to whom nifedipine was administered .
advise(e1,e2)	24	38	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	35	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	8	fluoxetine , ocs , sertraline , diltiazem , macrolide_antibiotics ( exercise caution ) .
None(e1,e2)	0	4	ergot_derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine contraindicated due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
None(e1,e2)	54	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	33	48	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	18	the incidence of upper gastrointestinal events in patients concomitantly taking aspirin or nsaids was similar in patients taking ibandronate 2.5 mg daily ( 21.7 % ) and 150 mg once monthly ( 22.0 % ) .
mechanism(e1,e2)	18	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	13	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
None(e1,e2)	0	3	dimenhydrinate may decrease emetic response to apomorphine .
None(e1,e2)	15	19	dolasetron mesylate did not inhibit the antitumor activity of four chemotherapeutic agents ( cisplatin , 5-fluorouracil , doxorubicin , cyclophosphamide ) in four murine models .
None(e1,e2)	31	40	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal_muscle_relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	11	29	acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16 % ( 90 % confidence interval : 8-23 % ) , decrease mean c max digoxin by 26 % ( 90 % confidence interval : 16-34 % ) and decrease mean trough concentrations of digoxin by 9 % ( 90 % confidence limit : 19 % decrease to 2 % increase ) .
effect(e1,e2)	2	9	corticosteroids and corticotropin ( acth ) : may potentiate amphotericin_b - induced hypokalemia which may predispose the patient to cardiac dysfunction .
None(e1,e2)	15	25	since apraclonidine may reduce pulse and blood pressure , caution in using drugs such as beta-blockers ( ophthalmic and systemic ) , antihypertensives , and cardiac_glycosides is advised .
None(e1,e2)	10	21	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta_blockers .
None(e1,e2)	0	2	antacids or h_2_-receptor_antagonists : the effect of increased gastric ph on the bioavailability of ceftibuten was evaluated in 18 healthy adult volunteers .
None(e1,e2)	3	13	potassium-sparing diuretics ( spironolactone , amiloride , triamterene , and others ) or potassium supplements can increase the risk of hyperkalemia .
None(e1,e2)	4	8	the antihypertensive effects of methyldopa , mecamylamine , reserpine , and veratrum alkaloids may be reduced by sympathomimetics .
advise(e1,e2)	14	29	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic_amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic_antidepressants can potentiate the effects of catecholamines .
None(e1,e2)	8	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	28	in a single subject given one dose of ciprofloxacin 2 hours after a dose of didanosine-placebo tablets , a greater than 50 % reduction in the auc of ciprofloxacin was observed .
effect(e1,e2)	7	14	when taken orally , imidazole compounds like ketoconazole may enhance the anticoagulant effect of coumarin -like drugs .
None(e1,e2)	3	21	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	18	53	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	51	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	129	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	23	agents that inhibit cytochrome p450 isoenzymes and/or epoxide hydrolase carbamazepine is metabolized mainly by cytochrome p450 ( cyp ) 3a4 to the active carbamazepine_10,11-epoxide , which is further metabolized to the trans-diol by epoxide hydrolase .
None(e1,e2)	2	29	steady-state plasma felbamate concentrations were found to be 29 % lower than the mean concentrations of a group of newly diagnosed subjects with epilepsy also receiving 2400 mg of felbamate a day .
None(e1,e2)	28	42	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	19	48	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	44	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	81	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	8	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
None(e1,e2)	39	44	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	30	70	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	12	22	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	14	17	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	19	33	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	116	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	16	since acetaminophen in high doses has been associated with hepatotoxicity , concomitant administration of diflunisal and acetaminophen should be used cautiously , with careful monitoring of patients .
None(e1,e2)	139	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	35	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	10	12	the pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide
None(e1,e2)	13	38	carbamazepine : carbamazepine causes an approximate 50 % increase in the clearance of felbatol at steady state and , therefore , the addition of carbamazepine results in an approximate 40 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	17	33	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	10	24	physiological changes resulting from smoking cessation , with or without nicotine replacement , may alter the pharmacokinetics of certain concomitant medications , such as tricyclic_antidepressants and theophylline .
advise(e1,e2)	2	7	therefore when central_nervous_system_depressants are administered concomitantly with hydroxyzine their dosage should be reduced .
None(e1,e2)	29	68	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	35	44	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	6	10	in a single-dose crossover study examining lansoprazole 30 mg and omeprazole 20 mg each administered alone and concomitantly with sucralfate 1 gram , absorption of the proton pump inhibitors was delayed and their bioavailability was reduced by 17 % and 16 % , respectively , when administered concomitantly with sucralfate .
None(e1,e2)	24	36	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	20	23	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	6	19	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	6	12	and calcium channel antagonists e.g. , verapamil ) , cyp1a2 inducers ( omeprazole ) and cyp1a2 inhibitors ( furafylline and clarithromycin ) .
None(e1,e2)	4	6	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine hcl was not altered .
None(e1,e2)	75	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	33	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	16	specific studies have confirmed these effects with sevoflurane , isoflurane , propofol , alfentanil , and midazolam .
None(e1,e2)	7	13	drug interactions : a . drugs enhancing heparin effect : oral anticoagulants : heparin_sodium may prolong the one-stage prothrombin time .
None(e1,e2)	31	55	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	96	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	28	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
None(e1,e2)	4	6	fluoxetine , fluvoxamine , paroxetine , sertraline ) .
None(e1,e2)	0	14	mao_inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic_agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
mechanism(e1,e2)	3	8	plasma levels of anticonvulsant_agents may become subtherapeutic during cisplatin therapy .
None(e1,e2)	39	57	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	14	erythromycin has been reported to significantly alter the metabolism of nonsedating antihistamines terfenadine and astemizole when taken concomitantly .
None(e1,e2)	24	30	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	10	25	clinical studies in healthy volunteers show that the pharmacokinetics of cancidas are not altered by itraconazole , amphotericin b , mycophenolate , nelfinavir , or tacrolimus .
None(e1,e2)	6	43	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	18	22	in a controlled clinical trial , a 20 % reduction of the phenytoin dose at the initiation of felbatol therapy resulted in phenytoin levels comparable to those prior to felbatol administration .
None(e1,e2)	25	38	in in vivo studies , 10- to 30-mg/day doses of aripiprazole had no significant effect on metabolism by cyp2d6 ( dextromethorphan ) , cyp2c9 ( warfarin ) , cyp2c19 ( omeprazole , warfarin ) , and cyp3a4 ( dextromethorphan ) substrates .
None(e1,e2)	0	6	loop_diuretics : furosemide administered concurrently with captopril does not alter the pharmacokinetics of captopril in renally impaired hypertensive patients .
None(e1,e2)	22	28	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	16	33	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	17	27	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	0	21	lithium : lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium , including ace_inhibitors .
mechanism(e1,e2)	18	51	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	2	8	meperidine : amphetamines potentiate the analgesic effect of meperidine .
effect(e1,e2)	0	6	tcas decrease the hypotensive effect of guanfacine .
None(e1,e2)	69	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	46	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	22	potentiation of the hypotensive effects of nitrates for patients with ischemic heart disease has not been evaluated , and concomitant use of vardenafil and nitrates is contraindicated .
None(e1,e2)	28	30	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	40	42	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta adrenergic blocking agents .
effect(e1,e2)	1	20	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co-administered with other psychotropic medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
None(e1,e2)	8	22	results of studies in multiple sclerosis patients taking tysabri and concomitant interferon beta-1a ( avonex 30 mcg im once weekly ) or glatiramer_acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate .
None(e1,e2)	0	12	antidepressants , tricyclic amphetamines may enhance the activity of tricyclic antidepressants or sympathomimetic_agents ;
None(e1,e2)	27	29	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
None(e1,e2)	127	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	67	73	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	35	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	38	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	35	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	10	24	nicardipine hcl usually does not alter the plasma levels of digoxin , however , serum digoxin levels should be evaluated after concomitant therapy with nicardipine_hcl is initiated .
None(e1,e2)	16	23	drugs that inhibit cytochrome p450iid6 , such as quinidine , might increase the plasma concentrations of flecainide in patients that are on chronic flecainide therapy ;
None(e1,e2)	1	12	elevated cyclosporine serum levels have been reported with the concomitant use of quinolones and cyclosporine .
None(e1,e2)	26	38	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	19	23	doxazosin mesylate has been administered without any evidence of an adverse drug interaction to patients receiving thiazide diuretics , beta-blocking_agent s , and nonsteroidal_anti-inflammatory_drugs .
effect(e1,e2)	10	20	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
None(e1,e2)	0	13	theophylline : as with some other quinolones , concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life .
mechanism(e1,e2)	14	27	co-medications that induce cyp 3a4 ( e.g. , rifampicin , phenytoin , carbamazepine , phenobarbital , or st. john s wort ) may significantly decrease exposure to exemestane .
None(e1,e2)	5	8	if antacids are required during omnicef therapy , omnicef should be taken at least 2 hours before or after the antacid .
effect(e1,e2)	15	17	ketamine : marked hypertension and tachycardia have been reported in association with concomitant administration of levothyroxine_sodium and ketamine .
None(e1,e2)	0	5	ace_inhibitors : reports suggest that nsaids may diminish the antihypertensive effect of ace inhibitors .
None(e1,e2)	0	29	naproxen : the concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen , but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite .
effect(e1,e2)	15	5	in an emergency situation when opioid analgesia must be administered to a patient receiving revia , the amount of opioid required may be greater than usual , and the resulting respiratory depression may be deeper and more prolonged .
None(e1,e2)	4	10	if replacing clonidine by beta-blocker therapy , the introduction of beta_blockers should be delayed for several days after clonidine administration has stopped .
None(e1,e2)	4	53	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	2	5	selegiline - l-phenylalanine and the selective_mao_inhibitor selegiline may have synergistic antidepressant activity if used concomitantly .
None(e1,e2)	12	16	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	33	36	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	30	36	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	30	42	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or h1-blocking_agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	83	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	25	35	it is recommended that buspirone hydrochloride not be used concomitantly with mao inhibitors because the effects of concomitant administration of buspirone hcl with most other psychotropic_drugs have not been studied , the concomitant use of buspirone_hcl with other cns-active drugs should be approached with caution .
None(e1,e2)	2	24	carbamazepine : carbamazepine causes an approximate 50 % increase in the clearance of felbatol at steady state and , therefore , the addition of carbamazepine results in an approximate 40 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	8	12	epinephrine should not be administered concomitantly with other sympathomimetic_drugs ( such as isoproterenol ) because of possible additive effects and increased toxicity .
None(e1,e2)	5	11	concurrent use of butorphanol with central_nervous_system_depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central nervous system depressant effects .
None(e1,e2)	0	17	amiodarone taken concomitantly with procainamide for less than seven days increases plasma concentrations of procainamide and n-acetyl procainamide by 55 % and 33 % , respectively .
None(e1,e2)	26	33	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
None(e1,e2)	10	15	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole_antifungal_agents , protease inhibitors , serotonin_reuptake_inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	35	37	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
mechanism(e1,e2)	9	18	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	22	47	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	25	49	this drug may interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine_oxidase_(_mao_)_inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	83	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	15	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	65	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	30	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	10	22	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
mechanism(e1,e2)	6	10	single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent , respectively .
None(e1,e2)	40	98	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	3	6	the effect of corticosteroids on oral anticoagulants is variable .
None(e1,e2)	85	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	32	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	21	25	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	59	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	18	33	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns_depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
None(e1,e2)	4	11	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
mechanism(e1,e2)	8	21	ketoconazole : when a single 125-mg dose of aprepitant was administered on day5 of a 10-day regimen of 400 mg/day of ketoconazole , a strong cyp3a4 inhibitor , the auc of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold .
None(e1,e2)	7	9	acidifying agents : gastrointestinal acidifying agents ( guanethidine , reserpine , glutamic acid hcl , ascorbic acid , fruit juices , etc . ) lower absorption of amphetamines .
None(e1,e2)	41	68	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	7	13	use in ambulatory patients the effects of romazicon may wear off before a long-acting_benzodiazepine is completely cleared from the body .
None(e1,e2)	88	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	51	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	17	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	38	52	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing_compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	9	28	interactions for vitamin d analogues ( vitamin d2 , vitamin_d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat_soluble_vitamins ;
None(e1,e2)	19	23	a similar association , though less marked , has been suggested with barbiturates , phenyl-butazone , phenytoin sodium , carbamazepine and possibly with griseofulvin , ampicillin , and tetracyclines ( 72 )
advise(e1,e2)	30	34	however , because bleeding has been reported when ibuprofen and other nonsteroidal anti-inflammatory agents have been administered to patients on coumarin-type anticoagulants , the physician should be cautious when administering ibuprofen to patients on anticoagulants .
None(e1,e2)	28	36	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	23	94	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	83	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	70	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	8	analgesic/anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	37	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	16	ritonavir and indinavir : upon concomitant administration of 5 mg of vardenafil with 600 mg bid ritonavir , the cmax and auc of ritonavir were reduced by approximately 20 % .
None(e1,e2)	21	25	the daily dose of enablex should not exceed 7.5 mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
None(e1,e2)	19	21	toxicologic and toxicokinetic studies in rats did not demonstrate any alterations in the clearance or toxicologic profile of either methotrexate or kineret when the two agents were administered together .
None(e1,e2)	28	44	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	17	24	clinical studies in healthy volunteers show that the pharmacokinetics of cancidas are not altered by itraconazole , amphotericin_b , mycophenolate , nelfinavir , or tacrolimus .
None(e1,e2)	2	9	diamox modifies phenytoin metabolism with increased serum levels of phenytoin .
None(e1,e2)	4	16	pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine , antipyrine , ketoconazole , erythromycin and azithromycin .
None(e1,e2)	20	31	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum_hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium_polystyrene_sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	12	34	at 24 hours postdose , a similar proportion of patients treated with methotrexate alone ( 94 % ) and subsequently treated with methotrexate co-administered with 75 mg of rofecoxib ( 88 % ) had methotrexate plasma concentrations below the measurable limit ( 5 ng/ml ) .
None(e1,e2)	72	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	2	27	therefore , esomeprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( eg , ketoconazole , iron salts and digoxin ) .
None(e1,e2)	39	49	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	18	insulin or oral hypoglycemics : agents with b-blocking properties may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics .
None(e1,e2)	4	6	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	44	66	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	11	18	non-steroidal anti-inflammatory agents : seizures have been reported in patients taking enoxacin concomitantly with the nonsteroidal anti-inflammatory drug fenbufen .
None(e1,e2)	45	63	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	56	80	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	18	duloxetine may have a clinically important interaction with the following other drugs : alcohol : when duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide , duloxetine did not increase the impairment of mental and motor skills caused by alcohol .
None(e1,e2)	39	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	20	therefore , interactions could occur following concomitant administration of psychotropic drugs ( e.g. , narcotics , analgesics , antiemetics , sedatives , tranquilizers ) .
effect(e1,e2)	5	15	pyrazolone derivatives ( phenylbutazone , oxyphenbutazone , and possibly dipyrone ) : concomitant administration with aspirin may increase the risk of gastrointestinal ulceration .
None(e1,e2)	77	84	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	27	29	in general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including anti-arrhythmic agents such as quinidine and procainamide , cardiac_glycosides and tricyclic_anti-depressants .
None(e1,e2)	69	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	68	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	17	20	international normalized ratio ( inr ) elevations and/or bleeding events have been reported in some patients taking warfarin while on iressa therapy .
None(e1,e2)	9	11	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
None(e1,e2)	40	42	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	10	52	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	41	43	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	31	68	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
advise(e1,e2)	3	14	dose reduction of crixivan to 600 mg every 8 hours is recommended when administering itraconazole concurrently .
None(e1,e2)	5	7	probenecid : as with other b-lactam_antibiotics , probenecid inhibits the renal excretion of cefdinir , resulting in an approximate doubling in a.c. a 54 % increase in peak cefdinir plasma levels , and a 50 % prolongation in the apparent elimination half-life .
None(e1,e2)	16	45	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	13	15	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	24	35	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting_enzyme_inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	92	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	18	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
advise(e1,e2)	4	17	a dose increase of lopinavir /ritonavir to 533/133 mg twice daily with food isrecommended in combination with nevirapine .
None(e1,e2)	2	4	interconversion between caffeine and theophylline has been reported in preterm neonates .
None(e1,e2)	6	30	phenobarbital : coadministration of felbamate with phenobarbital causes an increase in phenobarbital plasma concentrations , in 12 otherwise healthy male volunteers ingesting phenobarbital , the steady-state trough ( cmin ) phenobarbital concentration was 14.2 micrograms/ml .
None(e1,e2)	65	99	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	28	monoamine_oxidase_(_mao_)_inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	0	10	cyclosporine : combination hormonal contraceptives may inhibit the metabolism of cyclosporine , leading to increased plasma concentrations ;
None(e1,e2)	42	69	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	8	beta-blockers , clonidine , lithium salts , and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin .
None(e1,e2)	85	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	9	caffeine -related adverse effects have occurred in patients consuming caffeine while on therapy with enoxacin .
effect(e1,e2)	6	33	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	14	interactions for vitamin d analogues ( vitamin d2 , vitamin_d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	8	13	the gonadotropin levels may be transiently elevated by spironolactone , minimally elevated by levodopa , and suppressed by oral contraceptives and digoxin .
None(e1,e2)	36	40	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot_derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	2	14	products containing calcium and other multivalent cations ( such as aluminum , magnesium , iron ) are likely to interfere with absorption of ibandronate .
None(e1,e2)	36	46	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
advise(e1,e2)	15	34	since pletal is extensively metabolized by cytochrome p-450 isoenzymes , caution should be exercised when pletal is coadministered with inhibitors of c.p.a . such as ketoconazole and erythromycin or inhibitors of cyp2c19 such as omeprazole .
None(e1,e2)	71	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	77	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	0	9	acitretin : interferes with the contraceptive effect of microdosed progestin -containing minipill preparations .
None(e1,e2)	6	36	cancidas reduced the blood auc0-12 of tacrolimus by approximately 20 % , peak blood concentration ( cmax ) by 16 % , and 12-hour blood concentration ( c12hr ) by 26 % in healthy subjects when tacrolimus ( 2 doses of 0.1 mg/kg 12 hours apart ) was administered on the 10th day of cancidas 70 mg daily , as compared to results from a control period in which tacrolimus was administered alone .
None(e1,e2)	0	27	coumarin-type_anticoagulants : several short-term controlled studies failed to wshow that ibuprofen significantly affected prothrombin times or a variety of other clotting factors when administered to individuals on coumarin-type_anticoagulants .
None(e1,e2)	51	74	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	28	56	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
int(e1,e2)	8	16	caution should be exercised when administering nabumetone with warfarin since interactions have been seen with other nsaids .
None(e1,e2)	5	8	drugs that induce cyp3a4 ( rifampicin ) racemic zopiclone exposure was decreased 80 % by concomitant useof rifampicin , a potent inducer of cyp3a4 .
None(e1,e2)	16	22	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium_channel_blockers , analgesics , antipyretics , nonsteroidal_antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	15	17	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	8	20	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , paroxetine , and fluvoxamine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	57	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	44	97	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	19	152	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	50	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	23	27	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .
None(e1,e2)	85	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	14	24	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	17	20	dosage adjustment of strattera may be necessary when coadministered with cyp2d6 inhibitors , e.g. , paroxetine , fluoxetine , and quinidine .
None(e1,e2)	44	50	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium_chloride , folic acid , and acetaminophen .
advise(e1,e2)	8	16	it is recommended that the combination of intravenous dantrolene_sodium and calcium channel blockers , such as verapamil , not be used together during the management of malignant hyperthermia crisis until the relevance of these findings to humans is established .
None(e1,e2)	9	15	substrates , in vitro data suggest similar effects of grepafloxacin in cyp3a4 mediated metabolism and theophylline metabolism .
None(e1,e2)	19	21	psychoactive drugs : hallucinations have been reported when toradol was used in patients taking psychoactive drugs ( fluoxetine , thiothixene , alprazolam ) .
None(e1,e2)	11	33	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	11	13	limited data in patients receiving known enzyme inducers ( phenytoin , phenobarbital , carbamazepine ) indicate only a 30 % increase in the rate of flecainide elimination .
None(e1,e2)	28	42	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
mechanism(e1,e2)	5	13	serum theophylline concentrations increase when grepafloxacin is initiated in a patient maintained on theophylline .
None(e1,e2)	0	2	antacids , kaolin -pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
None(e1,e2)	24	50	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	24	26	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide_mononitrate , carvedilol , ethanol or itraconazole .
advise(e1,e2)	11	19	close supervision and careful adjustment of the dosage are required when nortriptyline_hydrochloride is used with other anticholinergic drugs or sympathomimetic_drugs .
None(e1,e2)	48	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	4	13	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	0	20	glibenclamide : in a study of 7 healthy male volunteers , acitretin treatment potentiated the blood glucose lowering effect of glibenclamide ( a sulfonylurea similar to chlorpropamide ) in 3 of the 7 subjects .
None(e1,e2)	28	36	therefore , coadministration of aprepitant with drugs that strongly induce cyp3a4 activity ( e.g. , rifampin , carbamazepine , phenytoin ) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of aprepitant .
None(e1,e2)	20	27	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	20	26	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
mechanism(e1,e2)	16	52	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	7	9	in controlled clinical trials , however , beta_blockers including metoprolol were concurrently administered with felodipine and were well tolerated .
None(e1,e2)	7	45	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	30	48	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
effect(e1,e2)	1	12	other nonsteroidal_anti-inflammatory_drugs that inhibit prostaglandin synthesis have been shown to interfere with thiazide_diuretics in some studies and with potassium-sparing diuretics .
effect(e1,e2)	2	19	cyclopropane or halogenated_hydrocarbon_anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines , such as dopamine .
None(e1,e2)	67	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	22	24	no differences in adverse events or qtc interval were observed when subjects were administered fexofenadine hydrochloride alone or in combination with either erythromycin or ketoconazole .
None(e1,e2)	21	41	ketoconazole : when a single 125-mg dose of aprepitant was administered on day5 of a 10-day regimen of 400 mg/day of ketoconazole , a strong cyp3a4 inhibitor , the auc of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold .
None(e1,e2)	6	27	may interact with the following : beta-adrenergic_blocking_agents ( these medicines may make your condition worse and prevent the adrenergic bronchodilators from working properly ) and disopyramide , quinidine , phenothiazines , and procainamide ( these medicines may increase the risk of heart problems ) .
None(e1,e2)	0	48	acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16 % ( 90 % confidence interval : 8-23 % ) , decrease mean c max digoxin by 26 % ( 90 % confidence interval : 16-34 % ) and decrease mean trough concentrations of digoxin by 9 % ( 90 % confidence limit : 19 % decrease to 2 % increase ) .
None(e1,e2)	13	21	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	3	18	as with other antihypertensive_agents , the antihypertensive effect of losartan may be blunted by the non-steroidal anti-inflammatory drug indomethacin
None(e1,e2)	0	6	antacids , kaolin-pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
None(e1,e2)	17	22	because there is a theoretical basis that these effects may be additive , use of ergotamine-containing or ergot-type_medications ( like dihydroergotamine or methysergide ) and axert within 24 hours of each other should be avoided .
effect(e1,e2)	0	4	ethopropazine may interact with alcohol or other cns depressants , causing increased sedative effects .
None(e1,e2)	0	11	morphine : a literature article reported that when a 60-mg controlled-release morphine capsule was administered 2 hours prior to a 600-mg neurontin capsule ( n=12 ) , mean gabapentin auc increased by 44 % compared to gabapentin administered without morphine .
mechanism(e1,e2)	0	3	acetazolamide may elevate cyclosporine levels .
None(e1,e2)	27	30	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	8	10	inhibitors or substrates of cyp2d6 ( i.e. , quinidine , selective_serotonin_reuptake_inhibitors [ ssris ] ) may increase the plasma concentration of doxepin when administered concomitantly .
None(e1,e2)	2	6	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	10	12	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	35	58	the results of a study of coadministration of ethambutol ( 50 mg/kg ) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20 % and 13 % , respectively , suggesting that the oral absorption of ethambutol may be reduced by these antacid_products .
None(e1,e2)	14	16	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	5	33	concomitant administration of diflunisal and acetaminophen in dogs , but not in rats , at approximately 2 times the recommended maximum human therapeutic dose of each ( 40 to 52 mg/kg/day of diflunisal/ acetaminophen ) resulted in greater gastrointestinal toxicity than when either drug was administered alone .
None(e1,e2)	5	9	cardiovascular agents ( e.g. , atenolol , hydrochlorothiazide , propranolol ) .
None(e1,e2)	13	37	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	44	75	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	8	19	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen .in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	66	68	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	93	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	22	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	16	24	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	22	26	the following medications have been administered in clinical trials with simulect with no increase in adverse reactions : atg/alg , azathioprine , corticosteroids , cyclosporine , mycophenolate_mofetil , and muromonab-cd3 .
None(e1,e2)	0	2	carbamazepine : tiagabine had no effect on the steady-state plasma concentrations of carbamazepine or its epoxide metabolite in patients with epilepsy .
None(e1,e2)	3	7	protease inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination hormonal contraceptives ;
None(e1,e2)	2	13	iodine or iodine excess may decrease the effect of carbimazole , and an iodine deficiency can increase the effect of carbimazole .
None(e1,e2)	3	11	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
None(e1,e2)	6	13	lotensin has been used concomitantly with beta-adrenergic-blocking_agents , calcium-channel-blocking agents , diuretics , digoxin , and hydralazine , without evidence of clinically important adverse interactions .
None(e1,e2)	17	44	plasma exposure of diazepam ( 10 mg bid ) was increased by 28 % following administration of valdecoxib ( 40 mg bid ) for 12 days , while plasma exposure of valdecoxib ( 40 mg bid ) was not substantially increased following administration of diazepam ( 10 mg bid ) for 12 days .
None(e1,e2)	9	26	concomitant administration of sonata ( 10 mg ) and cimetidine ( 800 mg ) produced an 85 % increase in the mean cmax and auc of zaleplon .
None(e1,e2)	21	23	notably , systemic exposure ( auc0-12 ) of dapsone hydroxylamine ( dha ) was more than doubled in the presence of tmp / smx .
None(e1,e2)	87	138	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	17	spontaneous reports of serotonin syndrome associated with co-administration of zyvox and serotonergic_agents , including antidepressants such as selective_serotonin_reuptake_inhibitors ( ssris ) , have been reported .
None(e1,e2)	12	14	in addition , under the influence of sympatholytic medicinal products such as beta-blockers , clonidine , guanethidine , and reserpine , the signs of hypoglycemia may be reduced or absent .
effect(e1,e2)	5	10	co-administration : concomitant use of argatroban with antiplatelet agents , thrombolytics , and other anticoagulants may increase the risk of bleeding .
None(e1,e2)	21	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	11	41	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	77	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	27	34	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
mechanism(e1,e2)	3	7	furosemide : when aliskiren was co-administered with furosemide , the auc and cmax of furosemide were reduced by about 30 % and 50 % , respectively .
None(e1,e2)	38	52	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	24	insulin : a clinical study in 6 insulin-dependent diabetic patients demonstrated no effect of extraneal on insulin absorption from the peritoneal cavity or on insulin s ability to control blood glucose when insulin was administered intraperitoneally with extraneal .
None(e1,e2)	9	11	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
effect(e1,e2)	2	10	co-administration of nelfinavir at steady-state with a single dose of azithromycin ( 2 x 600 mg tablets ) results in increased azithromycin serum concentrations .
None(e1,e2)	23	45	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	2	33	effects of erythromycin on felbatol the coadministration of erythromycin ( 1000 mg/day ) for 10 days did not alter the pharmacokinetic parameters of cmax , cmin , auc , ci/kg or tmax at felbamate daily doses of 3000 or 3600 mg/day in 10 otherwise healthy subjects with epilepsy .
None(e1,e2)	11	18	upon administration of 10 mg of vardenafil with 800 mg tid indinavir , the cmax and auc of indinavir were reduced by 40 % and 30 % , respectively .
None(e1,e2)	23	31	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	9	15	however , co-administration of duloxetine with aluminum- and magnesium-containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
None(e1,e2)	57	81	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	4	19	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen .in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	10	12	concomitant crohn s disease medications were antibiotics , antivirals , corticosteroids , 6-mp /aza and aminosalicylates .
None(e1,e2)	11	13	azlocillin should not be administered concomitantly with amikacin , ciprofloxacin , gentamicin , netilmicin , or tobramycin .
None(e1,e2)	59	80	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	0	6	leucovorin may enhance the toxicity of 5-fluorouracil .
None(e1,e2)	10	13	- a sulfa-based drug such as sulfamethoxazole-trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
advise(e1,e2)	2	17	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
None(e1,e2)	13	24	methotrexate : in an interaction study of rheumatoid arthritis patients taking methotrexate , celebrex did not have a significant effect on the pharmacokinetics of methotrexate .
None(e1,e2)	11	28	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel_blocking_drugs , and isoniazid .
None(e1,e2)	48	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	5	18	interactions for vitamin b3 ( niacin ) : antihypertensive therapy : nicotinic acid may potentiate the effects of ganglionic_blocking_agents and vasoactive drugs resulting in postural hypotension .
None(e1,e2)	0	8	pyrantel ( e.g. , antiminth ) - taking piperazine and pyrantel together may decrease the effects of piperazine .
mechanism(e1,e2)	6	31	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	21	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	23	25	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	76	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	139	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	47	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	44	83	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	25	30	increases in plasma levels of tricyclic antidepressants , and in the frequency and severity of side effects , particularly anticholinergic , have been reported when cimetidine was added to the drug regimen .
None(e1,e2)	35	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	24	80	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	42	49	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	12	26	it is , however , possible that concomitant use of other known photosensitizing_agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	48	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	18	in addition , drugs that are actively secreted via this route ( e.g. , triamterene , metformin and amiloride ) should be co-administered with care as they might increase dofetilide levels .
None(e1,e2)	57	76	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	83	85	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	5	15	therefore , increased monitoring of digoxin is recommended when initiating , adjusting , or discontinuing coreg .
None(e1,e2)	14	18	other strong inhibitors of cyp3a4 ( e.g. , itraconazole , clarithromycin , nefazodone , troleandomycin , ritonavir , nelfinavir ) would be expected to behave similarly .
None(e1,e2)	0	4	digoxin , methotrexate , cyclosporine : diclofenac , like other nsaids , may affect renal prostaglandins and increase the toxicity of certain drugs .
None(e1,e2)	30	35	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	14	dolasetron_mesylate did not inhibit the antitumor activity of four chemotherapeutic agents ( cisplatin , 5-fluorouracil , doxorubicin , cyclophosphamide ) in four murine models .
None(e1,e2)	8	19	probenecid : concomitant administration of toradol oral and probenecid resulted in decreased clearance of ketorolac and significant increases in ketorolac plasma levels ( total auc increased approximately threefold from 5.4 to 17.8 m g/h/ml ) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours .
None(e1,e2)	15	43	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	24	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium_channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	12	14	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
mechanism(e1,e2)	19	40	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	133	136	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	18	although deferasirox has a lower affinity for aluminum than for iron , exjade should not be taken with aluminum -containing antacid preparations .
effect(e1,e2)	0	14	quinolones , including norfloxacin , may enhance the effects of oral anticoagulants , including warfarin or its derivatives or similar agents .
int(e1,e2)	0	5	beta-adrenergic_blocking_agents may also interact with sympathomimetics .
int(e1,e2)	4	10	possible drug interactions of humorsol with succinylcholine or with other anticholinesterase_agents .
None(e1,e2)	14	16	although not studied systematically in clinical trials , no drug interactions were observed when vecuronium , pancuronium , or atracurium were administered following varying degrees of recovery from single doses or infusions of nimbex .
None(e1,e2)	34	70	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	24	45	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	0	35	central_nervous_system_depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	55	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	11	- methyldopa ( e.g. , aldomet ) use of methyldopa with sulfapyridine may increase the chance of side effects affecting the liver and/or the blood
None(e1,e2)	15	29	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	81	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	2	11	theophylline : grepafloxacin is a competitive inhibitor of the metabolism of theophylline .
None(e1,e2)	23	36	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	13	18	although the clinical significance is not known , it is not recommended that cefditoren_pivoxil be taken concomitantly with h2_receptor_antagonists .
None(e1,e2)	21	33	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	6	19	beta-blocking agents a pharmacokinetic study of felodipine in conjunction with metoprolol demonstrated no significant effects on the pharmacokinetics of felodipine .
effect(e1,e2)	22	27	sumatriptan - there have been rare postmarketing reports describing patients with weakness , hyperreflexia , and incoordination following the use of a selective_serotonin_reuptake_inhibitor ( ssri ) and sumatriptan .
None(e1,e2)	16	27	however , patients on digoxin may show elevations of digoxin concentrations after initiation of therapy with flolan , which may be clinically significant in patients prone to digoxin toxicity .
None(e1,e2)	43	49	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	3	10	drug interactions with beta-blockers : concomitant use of fenoldopam with beta-blockers should be avoided .
None(e1,e2)	23	33	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	40	50	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	9	13	medications can interfere with folate utilization , including : anticonvulsant_medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	0	3	benzodiazepines : combination hormonal_contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
effect(e1,e2)	14	53	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	3	19	other interactions : vardenafil had no effect on the pharmacodynamics of glyburide ( glucose and insulin concentrations ) and warfarin ( prothrombin time or other pharmacodynamic parameters ) .
None(e1,e2)	58	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	22	29	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	6	21	there is limited experience with concomitant antihypertensive_agents such as alpha-blockers , calcium channel-blockers , ace inhibitors , and diuretics ( both thiazide -like and loop ) .
None(e1,e2)	14	22	oral contraceptives multiple doses of cefditoren pivoxil had no effect on the pharmacokinetics of ethinyl_estradiol , the estrogenic component in most oral contraceptives .
None(e1,e2)	27	31	a drug-drug interaction study evaluated the effect of the use of aczone gel , 5 % , in combination with double strength ( 160 mg/800 mg ) trimethoprim /sulfamethoxazole ( tmp/ smx ) .
None(e1,e2)	15	23	spontaneous reports of serotonin syndrome associated with co-administration of zyvox and serotonergic agents , including antidepressants such as selective serotonin reuptake inhibitors ( ssris ) , have been reported .
None(e1,e2)	34	44	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	54	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	73	86	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	5	12	therefore the , combination of anakinra with other tnf-blocking agents , including humira , may also result i n similar toxicities .
None(e1,e2)	50	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	4	sedative/hypnotics : midazolam , triazolam
None(e1,e2)	21	34	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	18	29	in a study involving 12 adult volunteers , toradoloral was coadministered with a single dose of 25 mg warfarin , causing no significant changes in pharmacokinetics or pharmacodynamics of warfarin .
None(e1,e2)	10	12	other : there appears to be no pharmacokinetic interaction between acitretin and cimetidine , digoxin , or glyburide .
None(e1,e2)	20	32	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium_channel_blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
effect(e1,e2)	17	20	there is one reported case of a patient with acute delirium associated with the simultaneous use of fluphenazine and oral clonidine .
advise(e1,e2)	34	45	digitalis : immediate release capsules : since there have been isolated reports of patients with elevated digoxin levels , and there is a possible interaction between digoxin and nifedipine , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over- or under-digitalization .
None(e1,e2)	19	53	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	22	42	effects of felbatol on low-dose combination oral contraceptives a group of 24 nonsmoking , healthy white female volunteers established on an oral contraceptive regimen containing 30 mg ethinyl estradiol and 75 mg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle ( day 15 ) to midcycle ( day 14 ) of two consecutive oral contraceptive cycles .
None(e1,e2)	26	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	50	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth_subsalicylate ( pepto-bismol ) ;
None(e1,e2)	16	18	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	47	58	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic_acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	42	51	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	35	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	9	50	medications can interfere with folate utilization , including : anticonvulsant_medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	28	30	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin_b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	0	2	systemic_corticosteroids : systemic_corticosteroids are known to cause osteoporosis .
mechanism(e1,e2)	3	6	even when an aminoglycoside and a penicillin -type drug are administered separately by different routes , a reduction in aminoglycoside serum half-life or serum levels has been reported in patients with impaired renal function and in some patients with normal renal function .
effect(e1,e2)	0	7	phospholine_iodide potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and carbamate insecticides .
None(e1,e2)	17	74	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	0	23	methotrexate : concomitant administration of methotrexate and some nsaids has been reported to reduce the clearance of methotrexate , enhancing the toxicity of methotrexate .
None(e1,e2)	17	38	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal_anti-inflammatory_agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	9	11	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
None(e1,e2)	43	59	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	20	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
None(e1,e2)	19	23	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
mechanism(e1,e2)	0	18	cimetidine at doses of 100 mg bid ( otc dose ) resulted in a 13 % increase in dofetilide plasma levels ( 500 mcg single dose ) .
None(e1,e2)	59	97	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	5	simultaneous use of activated_prothrombin_complex_concentrates or prothrombin_complex_concentrates should be avoided .
None(e1,e2)	54	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	11	14	animal experience indicates that clorazepate dipotassium prolongs the sleeping time after hexobarbital or after ethyl_alcohol , increases the inhibitory effects of chlorpromazine , but does not exhibit monoamine oxidase inhibition .
None(e1,e2)	0	8	lithium -a drug interaction study of eplerenone with lithium has not been conducted .
None(e1,e2)	25	27	since pletal is extensively metabolized by cytochrome p-450 isoenzymes , caution should be exercised when pletal is coadministered with inhibitors of c.p.a . such as ketoconazole and erythromycin or inhibitors of cyp2c19 such as omeprazole .
None(e1,e2)	56	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	20	triazolam - combined administration of racemic citalopram ( titrated to 40 mg/day for 28 days ) and the cyp3a4 substrate triazolam ( single dose of 0.25 mg ) did not significantly affect the pharmacokinetics of either citalopram or triazolam .
None(e1,e2)	13	16	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/ hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	20	25	drug/laboratory tests interactions because false positive readings were reported with the ames n-multistix sg dipstick test for urinary protein when gabapentin was added to other antiepileptic_drugs , the more specific sulfosalicylic acid precipitation procedure is recommended to determine the presence of urine protein
None(e1,e2)	19	138	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	8	24	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine_class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety_agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	0	16	antihypertensive_medications , other , especially diazoxide , or preanesthetic and anesthetic agents used in surgery or skeletal-muscle_relaxants , nondepolarizing , used in surgery
None(e1,e2)	6	8	pharmacokinetic studies indicate that administration of disulfiram or diazepam does not affect the pharmacokinetics of acamprosate .
None(e1,e2)	12	22	at 24 hours postdose , a similar proportion of patients treated with methotrexate alone ( 94 % ) and subsequently treated with methotrexate co-administered with 75 mg of rofecoxib ( 88 % ) had methotrexate plasma concentrations below the measurable limit ( 5 ng/ml ) .
None(e1,e2)	7	25	however , concomitant administration of aspirin with celebrex may result in an increased rate of gi ulceration or other complications , compared to use of celebrex alone .
None(e1,e2)	3	9	as with other antihypertensive_agents , the antihypertensive effect of losartan may be blunted by the non-steroidal anti-inflammatory drug indomethacin
mechanism(e1,e2)	10	13	cytochrome p-450 inducers , such as phenytoin , carbamazepine and phenobarbital , induce clonazepam metabolism , causing an approximately 30 % decrease in plasma clonazepam levels .
None(e1,e2)	15	47	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta_blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide_diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	19	33	an adequate period of observation must be provided for any patient in whom either long-acting benzodiazepines ( such as diazepam ) or large doses of short-acting benzodiazepines ( such as 10 mg of midazolam ) have been used .
None(e1,e2)	8	37	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	57	106	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	1	5	- disulfiram ( e.g. , antabuse ) or
mechanism(e1,e2)	11	46	binding to serum proteins : the following agents may either inhibit levothyroxine_sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic_acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	59	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	29	in vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the pk properties of anagrelide , nor does anagrelide affect the pk properties of digoxin or warfarin .
None(e1,e2)	49	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	44	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	45	49	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type_1c_antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	3	5	insulin or oral hypoglycemics : agents_with_b-blocking_properties may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics .
None(e1,e2)	20	36	triazolam - combined administration of racemic citalopram ( titrated to 40 mg/day for 28 days ) and the cyp3a4 substrate triazolam ( single dose of 0.25 mg ) did not significantly affect the pharmacokinetics of either citalopram or triazolam .
None(e1,e2)	26	42	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	32	77	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	0	19	ethanol or triazolam : no significant differences were observed in the pharmacokinetics of triazolam ( 0.125 mg ) and tiagabine ( 10 mg ) when given together as a single dose .
None(e1,e2)	1	8	when carbamazepine is added to aripiprazole therapy , aripiprazole dose should be doubled .
None(e1,e2)	7	24	metoclopramide : when coadministered with monurol , metoclopramide , a drug which increases gastrointestinal motility , lowers the serum concentration and urinary excretion of fosfomycin .
None(e1,e2)	23	37	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	2	5	co-administration with antifungal_agents such as ketoconazole or itraconazole is not recommended .
effect(e1,e2)	2	32	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants .when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	9	13	compounds tested in man include warfarin , theophylline , phenytoin , diazepam , aminopyrine and antipyrine .
None(e1,e2)	4	6	certain other antibiotics ( aminoglycosides and polymyxin ) have also been reported to interfere with the nerve transmission at the neuromuscular junction .
None(e1,e2)	28	45	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	20	27	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	73	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	21	dopamine antagonists : since apomorphine is a dopamine_agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	2	6	additionally , anti-malarial_drugs , such as chloroquine and mefloquine , may antagonize the activity of carbamazepine .
None(e1,e2)	122	126	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	5	7	drugs that alter renal excretion ibuprofen : ibuprofen is known to affect renal function and , consequently , alter the renal excretion of other drugs .
None(e1,e2)	14	17	other : there appears to be no pharmacokinetic interaction between acitretin and cimetidine , digoxin , or glyburide .
effect(e1,e2)	4	21	renal clearance measurements of pah can not be made with any significant accuracy in patients receiving sulfonamides , procaine , or thiazolesulfone .
advise(e1,e2)	2	9	patients on lithium treatment should be closely monitored when celebrex is introduced or withdrawn .
mechanism(e1,e2)	2	13	cimetidine : cimetidine has been demonstrated to interfere with the elimination of other quinolones .
None(e1,e2)	45	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	20	33	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	8	12	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	27	44	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic_acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta_blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	41	58	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	2	probenecid or cimetidine : concomitant administration of probenecid or cimetidine decreases the elimination of zalcitabine , most likely by inhibition of renal tubular secretion of zalcitabine .
advise(e1,e2)	7	31	anticoagulants : while studies have not shown diclofenac to interact with anticoagulants of the warfarin type , caution should be exercised , nonetheless , since interactions have been seen with other nsaids .
None(e1,e2)	23	27	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	57	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	13	strong inducers of cytochrome p450 enzymes ( i.e . carbamazepine , phenytoin and phenobarbital ) have been shown to decrease the plasma levels of mhd ( 29-40 % ) .
None(e1,e2)	73	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	3	15	use of antithrombotics aspirin and heparin have been administered concomitantly with and following infusions of activase in the management of acute myocardial infarction or pulmonary embolism .
None(e1,e2)	9	11	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	2	6	fluoxetine , fluvoxamine , paroxetine , sertraline ) .
None(e1,e2)	0	2	ethosuximide : amphetamines may delay intestinal absorption of ethosuximide .
None(e1,e2)	21	43	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis_preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium_chloride , folic acid , and acetaminophen .
None(e1,e2)	6	11	lotensin has been used concomitantly with beta-adrenergic-blocking_agents , calcium-channel-blocking agents , diuretics , digoxin , and hydralazine , without evidence of clinically important adverse interactions .
None(e1,e2)	0	6	ketoconazole /itraconazole , macrolides , including erythromycin
None(e1,e2)	40	43	in vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce , inhibit , or are metabolized by cytochrome p450 3a4 , such as cyclosporine , terfenadine , ketoconazole , erythromycin , and troleandomycin .
effect(e1,e2)	10	12	if signs and symptoms suggestive of digoxin toxicity occur when enoxacin and digoxin are given concomitantly , physicians are advised to obtain serum digoxin levels and adjust digoxin doses appropriately .
None(e1,e2)	3	10	the pharmacokinetics of benzodiazepines are unaltered in the presence of flumazenil and vice versa .
None(e1,e2)	19	21	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	21	28	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	69	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	18	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	32	63	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	10	33	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	19	21	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
None(e1,e2)	25	27	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 3a4 ( cyp 3a4 ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
None(e1,e2)	34	38	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting_enzyme_(_ace_)_inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	26	28	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin_b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	87	148	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	39	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline_salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	11	22	notably , systemic exposure ( auc0-12 ) of dapsone hydroxylamine ( dha ) was more than doubled in the presence of tmp/ smx .
None(e1,e2)	2	16	- a diuretic ( water pill ) such as hydrochlorothiazide ( hctz , hydrodiuril ) , chlorothiazide ( diuril ) , and others ;
None(e1,e2)	12	16	these agents include medications such as : anticoagulants , platelet inhibitors including acetylsalicylic_acid , sali-cylates , nsaids ( including ketorolac tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	18	23	in vitro studies have shown no binding displacement between entacapone and other highly bound drugs , such as warfarin , salicylic acid , phenylbutazone , and diazepam .
None(e1,e2)	20	29	1- nc denotes a mean change of less than 10 % 2- pediatrics 3- mean increase in adults at high trileptal doses in vivo , the plasma levels of phenytoin increased by up to 40 % , when trileptal was given at doses above 1200 mg/day .
None(e1,e2)	14	22	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	17	22	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	100	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	17	5ht3_antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	90	98	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	45	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	0	2	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	13	21	no dose adjustment is necessary when simulect is added to triple-immunosuppression regimens including cyclosporine , corticosteroids , and either azathioprine or mycophenolate_mofetil .
None(e1,e2)	6	18	digoxin : plasma digoxin levels and digoxin clearance at steady-state were not affected by co-administration of 0.2 mg cerivastatin_sodium .
None(e1,e2)	38	49	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	9	36	drugs that may have their plasma concentration altered by gleevec gleevec increases the mean cmax and auc of simvastatin ( cyp3a4 substrate ) 2- and 3.5-fold , respectively , suggesting an inhibition of the cyp3a4 by gleevec .
None(e1,e2)	45	55	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex_sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
mechanism(e1,e2)	18	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	35	if desipramine_hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	4	6	a dose increase of lopinavir / ritonavir to 533/133 mg twice daily with food isrecommended in combination with nevirapine .
None(e1,e2)	21	76	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	5	11	in controlled clinical trials of augmentin_xr , 22 patients received concomitant allopurinol and augmentin xr .
None(e1,e2)	34	60	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	109	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	70	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	23	32	drug interactions with antacids administration of 120 mg of fexofenadine hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
None(e1,e2)	10	17	caution should be observed when anileridine is coadministered with other opioids , sedatives , phenothiazines , or anesthetics , as these agents may increase respiratory and circulatory depression .
None(e1,e2)	14	29	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	57	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	38	47	the plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decrease by concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and adjustment of the dosage of imipramine may therefore be necessary .
None(e1,e2)	20	38	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	11	43	quinidine : coadministration of a 10-mg single dose of aripiprazole with quinidine ( 166 mg/day for 13 days ) , a potent inhibitor of cyp2d6 , increased the auc of aripiprazole by 112 % but decreased the auc of its active metabolite , dehydroaripiprazole , by 35 % .
None(e1,e2)	0	28	levothyroxine_sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous_sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
mechanism(e1,e2)	6	15	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	0	29	probenecid : probenecid , a renal tubular secretion blocking agent , administered at a dose of 500 mg four times a day , did not change the pharmacokinetics of levetiracetam 1000 mg twice daily .
None(e1,e2)	16	20	additive depressant effect when used with general anesthetics , sedatives , antianxiety drugs , hypnotics , alcohol , and other opiate_analgesics .
None(e1,e2)	52	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	20	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
effect(e1,e2)	1	7	- lofexidine may enhance the effects of anti-hypertensive_drug therapy
None(e1,e2)	33	53	because of the increased risk of adverse reactions in patients who have been taking benzodiazepines on a regular basis , it is particularly important that physicians query patients or their guardians carefully about benzodiazepine , alcohol and sedative use as part of the history prior to any procedure in which the use of romazicon is planned .
None(e1,e2)	18	20	magnesium/aluminum-containing antacid products : absorption of zalcitabine is moderately reduced ( approximately 25 % ) when coadministered with magnesium /aluminum-containing antacid_products .
None(e1,e2)	20	23	these agents include medications such as : anticoagulants , platelet inhibitors including acetylsalicylic acid , sali-cylates , nsaids ( including ketorolac_tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	44	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	42	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	30	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	5	analgesic /anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	39	41	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	20	prior administration of succinylcholine had no effect on the duration of neuromuscular block following initial or maintenance bolus doses of nimbex .
None(e1,e2)	9	29	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	4	7	anticoagulants : potentiation of warfarin -type ( cyp2c9 and cyp3a4 substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .
None(e1,e2)	21	23	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace_inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	2	24	ketoconazole : ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60 % , leading to increased risk of corticosteroid side effects .
None(e1,e2)	0	45	alprazolam : when fluvoxamine maleate ( 100 mg qd ) and alprazolam ( 1 mg q.d . were co-administered to steady state , plasma concentration and other pharmacokinetics parameters ( auc , cmax , t1/2 , ) of alprazolam were approximately twice those observed when alprazolam was administered alone ;
None(e1,e2)	8	11	however , because bleeding has been reported when ibuprofen and other nonsteroidal_anti-inflammatory_agents have been administered to patients on coumarin-type anticoagulants , the physician should be cautious when administering ibuprofen to patients on anticoagulants .
None(e1,e2)	4	31	antibiotics ( ampicillin , tetracycline ) : pregnancy has been reported following concomitant use , however , pharmacokinetic studies have not shown consistent effects with these antibiotics on plasma concentrations of synthetic_steroids .
advise(e1,e2)	32	48	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	4	14	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
None(e1,e2)	5	27	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	12	19	additional reductions in blood pressure may occur when flolan is administered with diuretics , antihypertensive agents , or other vasodilators .
None(e1,e2)	8	21	notably , systemic exposure ( auc0-12 ) of dapsone_hydroxylamine ( dha ) was more than doubled in the presence of tmp/ smx .
None(e1,e2)	15	30	although increased plasma concentrations ( c max and auc 0-24 hrs ) of desloratadine and 3-hydroxydesloratadine were observed , there were no clinically relevant changes in the safety profile of desloratadine , as assessed by electrocardiographic parameters ( including the corrected qt interval ) , clinical laboratory tests , vital signs , and adverse events .
None(e1,e2)	16	31	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	3	32	drug interactions with antacids administration of 120 mg of fexofenadine hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
None(e1,e2)	8	16	skeletal muscle relaxants , nondepolarizing ( e.g. , tubocurarine ) : possible increased responsiveness to the muscle_relaxant .
effect(e1,e2)	8	26	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	0	24	ace_inhibitors and angiotensin ii receptor antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace inhibitors or angiotensin ii receptor antagonists ( acei/arb ) .
None(e1,e2)	64	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	22	37	results of studies in multiple sclerosis patients taking tysabri and concomitant interferon beta-1a ( avonex 30 mcg im once weekly ) or glatiramer_acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer_acetate .
None(e1,e2)	16	20	other drug interactions : no pharmacokinetic interactions were observed between vardenafil and the following drugs : glyburide , warfarin , digoxin , maalox , and ranitidine .
None(e1,e2)	4	30	total body clearance of simulect was reduced by an average 22 % and 51 % when azathioprine and mycophenolate mofetil , respectively , were added to a regimen consisting of cyclosporine , usp ( modified ) and corticosteroids .
effect(e1,e2)	0	14	edecrin may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin_antibiotics .
None(e1,e2)	15	24	because there is a theoretical basis that these effects may be additive , use of ergotamine -containing or ergot-type medications ( like dihydroergotamine or methysergide ) and axert within 24 hours of each other should be avoided .
None(e1,e2)	18	23	lithium reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ace_inhibitors , and with some angiotensin_ii_receptor_antagonists .
None(e1,e2)	8	26	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	19	31	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	85	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	19	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	40	42	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	2	16	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	9	20	diclofenac : administration of morning and lunch doses of starlix 120 mg in combination with a single 75-mg dose of diclofenac in healthy volunteers resulted in no significant changes to the pharmacokinetics of either agent .
None(e1,e2)	32	45	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	6	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	48	58	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel_blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa_reductase_inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	10	12	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-htv agonists .
None(e1,e2)	85	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	11	tetracycline , a bacteriostatic_antibiotic , may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided .
None(e1,e2)	3	14	the effects of ergomar may be potentiated by triacetyloleandomycin which inhibits the metabolism of ergotamine .
None(e1,e2)	0	28	alcohol - although lexapro did not potentiate the cognitive and motor effects of alcohol in a clinical trial , as with other psychotropic medications , the use of alcohol by patients taking lexapro is not recommended .
None(e1,e2)	45	58	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic_acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	6	14	dose adjustment is not recommended . levetiracetam had no effect on plasma concentrations of carbamazepine , valproate , topiramate , or lamotrigine .
mechanism(e1,e2)	13	20	cimetidine - in subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of 400 mg/day cimetidine for 8 days resulted in an increase in citalopram auc and cmax of 43 % and 39 % , respectively .
None(e1,e2)	10	19	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	29	38	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	15	17	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co-administered with other psychotropic_medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
None(e1,e2)	3	26	therefore , when hydrochlorothiazide and non-steroidal anti-inflammatory agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained .
mechanism(e1,e2)	14	23	products containing calcium and other multivalent cations ( such as aluminum , magnesium , iron ) are likely to interfere with absorption of ibandronate .
None(e1,e2)	0	22	lithium : in a study conducted in healthy subjects , mean steady-state lithium plasma levels increased approximately 17 % in subjects receiving lithium 450 mg bid with celebrex 200 mg bid as compared to subjects receiving lithium alone .
None(e1,e2)	26	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	19	23	however , other published reports describe modest elevations ( less than two-fold ) of clozapine and metabolite concentrations when clozapine was taken with paroxetine , fluoxetine , and sertraline .
None(e1,e2)	0	20	iron_supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron ( as feso4 ) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80 % and 31 % , respectively .
None(e1,e2)	0	18	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic acid , and warfarin .
None(e1,e2)	16	37	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	7	15	it is recommended that in patients taking anticoagulants , prothrombin time be determined before starting lovastatin and frequently enough during early therapy to insure that no significant alteration of prothrombin time occurs .
None(e1,e2)	49	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	76	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	3	17	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	37	59	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	23	28	monoamine oxidase inhibitors and tricyclic antidepressants : foradil should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic_antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	20	25	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type_1c_antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	21	24	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	8	19	antiretroviral agents : no drug interactions with other antiretroviral_medications have been identified that would warrant alteration of either the enfuvirtide dose or the dose of the other antiretroviral medication .
None(e1,e2)	37	51	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
advise(e1,e2)	11	24	this time window is different than for other oral formulations of ciprofloxacin , which are usually administered 2 hours before or 6 hours after antacids .
None(e1,e2)	22	24	sumatriptan - there have been rare postmarketing reports describing patients with weakness , hyperreflexia , and incoordination following the use of a selective_serotonin_reuptake_inhibitor ( ssri ) and sumatriptan .
None(e1,e2)	0	3	cyclosporine : because cyclosporine can produce nephrotoxicity with decreases in creatinine clearance and rises in serum creatinine , and because renal excretion is the primary elimination route of fibrate drugs including tricor , there is a risk that an interaction will lead to deterioration .
None(e1,e2)	1	20	oral contraceptives : multiple dose administration of tiagabine ( 8 mg/day monotherapy ) did not alter the pharmacokinetics of oral contraceptives in healthy women of childbearing age .
None(e1,e2)	13	15	no dose adjustment is necessary when simulect is added to triple-immunosuppression regimens including cyclosporine , corticosteroids , and either azathioprine or mycophenolate mofetil .
None(e1,e2)	51	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	64	aspirin/acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
None(e1,e2)	7	9	nursing mothers it is not known whether peginterferon or ribavirin or its components are excreted in human milk .
None(e1,e2)	46	87	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	17	however , no deleterious interactions were seen when romazicon was administered after narcotics , inhalational anesthetics , muscle_relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia .
None(e1,e2)	6	24	potentiation of the hypotensive effects of nitrates for patients with ischemic heart disease has not been evaluated , and concomitant use of vardenafil and nitrates is contraindicated .
None(e1,e2)	0	2	cimetidine : atorvastatin plasma concentrations and ldl-c reduction were not altered by coadministration of cimetidine .
None(e1,e2)	0	8	probenecid : as with other b-lactam antibiotics , probenecid inhibits the renal excretion of cefdinir , resulting in an approximate doubling in a.c. a 54 % increase in peak cefdinir plasma levels , and a 50 % prolongation in the apparent elimination half-life .
None(e1,e2)	0	7	somatrem /somatropin : excessive concurrent use of thyroid_hormone may accelerate epiphyseal closure .
None(e1,e2)	43	45	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
mechanism(e1,e2)	8	26	reciprocal interactions may occur with concomitant use of antizol and drugs that increase or inhibit the cytochrome p450 system ( e.g. , phenytoin , carbamazepine , cimetidine , ketoconazole ) , though this has not been studied
mechanism(e1,e2)	2	8	lithium : ibuprofen produced an elevation of plasma lithium levels and a reduction in renal lithium clearance in a study of eleven normal volunteers .
None(e1,e2)	17	35	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	21	66	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	26	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	0	7	acetaminophen : may increase plasma concentration of synthetic_estrogens , possibly by inhibiting conjugation .
None(e1,e2)	0	6	methadone : coadministration of amprenavir and methadone can decrease plasma levels of methadone .
None(e1,e2)	5	22	conversely , the administration of stadol_ns ( 1 mg butorphanol qid ) did not alter the pharmacokinetics of a 300-mg dose of cimetidine .
None(e1,e2)	11	13	an interaction study with warfarin showed no clinically significant effect of anastrozole on warfarin pharmacokinetics or anticoagulant activity .
None(e1,e2)	31	47	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	65	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	32	44	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	51	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	29	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	43	however , a crossover study in healthy subjects receiving either tagamet 300 mg q.i.d . or 800 mg h.s . concomitantly with a 300 mg b.i.d . dosage of theophylline ( theo-dur , key pharmaceuticals , inc. ) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s . regimen , particularly in subjects aged 54 years and older .
None(e1,e2)	2	5	naproxen , naproxen_sodium and other nsaids have been reported to reduce the tubular secretion of methotrexate in an animal model , possibly increasing the toxicity of methotrexate .
None(e1,e2)	38	40	as mhd , the predominant plasma substrate , is only a weak inducer of udp-glucuronyl transferase , it is unlikely to have an effect on drugs that are mainly eliminated by conjugation through udp-glucuronyl transferase ( e.g. , valproic_acid , lamotrigine ) .
None(e1,e2)	20	24	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	10	12	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	12	22	probenecid : as with other b-lactam antibiotics , co-administration of probenecid with cefditoren_pivoxil resulted in an increase in the plasma exposure of cefditoren , with a 49 % increase in mean cmax , a 122 % increase in mean auc , and a 53 % increase in half-life .
None(e1,e2)	16	18	doxazosin mesylate has been administered without any evidence of an adverse drug interaction to patients receiving thiazide_diuretics , beta-blocking_agent s , and nonsteroidal anti-inflammatory drugs .
None(e1,e2)	85	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	36	44	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	16	19	coumarin anticoagulants altered coagulation parameters and/or bleeding have been reported in patients taking capecitabine concomitantly with coumarin-derivative_anticoagulants such as warfarin and phenprocoumon .
None(e1,e2)	68	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	46	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
None(e1,e2)	28	51	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	34	43	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	85	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	15	17	drugs that cause significant sustained elevation in gastric ph ( histamine h2-receptor antagonists such as ranitidine or cimetidine ) may reduce plasma concentrations of iressa and therefore potentially may reduce efficacy .
None(e1,e2)	40	59	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	6	10	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
mechanism(e1,e2)	4	11	steady-state serum concentrations of tricyclic_antidepressants are reported to fluctuate significantly when cimetidine is either added or deleted from the drug regimen .
None(e1,e2)	11	31	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
None(e1,e2)	0	11	alprazolam : when fluvoxamine maleate ( 100 mg qd ) and alprazolam ( 1 mg q.d . were co-administered to steady state , plasma concentration and other pharmacokinetics parameters ( auc , cmax , t1/2 , ) of alprazolam were approximately twice those observed when alprazolam was administered alone ;
None(e1,e2)	12	16	no interactions have been observed between nizatidine and theophylline , chlordiazepoxide , lorazepam , lidocaine , phenytoin , and warfarin .
None(e1,e2)	1	7	- vitamin_k ( e.g. , aquamephyton , synkayvite ) use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood
None(e1,e2)	9	11	co-medications that induce cyp3a4 ( e.g. , dexamethasone , phenytoin , carbamazepine , rifampin , phenobarbital or st .
None(e1,e2)	3	10	protease inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination hormonal contraceptives ;
None(e1,e2)	3	6	drug interaction with erythromycin and ketoconazole fexofenadine has been shown to exhibit minimal ( ca . 5 % ) metabolism .
None(e1,e2)	13	17	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	24	36	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	32	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	11	the potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via cyp3a4 ( alprazolam , triazolam ) should be considered when coadministering these agents with aprepitant .
None(e1,e2)	24	29	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium channel antagonists , angiotensin converting enzyme inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	34	41	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	4	19	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	6	18	theophylline - combined administration of racemic citalopram ( 40 mg/day for 21 days ) and the cyp1a2 substrate theophylline ( single dose of 300 mg ) did not affect the pharmacokinetics of theophylline .
None(e1,e2)	55	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	14	anesthetics /sedatives/hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	0	9	lithium : diclofenac decreases lithium renal clearance and increases lithium plasma levels .
None(e1,e2)	28	49	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics * ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	55	77	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	26	32	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	8	29	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	14	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	16	28	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin_b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	17	22	in patients given very high doses ( 3900 mg ) of aspirin daily , increases in serum salicylate levels were seen when nizatidine , 150 mg b.i.d. , was administered concurrently .
effect(e1,e2)	0	8	isoflurane potentiates the muscle relaxant effect of all muscle_relaxants , most notably nondepolarizing muscle relaxants , and mac ( minimum alveolar concentration ) is reduced by concomitant administration of n 2o .
None(e1,e2)	127	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	46	56	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	9	18	the use of mao inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone .
None(e1,e2)	48	50	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	8	18	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	10	12	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	18	36	digoxin - in subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of citalopram and digoxin ( single dose of 1 mg ) did not significantly affect the pharmacokinetics of either citalopram or digoxin .
None(e1,e2)	24	32	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	0	20	beta-adrenergic_blocking_agents : experience in over 1400 patients in a non-comparative clinical trial has shown that concomitant administration of nifedipine and beta-blocking_agents is usually well tolerated , but there have been occasional literature reports suggesting that the combination may increase the likelihood of congestive heart failure , severe hypotension or exacerbation of angina .
mechanism(e1,e2)	2	9	lithium : nsaids have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance .
None(e1,e2)	6	10	in clinical studies , coadministration of welchol with atorvastatin , lovastatin , or simvastatin did not interfere with the lipid-lowering activity of the hmg-coa reductase inhibitor .
None(e1,e2)	10	41	because prostaglandins play an important role in hemostasis , and nsaids affect platelet function as well , concurrent therapy with all nsaids , including diclofenac , and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required .
None(e1,e2)	8	28	the following drug interactions have been identified involving nizoral tablets and other drugs metabolized by the cytochrome p450 3a4 enzyme system : ketoconazole tablets inhibit the metabolism of terfenadine , resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite .
None(e1,e2)	31	45	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	26	47	in a single-dose crossover study examining lansoprazole 30 mg and omeprazole 20 mg each administered alone and concomitantly with sucralfate 1 gram , absorption of the proton_pump_inhibitors was delayed and their bioavailability was reduced by 17 % and 16 % , respectively , when administered concomitantly with sucralfate .
None(e1,e2)	16	20	substances that are potent inhibitors of cyp3a4 activity ( eg , ketoconazole and itraconazole ) decrease gefitinib metabolism and increase gefitinib plasma concentrations .
None(e1,e2)	21	25	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	0	15	digoxin : concomitant administration of erythromycin and digoxin has been reported to result in elevated digoxin serum levels .
None(e1,e2)	29	41	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	26	57	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	22	31	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	26	38	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	5	24	other drug interactions oral contraceptives keppra ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl_estradiol and 0.15 mg levonorgestrel , or of the luteinizing hormone and progesterone levels , indicating that impairment of contraceptive efficacy is unlikely .
None(e1,e2)	26	28	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	26	29	because of foscarnets tendency to cause renal impairment , the use of foscavir should be avoided in combination with potentially nephrotoxic drugs such as aminoglycosides , amphotericin_b and intravenous pentamidine unless the potential benefits outweigh the risks to the patient .
None(e1,e2)	45	73	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	39	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	69	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	18	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	22	32	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	25	27	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .
effect(e1,e2)	0	18	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
None(e1,e2)	31	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	11	13	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	6	22	phenobarbital : coadministration of felbamate with phenobarbital causes an increase in phenobarbital plasma concentrations , in 12 otherwise healthy male volunteers ingesting phenobarbital , the steady-state trough ( cmin ) phenobarbital concentration was 14.2 micrograms/ml .
None(e1,e2)	7	10	synergism between xanthine bronchodilators ( e.g. , theophylline ) , ephedrine , and other sympathomimetic bronchodilators has been reported .
None(e1,e2)	12	23	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	22	27	since the concomitant administration of these two drugs can lead to phenytoin intoxication , prior to administering disulfiram to a patient on phenytoin therapy , a baseline phenytoin serum level should be obtained .
None(e1,e2)	11	23	at a median follow-up of 33 months , the combination of arimidex and tamoxifen did not demonstrate any efficacy benefit when compared with tamoxifen in all patients as well as in the hormone receptor-positive subpopulation .
None(e1,e2)	25	33	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	86	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	6	8	anticoagulants : potentiation of warfarin-type ( cyp2c9 and cyp3a4 substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .
None(e1,e2)	10	17	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	18	20	no significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide , digoxin , warfarin , cimetidine and phenobarbital .
None(e1,e2)	0	44	levothyroxine_sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	28	31	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium_channel_blocking_drugs , and isoniazid .
None(e1,e2)	9	17	intestinal adsorbents ( e. g. , charcoal ) and digestive_enzyme_preparations containing carbohydrate-splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
None(e1,e2)	0	37	methotrexate vioxx 12.5 , 25 , and 50 mg , each dose administered once daily for 7 days , had no effect on the plasma concentration of methotrexate as measured by auc0-24hr in patients receiving single weekly methotrexate doses of 7.5 to 20 mg for rheumatoid arthritis .
None(e1,e2)	22	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	25	31	drug-drug interactions albuterol - strattera should be administered with caution to patients being treated with systemically-administered ( oral or intravenous ) albuterol ( or other beta2_agonists ) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure .
None(e1,e2)	2	10	lithium : lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium , including ace inhibitors .
None(e1,e2)	4	29	experience with co-administration of hmg-coa_reductase_inhibitors and fentanyl in patients is limited , therefore , consideration should be given to temporarily suspending use of hmg-coa reductase inhibitors in patients receiving fentanyl .
None(e1,e2)	39	48	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide_diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	1	2	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv protease inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
None(e1,e2)	17	40	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	30	38	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin- converting enzyme ( ace ) inhibitors , betablockers , calcium-channel blockers , diuretics , and nonsteroidal_anti-inflammatory_drugs ( nsaids ) without evidence of clinically significant adverse interactions .
effect(e1,e2)	6	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	35	cmax and auc values are 3 % to 4 % lower , respectively , after administration of 125 mg neurontin and 21 % to 22 % lower , respectively , after administration of 500 mg neurontin .
advise(e1,e2)	5	10	although a 3-day regimen of aprepitant given concomitantly with oral contraceptives has not been studied , alternative or back-up methods of contraception should be used .
None(e1,e2)	0	3	furosemide : when aliskiren was co-administered with furosemide , the auc and cmax of furosemide were reduced by about 30 % and 50 % , respectively .
None(e1,e2)	40	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	16	32	antifungals : in vitro and/or in vivo data indicate that fluconazole , itraconazole , and oral ketoconazole markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	8	11	administration of epinephrine to patients receiving cyclopropane or halogenated_hydrocarbon_general_anesthetics such as halothane which sensitize the myocardium , may induce cardiac arrhythmia..
None(e1,e2)	15	23	the findings of these studies are summarized in the following table : effects on steady-state fexofenadine pharmacokinetics after 7 days of co-administration with fexofenadine_hydrochloride 120 mg every 12 hours ( two times the recommended twice daily dose ) in healthy volunteers ( n=24 )
None(e1,e2)	17	19	although there are no study data to evaluate the possibility , nitric oxide donor compounds , including sodium_nitroprusside and nitroglycerin , may have an additive effect with inomax on the risk of developing methemoglobinemia .
advise(e1,e2)	4	17	therefore , co-administration of tricyclic_antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	0	14	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on day 1 , and aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on days 2 through 5 , increased the auc of dexamethasone , a cyp3a4 substrate by 2.2-fold , on days 1 and 5 .
None(e1,e2)	14	16	oral contraceptives : coadministration of atorvastatin and an oral contraceptive increased auc values for norethindrone and ethinyl_estradiol by approximately 30 % and 20 % .
None(e1,e2)	26	48	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	69	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	56	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	3	phenytoin : serum phenytoin levels may be increased by aspirin .
None(e1,e2)	1	12	because anafranil is highly bound to serum protein , the administration of anafranil to patients taking other drugs that are highly bound to protein ( e.g. , warfarin , digoxin ) may cause an increase in plasma concentrations of these drugs , potentially resulting in adverse effects .
None(e1,e2)	9	15	caution should be exercised when taking this medicine certain antibiotics , such as erythromycin , clarithromycin , or azithromycin .
effect(e1,e2)	7	11	paralytic ileus may occur in patients taking tricyclic_antidepressants in combination with anticholinergic -type drugs .
None(e1,e2)	27	54	paroxetine : coadministration of once daily doses of aprepitant , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation , with paroxetine 20 mg once daily , resulted in a decrease in auc by approximately 25 % and cmax , by approximately 20 % of both aprepitant and paroxetine .
None(e1,e2)	51	53	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
mechanism(e1,e2)	3	26	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	20	26	glibenclamide : in a study of 7 healthy male volunteers , acitretin treatment potentiated the blood glucose lowering effect of glibenclamide ( a sulfonylurea similar to chlorpropamide ) in 3 of the 7 subjects .
None(e1,e2)	59	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	10	16	thus , careful monitoring of clinical status is warranted when rifampin is administered or discontinued in haloperidol -treated patients .
None(e1,e2)	23	35	both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when alfenta is administered in combination with other cns_depressants such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .
None(e1,e2)	14	33	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease_inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	39	57	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	6	18	dosage adjustment may be warranted when levobupivacaine is concurrently administered with cyp3a4 inhibitors and cyp1a2 inhibitors as systemic levobupivacaine levels may rise resulting in toxicity .
None(e1,e2)	5	7	treatment with entacapone coadministered with levodopa / dopa_decarboxylase_inhibitor does not change these effects .
None(e1,e2)	32	40	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot_derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
advise(e1,e2)	3	5	concurrent therapy with orencia and tnf_antagonists is not recommended .
None(e1,e2)	23	37	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal_anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	16	23	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type_1c_antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	0	38	macrolide_antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e . 45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	8	15	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	4	22	an increase in serum lithium concentration has been reported during concomitant administration of lithium with atacand , so careful monitoring of serum lithium levels is recommended during concomitant use .
None(e1,e2)	12	21	infusion requirements of nimbex in patients administered succinylcholine prior to infusions of nimbex were comparable to or slightly greater than when succinylcholine was not administered .
None(e1,e2)	36	75	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	9	12	potassium-sparing diuretics such as spironolactone , triamterene , or amiloride , or potassium supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
None(e1,e2)	79	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	23	28	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	45	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	38	44	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium_chloride , folic acid , and acetaminophen .
None(e1,e2)	39	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	59	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	43	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	46	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	7	11	drug-drug interactions have not been observed between argatroban and digoxin or erythromycin .
mechanism(e1,e2)	2	20	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	34	38	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
effect(e1,e2)	22	36	a rare , but serious , constellation of symptoms , termed serotonin syndrome , has been reported with the concomitant use of selective_serotonin_reuptake_inhibitors ( ssris ) and agents for migraine therapy , such as imitrex ( sumatriptan_succinate ) and dihydroergotamine .
None(e1,e2)	129	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	31	central_nervous_system_depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	52	87	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	12	antidepressants , tricyclic : amphetamines may enhance the activity of tricyclic or sympathomimetic_agents ;
None(e1,e2)	10	23	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	9	26	interactions may also occur with the following : anti-depressants/ anti-anxiety_drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	25	34	coadministration of valdecoxib ( 40 mg bid ( day 1 ) and 40 mg qd ( days 2-7 ) ) with glyburide ( 10 mg glyburide bid ) resulted in 21 % increase in glyburide auc0-12 and a 16 % increase in glyburide cmax leading to a 16 % decrease in glucose auc0-24 .
None(e1,e2)	35	50	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	30	46	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	8	14	because of its lack of platelet effects , vioxx is not a substitute for aspirin for cardiovascular prophylaxis .
effect(e1,e2)	9	32	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	36	48	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	34	36	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	24	56	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	29	31	although no clinical studies have been conducted , it is likely that the metabolism of levobupivacaine may be affected by the known cyp3a4 inducers ( such as phenytoin , phenobarbital , rifampin ) , cyp3a4 inhibitors ( azole antimycotics e.g. , ketoconazole ;
None(e1,e2)	4	26	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
mechanism(e1,e2)	16	27	coadministration with compounds that are potent inducers of cyp3a4 ( eg , phenobarbital , phenytoin , dexamethasone , carbamazepine ) may result in decreased plasma levels of saquinavir .
None(e1,e2)	44	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	83	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	37	39	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline_salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	35	51	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	14	16	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	24	28	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	2	36	administration of eplerenone with other cyp3a4 inhibitors ( e.g. , erythromycin 500 mg bid , verapamil 240 mg qd , saquinavir 1200 mg tid , fluconazole 200 mg qd ) resulted in increases in cmax of eplerenone ranging from 1.4- to 1.6- fold and auc from 2.0- to 2.9- fold .
None(e1,e2)	7	22	ergot derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine contraindicated due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
None(e1,e2)	0	18	lithium reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ace_inhibitors , and with some angiotensin ii receptor antagonists .
None(e1,e2)	11	26	for example , when vitamin k antagonists are administered concomitantly with nilutamide , prothrombin time should be carefully monitored and if necessary , the dosage of vitamin_k_antagonists should be reduced .
effect(e1,e2)	23	42	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
None(e1,e2)	13	20	it is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least 4 hours following ethambutol administration .
None(e1,e2)	26	29	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	65	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	19	although concomitant use of clozapine and carbamazepine is not recommended , it should be noted that discontinuation of concomitant carbamazepine administration may result in an increase in clozapine plasma levels .
None(e1,e2)	12	30	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	10	12	clinical studies with celecoxib have identified potentially significant interactions with fluconazole and lithium .
None(e1,e2)	39	49	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	36	49	phenytoin : in a single ( 400 mg ) and multiple dose ( 400 mg tid ) study of neurontin in epileptic patients ( n=8 ) maintained on phenytoin monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics .
None(e1,e2)	0	15	curariform_muscle_relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
None(e1,e2)	20	32	in in vivo studies , 10- to 30-mg/day doses of aripiprazole had no significant effect on metabolism by cyp2d6 ( dextromethorphan ) , cyp2c9 ( warfarin ) , cyp2c19 ( omeprazole , warfarin ) , and cyp3a4 ( dextromethorphan ) substrates .
None(e1,e2)	9	17	however , co-administration of duloxetine with aluminum- and magnesium-containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
advise(e1,e2)	15	17	aripiprazole dose should be reduced to one-half of its normal dose when concomitant administration of quinidine with aripiprazole occurs .
None(e1,e2)	0	14	probenecid : as with other b-lactam antibiotics , probenecid inhibits the renal excretion of cefdinir , resulting in an approximate doubling in a.c. a 54 % increase in peak cefdinir plasma levels , and a 50 % prolongation in the apparent elimination half-life .
None(e1,e2)	14	55	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
mechanism(e1,e2)	0	23	starlix is a potential inhibitor of the cyp2c9 isoenzyme in vivo as indicated by its ability to inhibit the in vitro metabolism of tolbutamide .
None(e1,e2)	20	26	these agents include medications such as : anticoagulants , platelet inhibitors including acetylsalicylic acid , sali-cylates , nsaids ( including ketorolac_tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	6	13	anticholinergics : concurrent administration of certain anticholinergic_compounds , such as belladonna alkaloids and dicyclomine , would be expected to compromise the beneficial effects of cisapride .
None(e1,e2)	10	12	the combination of therapeutic doses of intravenous dantrolene sodium and verapamil in halothane a-chloralose anesthetized swine has resulted in ventricular fibrillation and cardiovascular collapse in association with marked hyperkalemia .
mechanism(e1,e2)	3	22	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	9	45	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	17	23	patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other cns depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
None(e1,e2)	11	24	it is recommended that buspirone hydrochloride not be used concomitantly with mao_inhibitors because the effects of concomitant administration of buspirone hcl with most other psychotropic_drugs have not been studied , the concomitant use of buspirone hcl with other cns-active drugs should be approached with caution .
None(e1,e2)	92	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	10	21	phenobarbital ( primidone ) : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenobarbital ( primidone ) with or without other enzyme-inducing aeds .
None(e1,e2)	26	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	24	26	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting_enzyme_inhibitors , aminosalicylic_acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	0	2	nitroglycerin : dynacirc ( isradipine ) has been safely coadministered with nitroglycerin .
None(e1,e2)	46	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	16	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	11	14	other cns depressant drugs ( e.g . barbiturates , tranquilizers , opioids and general anesthetics ) have additive or potentiating effects with inapsine .
None(e1,e2)	17	27	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	51	73	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	39	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	15	23	the concurrent use of two or more drugs with anticholinergic activity -- such as an antipsychotic_drug ( eg , chlorpromazine ) , an antiparkinsonian_drug ( eg , trihexyphenidyl ) , and/or a tricyclic antidepressant ( eg , amitriptyline ) -- commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
advise(e1,e2)	13	49	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	7	18	( see clinical pharmacology ) coadministration of femara and tamoxifen 20 mg daily resulted in a reduction of letrozole plasma levels by 38 % on average .
int(e1,e2)	0	10	sulfapyridine may interact with any of the following : - acetaminophen ( e.g. , tylenol ) ( with long-term , high-dose use ) or
None(e1,e2)	71	76	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	0	13	digitalis toxicity may be aggravated by the initial release of norepinephrine caused by bretylium_tosylate injection .
None(e1,e2)	19	35	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	24	28	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
mechanism(e1,e2)	3	28	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	8	12	co-medications that induce cyp 3a4 ( e.g. , rifampicin , phenytoin , carbamazepine , phenobarbital , or st. john s wort ) may significantly decrease exposure to exemestane .
None(e1,e2)	12	14	products containing calcium and other multivalent cations ( such as aluminum , magnesium , iron ) are likely to interfere with absorption of ibandronate .
None(e1,e2)	51	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	11	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	20	45	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium_channel_blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	7	10	mineral oil interferes with the absorption of fat-soluble_vitamins , including vitamin_d_preparations .
None(e1,e2)	26	32	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	8	13	antiarrhythmic agents , class i ( such as flecainide , lidocaine , or quinidine ) : concurrent use with arbutamine may have a proarrhythmic effect .
None(e1,e2)	26	30	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	2	33	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	26	37	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	23	63	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
effect(e1,e2)	3	17	tablets : the benzodiazepines , including lorazepam , produce cns-depressant effects when administered with such medications as barbiturates or alcohol .
None(e1,e2)	100	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	110	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	23	25	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
None(e1,e2)	18	20	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	21	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	28	31	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal_anti-inflammatory_drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	13	40	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	7	21	the extent of plasma protein binding of atovaquone in human plasma is not affected by the presence of therapeutic concentrations of phenytoin ( 15 mcg/ ml ) , nor is the binding of phenytoin affected by the presence of atovaquone .
None(e1,e2)	0	27	central_nervous_system_depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	76	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	18	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	5	13	in vitro studies have shown casodex can displace coumarin anticoagulants , such as warfarin , from their protein-binding sites .
None(e1,e2)	12	19	potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( phenytoin , valproate , oral contraceptive , digoxin , warfarin , probenecid ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .
None(e1,e2)	5	30	use lowest possible dose of atorvastatin with careful monitoring , or consider hmg-coa reductase inhibitors that are not primarily metabolized by cyp3a4 , such as pravastatin , fluvastatin , or rosuvastatin in combination with crixivan .
None(e1,e2)	106	116	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	2	triazolam : erythromycin has been reported to decrease the clearance of triazolam and , thus , may increase the pharmacologic effect of triazolam .
None(e1,e2)	24	26	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf_blocking_agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	62	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	4	magnesium - and aluminum-containing antacids , administered concomitantly with lomefloxacin , significantly decreased the bioavailability ( 48 % ) of lomefloxacin .
None(e1,e2)	0	7	cimetidine : co-administration with high doses of cimetidine [ 800 mg twice daily ] increased the cmax of rofecoxib by 21 % , the auc0-120hr by 23 % and the t1/2 by 15 % .
effect(e1,e2)	1	7	( thiazide_drugs may increase the responsiveness to tubocurarine . )
None(e1,e2)	36	51	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	33	35	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns_depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
None(e1,e2)	53	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	33	39	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
None(e1,e2)	14	30	mao inhibitors : duragesic is not recommended for use in patients who have received maoi within 14 days because severe and unpredictable potentiation by mao inhibitors has been reported with opioid_analgesics
None(e1,e2)	35	42	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	13	36	however , because some quinolones have been reported to enhance the effects of warfarin or its derivatives , prothrombin time or other suitable anticoagulation test should be monitored closely if a quinolone antimicrobial is administered with warfarin or its derivatives .
None(e1,e2)	28	70	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	44	51	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	2	7	interactions for vitamin_d_analogues ( vitamin d2 , vitamin_d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	7	9	these agents include medications such as : anticoagulants , platelet_inhibitors including acetylsalicylic acid , sali-cylates , nsaids ( including ketorolac tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	18	30	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	14	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	12	14	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
effect(e1,e2)	6	80	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	22	38	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	38	52	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	10	15	nicardipine hcl usually does not alter the plasma levels of digoxin , however , serum digoxin levels should be evaluated after concomitant therapy with nicardipine hcl is initiated .
None(e1,e2)	45	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	4	tetracyclines : since both acitretin and tetracyclines can cause increased intracranial pressure , their combined use is contraindicated .
None(e1,e2)	9	13	caution should be exercised when taking this medicine certain antibiotics , such as erythromycin , clarithromycin , or azithromycin .
None(e1,e2)	0	7	orlistat -orlistat may decrease the absorption of vitamin_k .
None(e1,e2)	10	21	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	10	13	the patient was also chronically receiving phenytoin , phenobarbital , digoxin , and levothyroxine_sodium .
None(e1,e2)	66	153	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	22	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	34	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium_hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	9	11	several drug interaction studies have been completed with both invirase and fortovase .
None(e1,e2)	19	39	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	0	35	cimetidine : in a study in healthy volunteers , a one-week course of cimetidine at 400 mg b.i.d . with a single 5 mg dose of isradipine on the sixth day showed an increase in isradipine mean peak plasma concentrations ( 36 % ) and significant increase in area under the curve ( 50 % ) .
None(e1,e2)	35	52	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	7	hctz 50 mg qd or hctz / triamterene 50/100 mg qd was co-administered with tikosyn ( 500 mcg bid ) for 5 days ( following 2 days of diuretic use at half dose ) .
None(e1,e2)	19	29	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	46	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis_preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic_acid , and acetaminophen .
None(e1,e2)	29	31	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	19	73	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	57	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	56	75	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	11	29	drug interactions : flupenthixol may interact with some drugs , like monoamine_oxidase_inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	1	22	ampicillin/ amoxicillin : an increase in the frequency of skin rash has been reported among patients receiving ampicillin or amoxicillin concurrently with allopurinol compared to patients who are not receiving both drugs .
int(e1,e2)	0	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	4	22	the potentiating action of hydroxyzine must be considered when the drug is used in conjunction with central nervous system depressants such as narcotics , non-narcotic analgesics and barbiturates .
None(e1,e2)	17	27	during administration of multiple oral doses of tambocor to healthy subjects stabilized on a maintenance dose of digoxin , a 13 % -19 % increase in plasma digoxin levels occurred at six hours postdose .
None(e1,e2)	0	39	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
advise(e1,e2)	7	17	to avoid this interaction , delavirdine or indinavir should be given 1 hour prior to dosing with videx .
None(e1,e2)	21	42	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	11	14	nonsteroidal anti-inflammatory drugs ( nsaids ) -a drug interaction study of eplerenone with an nsaid has not been conducted .
None(e1,e2)	14	38	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux_sodium .
mechanism(e1,e2)	10	14	there is a single case report , which suggests that sucralfate may interfere with anagrelide absorption .
None(e1,e2)	5	13	this could lead to decreased salicylate serum levels or increase the risk of salicylate toxicity when corticosteroid is withdrawn .
effect(e1,e2)	28	50	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	16	18	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	9	26	in vitro studies have shown no binding displacement between entacapone and other highly bound drugs , such as warfarin , salicylic acid , phenylbutazone , and diazepam .
None(e1,e2)	29	36	although glucocorticoids have been shown to reduce proleukin-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
None(e1,e2)	57	90	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	17	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	5	7	potassium-sparing diuretics ( spironolactone , amiloride , triamterene , and others ) or potassium supplements can increase the risk of hyperkalemia .
None(e1,e2)	34	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	10	28	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole_antifungal_agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	0	54	paroxetine : coadministration of once daily doses of aprepitant , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation , with paroxetine 20 mg once daily , resulted in a decrease in auc by approximately 25 % and cmax , by approximately 20 % of both aprepitant and paroxetine .
None(e1,e2)	28	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	55	78	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	7	31	inhibitors of this isoenzyme ( e.g. , macrolide_antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	14	23	although a dose adjustment of azithromycin is not recommended when administered in combination with nelfinavir , close monitoring for known side effects of azithromycin , such as liver enzyme abnormalities and hearing impairment , is warranted .
None(e1,e2)	7	17	the bioavailability of the capsule formulation of cefprozil was not affected when administered 5 minutes following an antacid .
None(e1,e2)	0	9	caverject : the potential for pharmacokinetic drug-drug interactions between alprostadil and other agents has not been formally studied .
None(e1,e2)	10	13	in clinical studies , coadministration of welchol with atorvastatin , lovastatin , or simvastatin did not interfere with the lipid-lowering activity of the hmg-coa reductase inhibitor .
effect(e1,e2)	10	26	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid -associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
effect(e1,e2)	4	17	the concurrent use of robinul injection with other anticholinergics or medications with anticholinergic activity , such as phenothiazines , antiparkinson drugs , or tricyclic antidepressants , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
None(e1,e2)	21	36	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace_inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	2	12	patients receiving azathioprine and allopurinol concomitantly should have a dose reduction of azathioprine , to approximately 1/3 to 1/4 the usual dose .
None(e1,e2)	1	6	potential terfenadine , astemizole , and cisapride interactions
None(e1,e2)	3	17	example inhibitors include azole_antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	6	18	there is limited experience with concomitant antihypertensive_agents such as alpha-blockers , calcium channel-blockers , ace inhibitors , and diuretics ( both thiazide-like and loop ) .
None(e1,e2)	69	73	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	18	21	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
None(e1,e2)	9	42	phenytoin : no significant differences were observed in mean phenytoin auc , c max , c min or t max ( although c max increased by 11 % ) when extended phenytoin sodium capsules ( 100 mg tid ) were coadministered with lomefloxacin ( 400 mg qd ) for five days in 15 healthy males .
None(e1,e2)	11	28	in patients who have been reported to be well controlled on tricyclic_antidepressants receiving concurrent cimetidine therapy , discontinuation of cimetidine has been reported to decrease established steady-state serum tricyclic_antidepressant levels and compromise their therapeutic effects .
None(e1,e2)	26	54	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
mechanism(e1,e2)	5	9	oral contraceptives : coadministration of atorvastatin and an oral contraceptive increased auc values for norethindrone and ethinyl estradiol by approximately 30 % and 20 % .
None(e1,e2)	13	29	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	28	39	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	77	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	18	58	the results of a study of coadministration of ethambutol ( 50 mg/kg ) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20 % and 13 % , respectively , suggesting that the oral absorption of ethambutol may be reduced by these antacid_products .
None(e1,e2)	12	16	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
None(e1,e2)	12	26	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	77	86	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	76	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	11	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	2	7	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	27	42	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	42	71	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	20	26	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
effect(e1,e2)	3	8	in patients receiving coumarin-type_anticoagulants , the addition of nalfon to therapy could prolong the prothrombin time .
None(e1,e2)	8	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	11	14	the concomitant use of other cyp3a4 inhibitors such as diltiazem and erythromycin with transdermal fentanyl may also result in an increase in fentanyl plasma concentrations , which could increase or prolong adverse drug effects and may cause serious respiratory depression .
effect(e1,e2)	2	6	administration of phenytoin to patients receiving dopamine_hcl has been reported to lead to hypotension and bradycardia .
effect(e1,e2)	24	36	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	16	33	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	23	38	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	26	38	limited clinical experience indicates that requirements for volatile inhalation anesthetics are reduced by 30 to 50 % for the first sixty ( 60 ) minutes following alfenta induction the concomitant use of erythromycin with alfenta can significantly inhibit alfenta clearance and may increase the risk of prolonged or delayed respiratory depression .
None(e1,e2)	10	53	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	23	29	the risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric acid derivatives , niacin ( nicotinic acid ) , erythromycin , azole antifungals .
None(e1,e2)	12	17	it is , however , possible that concomitant use of other known photosensitizing_agents such as griseofulvin , thiazide_diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	0	11	antacid : the effect of an aluminum hydroxide- and magnesium hydroxide-containing antacid ( maalox ) * on the pharmacokinetics of capecitabine was investigated in 12 cancer patients .
None(e1,e2)	0	25	warfarin : when healthy subjects were administered starlix 120 mg three times daily before meals for four days in combination with a single dose of warfarin 30 mg on day 2 , there were no alterations in the pharmacokinetics of either agent .
None(e1,e2)	38	66	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	1	3	anesthetics/ sedatives / hypnotics /opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	30	40	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	15	40	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	3	7	concomitant administration of kerlone with the oral anticoagulant warfarin has been shown not to potentiate the anticoagulant effect of warfarin .
None(e1,e2)	7	12	in patients taking furosemide , nifedipine , diltiazem , ace inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	0	12	propanolol : the pharmacokinetics of almotriptan were not affected by coadministration of propranolol .
None(e1,e2)	21	37	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline_salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	92	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	13	amphotericin_b or potassium-depleting diuretics ( benzothiadiazines and related drugs , ethacrynic acid and furosemide ) enhanced hypokalemia .
None(e1,e2)	1	5	intravenous pentamidine : treatment with hivid should be interrupted when the use of a drug that has the potential to cause pancreatitis is required .
None(e1,e2)	49	68	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	33	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	20	however , in a study of 12 normal subjects , concurrent administration of aspirin decreased ketoprofen protein binding and increased ketoprofen plasma clearance from 0.07 l/kg/h without aspirin to 0.11 l/kg/h with aspirin .
None(e1,e2)	34	46	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	4	15	cyclosporine : administration of nonsteroial_anti-inflammatory_drugs concomitantly with cyclosporine has been associated with an increase in cyclosporine -induced toxicity , possibly due to decreased synthesis of renal prostacyclin .
None(e1,e2)	59	85	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	1	25	if antacid therapy is needed , the antacid dose should be administered at least 2 hours prior to or 2 hours after the dose of sprycel .
None(e1,e2)	14	16	in addition , certain drugs that are metabolized by this isoenzyme , including many antidepressants ( tricyclic_antidepressants , selective serotonin reuptake inhibitors , and others ) , may inhibit the activity of this isoenzyme , and thus may make normal metab-olizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system , leading to drug interactions .
None(e1,e2)	47	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	69	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	0	14	folic_acid in large amounts may counteract the antiepileptic effect of phenobarbital , phenytoin and primidone , and increase the frequency of seizures in susceptible pediatric patients .
mechanism(e1,e2)	2	8	co-administration of bosentan decreased the plasma concentrations of cyclosporine_a ( a cyp3a4 substrate ) by approximately 50 % .
mechanism(e1,e2)	18	59	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	19	although concomitant use of clozapine and carbamazepine is not recommended , it should be noted that discontinuation of concomitant carbamazepine administration may result in an increase in clozapine plasma levels .
None(e1,e2)	30	39	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	6	27	iron supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron ( as feso4 ) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80 % and 31 % , respectively .
None(e1,e2)	20	33	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone_classes_of_antipsychotic_agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	18	20	other concomitant therapies : in clinical trials , the safety profile in subjects treated with acamprosate concomitantly with anxiolytics , hypnotics and sedatives ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .
int(e1,e2)	5	10	the in vitro interaction between nevirapine and the antithrombotic agent warfarin is complex .
None(e1,e2)	21	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	54	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	23	32	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle_relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	4	11	nitroglycerin : dynacirc ( isradipine ) has been safely coadministered with nitroglycerin .
advise(e1,e2)	4	6	during concomitant therapy of ponstel with furosemide , the patient should be observed closely for signs of renal failure , as well as to assure diuretic efficacy .
effect(e1,e2)	1	7	when mefloquine is taken concurrently with oral live_typhoid_vaccines , attenuation of immunization can not be excluded .
None(e1,e2)	59	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	69	81	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	11	18	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic drugs .
None(e1,e2)	21	66	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	16	22	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic_agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .
None(e1,e2)	19	46	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	13	27	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	11	29	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	11	22	triazolam : erythromycin has been reported to decrease the clearance of triazolam and , thus , may increase the pharmacologic effect of triazolam .
None(e1,e2)	5	11	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	17	19	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	0	37	venlafaxine : coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine er ( extended release ) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or venlafaxine .
None(e1,e2)	21	28	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel-blocking_drugs , and isoniazid .
None(e1,e2)	65	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	35	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	23	25	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	35	37	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal_anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	22	33	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	13	15	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium carbonate , and terbutaline .
effect(e1,e2)	2	14	when other antiplatelet_agents or anticoagulants are used concomitantly , there is the potential for flolan to increase the risk of bleeding .
None(e1,e2)	9	21	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
effect(e1,e2)	4	20	the adverse effects of camptosar , such as myelosuppression and diarrhea , would be expected to be exacerbated by other antineoplastic_agents having similar adverse effects .
None(e1,e2)	3	10	specific effects of felbatol on other antiepileptic drugs phenytoin : felbatol causes an increase in steady-state phenytoin plasma concentrations .
None(e1,e2)	4	6	antiarrhythmics : amiodarone , bepridil , flecainide , propafenone , quinidine contraindicated due to potential for serious and/or life-threatening reactions .
None(e1,e2)	11	18	in healthy subjects , no significant drug-drug interaction was observed when norpace was coadministered with either propranolol or diazepam .
None(e1,e2)	32	34	ace inhibitors and angiotensin ii receptor antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace_inhibitors or angiotensin_ii_receptor_antagonists ( acei/arb ) .
None(e1,e2)	19	21	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	6	20	other potentially important drug interactions : benzodiazepines : benzodiazepines metabolized by hepatic oxidation ( e.g. , alprazolam , midazolam , triazolam elc . ) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine .
None(e1,e2)	25	31	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	34	57	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	44	58	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	14	18	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	95	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	7	ganciclovir : the pharmacokinetics of foscarnet and ganciclovir were not altered in 13 patients receiving either concomitant therapy or daily alternating therapy for maintenance of cmv disease .
None(e1,e2)	18	20	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	7	20	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	0	22	ketoconazole : co-administration of bosentan 125 mg b.i.d . and ketoconazole , a potent cyp3a4 inhibitor , increased the plasma concentrations of bosentan by approximately 2-fold .
None(e1,e2)	23	35	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	5	24	therefore , when hydrochlorothiazide and non-steroidal_anti-inflammatory_agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained .
advise(e1,e2)	14	22	due to a theoretical risk of a pharmacodynamic interaction , use of ergotamine-containing or ergot-type_medications ( like dihydroergotamine or methysergide ) and frova within 24 hours of each other should be avoided ( see a href= frova_od.htm # ci contraindications ) .
None(e1,e2)	0	9	chlorpropamide : chlorpropamides plasma half-life may be prolonged by allopurinol , since allopurinol and chlorpropamide may compete for excretion in the renal tubule .
None(e1,e2)	35	45	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	6	18	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
advise(e1,e2)	9	16	at least 3 weeks should elapse between discontinuation of dexfenfluramine and initiation of treatment with a mao_inhibitor .
None(e1,e2)	17	66	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	0	21	eprosartan doses of up to 300 mg b.i.d . have been safely used concomitantly with sustained-release calcium channel blockers ( sustained-release nifedipine ) with no clinically significant adverse interactions .
None(e1,e2)	11	75	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone_anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	2	4	additionally , aripiprazole and dehydroaripiprazole did not show potential for altering cyp1a2-mediated metabolism in vitro .
None(e1,e2)	78	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	10	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine hcl was not altered .
None(e1,e2)	12	17	garlic capsules garlic capsules should not be used while taking saquinavir ( fortovase ) as the sole protease_inhibitor due to the risk of decreased saquinavir plasma concentrations .
None(e1,e2)	14	19	although these results do not indicate a significant interaction between toradol and warfarin or heparin , the administration of toradol to patients taking anticoagulants should be done extremely cautiously , and patients should be closely monitored .
None(e1,e2)	4	14	a single dose of pravastatin had no clinically important effect on the pharmacokinetics of fenofibric_acid .
None(e1,e2)	9	15	valproate : the addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics , but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8 % , which resulted in an increase of approximately 40 % in the free tiagabine concentration .
None(e1,e2)	45	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	51	55	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	26	71	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	20	fluconazole , and the 5-ht3 antiemetics ondansetron ( zofran ) and granisetron ( kytril ) have all been used with busulfex .
None(e1,e2)	28	40	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	2	10	ironically , benzodiazepines are often used in the treatment of heroin addiction while they cause much more severe withdrawal symptoms .
effect(e1,e2)	8	26	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	1	17	oral contraceptives rofecoxib did not have any clinically important effect on the pharmacokinetics of ethinyl estradiol and norethindrone .
None(e1,e2)	13	33	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	2	14	- a steroid_medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	68	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	4	6	thus patients receiving oral anticoagulants and fluvoxamine tablets should have their prothrombin time monitored and their anticoagulant dose adjusted accordingly .
int(e1,e2)	3	10	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic_drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels ) .
None(e1,e2)	47	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	21	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	6	8	based on the chemical resemblance of itraconazole and ketoconazole , coadministration of astemizole with itraconazole is contraindicated .
None(e1,e2)	40	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	62	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	6	nitrates : the concomitant use of bepridil with long- and short-acting nitrates has been safely tolerated in patients with stable angina pectoris .
None(e1,e2)	54	66	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	5	20	other drug interactions oral contraceptives keppra ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel , or of the luteinizing hormone and progesterone levels , indicating that impairment of contraceptive efficacy is unlikely .
None(e1,e2)	14	17	compounds that have been tested in man include antipyrine , digoxin , propranolol , theophylline , and warfarin and no clinically meaningful interactions were found .
None(e1,e2)	54	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	13	28	tell your doctor if you are taking any of the following drugs : blood_thinner s ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
mechanism(e1,e2)	14	26	drugs which inhibit cyp 3a4 ( e.g. , ketoconazole , macrolide antibiotics such as erythromycin ) have the potential to result in increased plasma concentrations of corticosteroids .
None(e1,e2)	8	21	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	32	33	however , the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline , interfere with the metabolism of caffeine , and enhance the effects of the oral anticoagulant warfarin and its derivatives , and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly .
None(e1,e2)	55	67	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	69	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	21	drug-drug interactions albuterol - strattera should be administered with caution to patients being treated with systemically-administered ( oral or intravenous ) albuterol ( or other beta2 agonists ) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure .
None(e1,e2)	35	45	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	4	10	co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27 % compared with those achieved with anastrozole alone .
None(e1,e2)	0	6	naproxen , naproxen sodium and other nsaids have been reported to reduce the tubular secretion of methotrexate in an animal model , possibly increasing the toxicity of methotrexate .
None(e1,e2)	35	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	20	hormonal_contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive ortho-novum produced average decreases of norethindrone and ethinyl estradiol levels of 14 % and 31 % , respectively .
None(e1,e2)	27	36	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
advise(e1,e2)	0	14	netilmicin should not be administered concomitantly with potent loop diuretics such as furosemide and ethacrynic_acid as the potential for ototoxicity is enhanced by the combination .
None(e1,e2)	12	25	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	71	109	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	8	15	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine hcl was not altered .
None(e1,e2)	109	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	18	29	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	1	21	although betagan used alone has little or no effect on pupil size , mydriasis resulting from concomitant therapy with betagan and epinephrine may occur .
None(e1,e2)	2	20	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	3	48	acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16 % ( 90 % confidence interval : 8-23 % ) , decrease mean c max digoxin by 26 % ( 90 % confidence interval : 16-34 % ) and decrease mean trough concentrations of digoxin by 9 % ( 90 % confidence limit : 19 % decrease to 2 % increase ) .
None(e1,e2)	8	39	hypotension was more likely to occur if the calcium_antagonist were a dihydropyridine derivative , e.g. , nifedipine , while left ventricular failure and av conduction disturbances , including complete heart block , were more likely to occur with either verapamil or diltiazem .
None(e1,e2)	1	4	other tnfa-blocking_agents ( including remicade ) used in combination with anakinra may also result in similar toxicities .
None(e1,e2)	23	30	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	6	15	antacid ( magnesium-aluminum hydroxide ) : cerivastatin plasma concentrations were not affected by co-administration of antacid .
None(e1,e2)	107	132	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	13	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type 1c antiarrhythmics propafenone and flecainide ) .
None(e1,e2)	0	19	levothyroxine_sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum_hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	2	16	interactions for vitamin_d_analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	16	18	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide_diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	4	8	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	39	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	4	interactions for vitamin_b3 ( niacin ) : antihypertensive therapy : nicotinic acid may potentiate the effects of ganglionic blocking agents and vasoactive drugs resulting in postural hypotension .
None(e1,e2)	10	14	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	17	37	in a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline ( an anticholinergic agent with multiple effects on the gi tract ) to healthy volunteers , the auc of clonazepam was 10 % lower and the cmax of clonazepam was 20 % lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .
None(e1,e2)	49	60	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin_b12 and folic acid .
None(e1,e2)	28	30	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	80	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	32	52	however , the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline , interfere with the metabolism of caffeine , and enhance the effects of the oral anticoagulant warfarin and its derivatives , and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly .
None(e1,e2)	8	18	the pharmacokinetics and protein binding of fosphenytoin , phenytoin , and diazepam were not altered when diazepam and cerebyx were concurrently administered in single submaximal doses .
None(e1,e2)	35	41	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic_antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	1	2	since cholestyramine resin may bind other drugs given concurrently , it is recommended that patients take other drugs at least 1 hour before or 4 to 6 hours after cholestyramine resin ( or at as great an interval as possible ) to avoid impeding their absorption .
None(e1,e2)	8	17	antidepressants ( tricyclic ) , atropine or other anticholinergic_agents , or digitalis glycosides : concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects .
None(e1,e2)	30	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	45	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	26	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	32	34	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
effect(e1,e2)	6	8	the effects of concomitant administration of tambocor and propranolol on the pr interval were less than additive .
None(e1,e2)	20	29	cimetidine - in subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of 400 mg/day cimetidine for 8 days resulted in an increase in citalopram auc and cmax of 43 % and 39 % , respectively .
None(e1,e2)	10	35	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	4	20	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ace_inhibitor therapy .
None(e1,e2)	8	19	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	19	21	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	27	62	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic_acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin_synthetase_inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	114	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	41	59	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	7	9	the combination of therapeutic doses of intravenous dantrolene_sodium and verapamil in halothane a-chloralose anesthetized swine has resulted in ventricular fibrillation and cardiovascular collapse in association with marked hyperkalemia .
None(e1,e2)	4	6	potassium-sparing diuretics such as spironolactone , triamterene , or amiloride , or potassium supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
None(e1,e2)	1	27	- phenytoin ( e.g. , dilantin ) use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of phenytoin
None(e1,e2)	50	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	33	55	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	69	71	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	30	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	12	acetaminophen and methotrexate - l-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate .
None(e1,e2)	76	98	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	19	although deferasirox has a lower affinity for aluminum than for iron , exjade should not be taken with aluminum-containing antacid_preparations .
None(e1,e2)	102	120	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	45	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	65	108	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	102	106	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	20	no significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide , digoxin , warfarin , cimetidine and phenobarbital .
None(e1,e2)	8	20	in the same study it was shown that didanosine and stavudine had no significant effect on the intracellular phosphorylation of zalcitabine in peripheral blood mononuclear cells .
None(e1,e2)	17	19	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	4	29	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium channel antagonists , angiotensin converting enzyme inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	65	116	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	13	14	warfarin : quinolones have been reported to enhance the effects of the oral anticoagulant warfarin or its derivatives .
None(e1,e2)	12	14	netilmicin should not be administered concomitantly with potent loop diuretics such as furosemide and ethacrynic_acid as the potential for ototoxicity is enhanced by the combination .
mechanism(e1,e2)	16	21	valproate : a recent case study has shown a possible increase in the plasma level of valproate when co administered with isoniazid .
effect(e1,e2)	0	13	diphenhydramine_hydrochloride has additive effects with alcohol and other cns depressants ( hypnotics , sedatives , tranquilizers , etc ) .
None(e1,e2)	13	15	the administration of local anesthetic solutions containing epinephrine or norepinephrine to patients receiving monoamine_oxidase_inhibitors , tricyclic_antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
None(e1,e2)	0	17	terfenadine : no clinically significant changes occurred in heart rate or corrected qt intervals , or in terfenadine metabolite or lomefloxacin pharmacokinetics , during concurrent administration of lomefloxacin and terfenadine at steady-state in 28 healthy males .
None(e1,e2)	40	45	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	33	39	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin_g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	15	37	the similarity of the tysabri -associated adverse event profile between study 1 ( without co-administered avonex ) and study 2 ( with co-administered avonex ) indicates that this alteration in clearance does not necessitate reduction of the tysabri dose to maintain safety , general ) .
None(e1,e2)	0	6	rifampin : co-administration of vioxx with rifampin 600 mg daily , a potent inducer of hepatic metabolism , produced an approximate 50 % decrease in rofecoxib plasma concentrations .
None(e1,e2)	48	57	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	76	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	8	cholestyramine : the influence of the bile-acidsequestering agent cholestyramine on the pharmacokinetits of cerivastatin sodium was evaluated in 12 healthy males in 2 separate randomized crossover studies .
None(e1,e2)	24	32	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	25	29	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	41	124	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	20	22	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium channel blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	46	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	8	22	reciprocal interactions may occur with concomitant use of antizol and drugs that increase or inhibit the cytochrome p450 system ( e.g. , phenytoin , carbamazepine , cimetidine , ketoconazole ) , though this has not been studied
None(e1,e2)	10	19	although deferasirox has a lower affinity for aluminum than for iron , exjade should not be taken with aluminum-containing antacid_preparations .
effect(e1,e2)	17	22	ethanol / nutrition / herb interactions : food : cns effects of caffeine may be enhanced if combination_hormonal_contraceptives are used concurrently with caffeine .
None(e1,e2)	6	20	antacid : the effect of an aluminum_hydroxide - and magnesium hydroxide-containing antacid ( maalox ) * on the pharmacokinetics of capecitabine was investigated in 12 cancer patients .
None(e1,e2)	39	41	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	15	17	there have been no reported cases from spontaneous reports of drug interaction between ssris and d.h.e_._45 ( dihydroergotamine_mesylate ) injection , usp .
None(e1,e2)	26	28	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
advise(e1,e2)	0	11	tracrium should not be administered until a patient has recovered from succinylcholine -induced neuromuscular block .
None(e1,e2)	40	56	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	21	38	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	8	13	it is recommended to avoid concurrent administration of ethambutol with aluminum hydroxide containing antacids for at least 4 hours following ethambutol administration .
None(e1,e2)	14	18	no significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide , digoxin , warfarin , cimetidine and phenobarbital .
None(e1,e2)	39	41	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
mechanism(e1,e2)	16	20	pharmacokinetic data from these patients demonstrated a decrease in paclitaxel clearance of approximately 33 % when taxol was administered following cisplatin .
None(e1,e2)	78	82	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	26	hctz 50 mg qd or hctz/triamterene 50/100 mg qd was co-administered with tikosyn ( 500 mcg bid ) for 5 days ( following 2 days of diuretic use at half dose ) .
None(e1,e2)	0	9	digoxin : in controlled studies in healthy volunteers , bepridil_hydrochloride either had no effect ( one study ) or was associated with modest increases , about 30 % ( two studies ) in steady-state serum digoxin concentrations .
effect(e1,e2)	8	55	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	124	136	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	2	8	coadministration of almotriptan and the potent cyp3a4 inhibitor ketoconazole ( 400 mg q.d . for 3 days ) resulted in an approximately 60 % increase in the area under the plasma concentration-time curve and maximal plasma concentrations of almotriptan .
None(e1,e2)	22	38	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	11	24	however , due to possible pharmacodynamic interactions , when co-administered with precedex , a reduction in dosage of precedex on the concomitant anesthetic , sedative , hypnotic or opioid may be required .
None(e1,e2)	38	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	13	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	37	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	40	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum_hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	110	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	30	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	7	25	interaction of gabitril with other drugs : cimetidine : co-administration of cimetidine ( 800 mg/day ) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics .
None(e1,e2)	4	22	phenobarbital : coadministration of felbamate with phenobarbital causes an increase in phenobarbital plasma concentrations , in 12 otherwise healthy male volunteers ingesting phenobarbital , the steady-state trough ( cmin ) phenobarbital concentration was 14.2 micrograms/ml .
mechanism(e1,e2)	15	41	although no clinical studies have been conducted , it is likely that the metabolism of levobupivacaine may be affected by the known cyp3a4 inducers ( such as phenytoin , phenobarbital , rifampin ) , cyp3a4 inhibitors ( azole antimycotics e.g. , ketoconazole ;
None(e1,e2)	1	14	oral contraceptives rofecoxib did not have any clinically important effect on the pharmacokinetics of ethinyl_estradiol and norethindrone .
None(e1,e2)	18	20	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
advise(e1,e2)	8	24	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	2	20	discontinuation of cimetidine in well-controlled patients receiving tricyclic antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants .
None(e1,e2)	9	43	quinidine : coadministration of a 10-mg single dose of aripiprazole with quinidine ( 166 mg/day for 13 days ) , a potent inhibitor of cyp2d6 , increased the auc of aripiprazole by 112 % but decreased the auc of its active metabolite , dehydroaripiprazole , by 35 % .
None(e1,e2)	0	18	dolasetron_mesylate did not inhibit the antitumor activity of four chemotherapeutic agents ( cisplatin , 5-fluorouracil , doxorubicin , cyclophosphamide ) in four murine models .
None(e1,e2)	3	10	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
None(e1,e2)	9	31	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	49	66	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	11	anticholinergics : concurrent administration of certain anticholinergic compounds , such as belladonna_alkaloids and dicyclomine , would be expected to compromise the beneficial effects of cisapride .
mechanism(e1,e2)	1	15	oral anticoagulants may potentiate the hypoglycemic action of hypoglycemic agents , eg , tolbutamide and chlorpropamide , by inhibiting their metabolism in the liver .
None(e1,e2)	45	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	104	116	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	13	18	in a study in normal volunteers , concomitant administration of buspirone hcl and haloperidol resulted in increased serum haloperidol concentrations .
None(e1,e2)	32	70	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	20	26	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	0	7	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	2	4	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
effect(e1,e2)	14	41	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic_antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	127	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	7	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin sodium .
None(e1,e2)	18	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	29	33	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic_hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	32	41	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	65	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	29	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	18	20	another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl_estradiol and levonorgestrel ( cyp3a4 substrates ) .
None(e1,e2)	0	12	paroxetine : coadministration of a single dose of sonata 20 mg and paroxetine 20 mg daily for 7 days did not produce any interaction on psychomotor performance .
advise(e1,e2)	8	28	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	29	31	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	38	80	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	50	56	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic_acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	8	30	however , because bleeding has been reported when ibuprofen and other nonsteroidal anti-inflammatory agents have been administered to patients on coumarin-type anticoagulants , the physician should be cautious when administering ibuprofen to patients on anticoagulants .
None(e1,e2)	18	20	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
effect(e1,e2)	6	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	29	31	may interact with the following : beta-adrenergic blocking agents ( these medicines may make your condition worse and prevent the adrenergic bronchodilators from working properly ) and disopyramide , quinidine , phenothiazines , and procainamide ( these medicines may increase the risk of heart problems ) .
None(e1,e2)	7	19	discontinuation of cimetidine in well-controlled patients receiving tricyclic_antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants .
None(e1,e2)	16	18	in addition , certain drugs that are metabolized by this isoenzyme , including many antidepressants ( tricyclic_antidepressants , selective_serotonin_reuptake_inhibitors , and others ) , may inhibit the activity of this isoenzyme , and thus may make normal metab-olizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system , leading to drug interactions .
None(e1,e2)	12	18	nabilone should be administered with caution to patients who are taking other psychoactive_drugs or cns depressants , including alcohol , barbiturates and narcotic analgesics , or to those with a history of psychiatric disorder ( including manic-depressive illness and schizophrenia ) .
None(e1,e2)	3	9	standard therapy includes antibiotics , such as penicillin and gentamicin ;
None(e1,e2)	8	48	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	19	45	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	49	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	21	52	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	15	19	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	1	29	if rifampicin therapy is required , isradipine concentrations and therapeutic effects are likely to be markedly reduced or abolished as a consequence of increased metabolism and higher clearance of isradipine .
None(e1,e2)	18	43	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium_salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	14	48	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	2	19	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	37	41	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	0	4	antacids , kaolin-pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
None(e1,e2)	0	2	chlorpromazine : chlorpromazine blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of amphetamines , and can be used to treat amphetamine poisoning .
None(e1,e2)	60	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	29	35	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	26	33	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	4	14	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
mechanism(e1,e2)	4	16	total body clearance of simulect was reduced by an average 22 % and 51 % when azathioprine and mycophenolate mofetil , respectively , were added to a regimen consisting of cyclosporine , usp ( modified ) and corticosteroids .
None(e1,e2)	114	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	29	40	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	50	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	4	10	following the administration of inapsine , the dose of other cns_depressant_drugs should be reduced .
None(e1,e2)	18	27	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	58	64	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic_acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	4	14	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	29	49	warfarin : in a study in healthy volunteers , no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin ( 0.7 mg/kg body weight ) were administered during 11 days of multipledose treatment with 5 mg b.i.d . isradipine .
advise(e1,e2)	2	24	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline_salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
effect(e1,e2)	16	49	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic_agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	7	19	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	9	14	there has been little experience with the coadministration of tambocor and either disopyramide or verapamil .
None(e1,e2)	106	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	15	vitamin_a and oral retinoids : concomitant administration of vitamin a and/or other oral retinoids with acitretin must be avoided because of the risk of hypervitaminosis a .
None(e1,e2)	4	9	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	8	14	in a study of schizophrenic patients who received clozapine under steady state conditions , fluvoxamine or paroxetine was added in 16 and 14 patients , respectively .
None(e1,e2)	21	56	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	21	30	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	32	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	17	other drugs : drugs such as quinidine , disopyramide , procainamide , phenothiazines , antihistamines , and tricyclic_antidepressants may be associated with qt-interval prolongation and an increased risk of ventricular arrhythmia .
None(e1,e2)	9	18	drugs that may have their plasma concentration altered by gleevec gleevec increases the mean cmax and auc of simvastatin ( cyp3a4 substrate ) 2- and 3.5-fold , respectively , suggesting an inhibition of the cyp3a4 by gleevec .
None(e1,e2)	0	6	phenobarbital : coadministration of felbamate with phenobarbital causes an increase in phenobarbital plasma concentrations , in 12 otherwise healthy male volunteers ingesting phenobarbital , the steady-state trough ( cmin ) phenobarbital concentration was 14.2 micrograms/ml .
None(e1,e2)	8	19	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	46	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	1	9	monitor salicylate levels or the therapeutic effect for which aspirin is given ;
None(e1,e2)	2	4	effect of probenecid : probenecid is a blocker of renal tubular secretion .
None(e1,e2)	40	50	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	31	67	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	41	43	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	28	42	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	5	10	drug/laboratory test interactions as with cephalothin , high concentrations of cefoxitin ( 100 micrograms/ml ) may interfere with measurement of serum and urine creatinine levels by the jaff reaction , and produce false increases of modest degree in the levels of creatinine reported .
None(e1,e2)	5	17	it is desirable to monitor tca plasma levels whenever an agent of the tricyclic antidepressant class including anafranil is going to be co-administered with another drug known to be an inhibitor of p450 2d6 ( and/or p450 1a2 ) .
effect(e1,e2)	7	20	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic_agonists .
None(e1,e2)	13	20	other drug interaction information digoxin : studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics of digoxin .
None(e1,e2)	23	33	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	6	27	hctz 50 mg qd or hctz/ triamterene 50/100 mg qd was co-administered with tikosyn ( 500 mcg bid ) for 5 days ( following 2 days of diuretic use at half dose ) .
mechanism(e1,e2)	1	7	when itraconazole was coadministered with phenytoin , rifampin , or h2antagonists , reduced plasma concentrations of itraconazole were reported .
None(e1,e2)	1	23	oral hypoglycemics : bepridil has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for insulin or oral hypoglycemic agents .
None(e1,e2)	21	30	when duloxetine was administered ( at a dose of 60 mg bid ) in conjunction with a single 50-mg dose of desipramine , a cyp2d6 substrate , the auc of desipramine increased 3-fold .
advise(e1,e2)	22	38	also , due to the potential for additive effects such as bradycardia and av block , caution is warranted in patients receiving clonidine with agents known to affect sinus node function or av nodal conduction ( e.g. , digitalis , calcium channel blockers , and beta-blockers . )
effect(e1,e2)	9	13	rarely salicylate toxicity may occur in patients who discontinue steroids after concurrent high-dose aspirin therapy .
effect(e1,e2)	11	17	interactions for vitamin b3 ( niacin ) : antihypertensive therapy : nicotinic_acid may potentiate the effects of ganglionic_blocking_agents and vasoactive drugs resulting in postural hypotension .
None(e1,e2)	0	14	digoxin : when multiple doses of atorvastatin and digoxin were coadministered , steady-state plasma digoxin concentrations increased by approximately 20 % .
None(e1,e2)	76	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	18	31	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	5	9	inomax has been administered with tolazoline , dopamine , dobutamine , steroids , surfactant , and high-frequency ventilation .
None(e1,e2)	3	6	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	22	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	23	48	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics * ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	8	10	protease inhibitors : in vitro data indicate that indinavir and ritonavir markedly inhibit the metabolism of cisapride which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	33	45	particular caution is necessary when using romazicon in cases of mixed drug overdosage since the toxic effects ( such as convulsions and cardiac dysrhythmias ) of other drugs taken in overdose ( especially cyclic_antidepressants ) may emerge with the reversal of the benzodiazepine effect by flumazenil .
None(e1,e2)	17	34	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin_reuptake_inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	29	31	in vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the pk properties of anagrelide , nor does anagrelide affect the pk properties of digoxin or warfarin .
None(e1,e2)	8	18	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	2	23	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists_.
mechanism(e1,e2)	0	16	naproxen , naproxen sodium and other nsaids have been reported to reduce the tubular secretion of methotrexate in an animal model , possibly increasing the toxicity of methotrexate .
None(e1,e2)	2	9	nevirapine and rifampin should not beadministered concomitantly becausedecreases in nevirapine plasmaconcentrations may reduce the efficacy ofthe drug .
None(e1,e2)	31	38	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	13	the potential for drug interactions with emtriva has been studied in combination with indinavir , stavudine , famciclovir , and tenofovir disoproxil fumarate .
None(e1,e2)	24	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	45	62	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta_blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin_synthetase_inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	2	9	albuterol , antihistamines , antidiabetic drugs , diuretics , digitalis .
None(e1,e2)	4	6	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	7	24	nonsteroidal anti-inflammatory drugs : the administration of diflunisal to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of indomethacin .
None(e1,e2)	37	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	32	47	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic_acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	41	113	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	25	36	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 3a4 ( cyp 3a4 ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
None(e1,e2)	16	20	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin_sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	16	40	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic_agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	9	13	the co-administration of natrecor with iv vasodilators such as nitroglycerin , nitroprusside , milrinone , or iv ace inhibitors has not been evaluated ( these drugs were not co-administered with natrecor in clinical trials ) .
None(e1,e2)	17	51	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	13	metformin : in healthy subjects given single 500 mg doses of cephalexin and metformin , plasma metformin mean cmax and auc increased by an average of 34 % and 24 % , respectively , and metformin mean renal clearance decreased by 14 % .
None(e1,e2)	25	45	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type_1c_antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	26	31	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin_b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
advise(e1,e2)	15	49	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	7	21	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	11	58	however , in the second study , administration of 12 g cholestyramine 1 hour before the evening meal and 0.3 mg cerivastatin sodium approximately 4 hours after the same evening meal resulted in a decrease in the cerivastatin auc of less than 8 % , and a decrease in cmax of about 30 % when compared to dosing cerivastatin_sodium alone .
None(e1,e2)	3	28	therefore , when edecrin and non- steroidal anti- inflammatory agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained .
None(e1,e2)	19	21	antiepileptic drugs : sporadic cases of seizures have been reported during concomitant use of toradol and antiepileptic drugs ( phenytoin , carbamazepine ) .
None(e1,e2)	3	7	ergot derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine
None(e1,e2)	35	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	59	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	7	23	patients receiving catecholamine-depleting drugs , such as reserpine or guanethidine , should be closely monitored , because the added beta-adrenergic blocking action of zebeta may produce excessive reduction of sympathetic activity .
None(e1,e2)	37	47	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal_anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
effect(e1,e2)	8	30	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	72	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	14	non-steroidal_anti-inflammatory_agents : in some patients with compromised renal function who are being treated with non-steroidal_anti-inflammatory_drugs , the co-administration of lisinopril may result in a further deterioration of renal function .
None(e1,e2)	0	2	digoxin : enoxacin may raise serum digoxin levels in some individuals .
None(e1,e2)	0	18	antiepileptic_drugs : sporadic cases of seizures have been reported during concomitant use of toradol and antiepileptic drugs ( phenytoin , carbamazepine ) .
None(e1,e2)	4	18	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	9	29	in eight hiv-infected patients , the steady-state auc of ciprofloxacin was decreased an average of 26 % ( 95 % ci = 14 % , 37 % ) when ciprofloxacin was administered 2 hours prior to a marketed chewable/dispersible tablet formulation of videx .
None(e1,e2)	20	38	in vitro studies indicate that , at therapeutic concentrations of salicylate ( 300 m g/ml ) , the binding of ketorolac was reduced from approximately 99.2 % to 97.5 % , representing a potential twofold increase in unbound ketorolac plasma levels .
mechanism(e1,e2)	13	19	the reddish color is due to the formation of a nonabsorbable complex between cefdinir or its breakdown products and iron in the gastrointestinal tract .
None(e1,e2)	31	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	22	- a sulfa-based drug such as sulfamethoxazole- trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
effect(e1,e2)	3	11	concomitant administration of mefloquine and other related compounds ( eg , quinine , quinidine and chloroquine ) may produce electrocardiographic abnormalities and increase the risk of convulsions .
None(e1,e2)	23	35	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	17	19	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	8	10	concomitant crohn s disease medications were antibiotics , antivirals , corticosteroids , 6-mp/aza and aminosalicylates .
None(e1,e2)	28	54	phenytoin : in a single ( 400 mg ) and multiple dose ( 400 mg tid ) study of neurontin in epileptic patients ( n=8 ) maintained on phenytoin monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics .
None(e1,e2)	31	44	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	17	allopurinol : in a study of healthy male volunteers no significant pharmacokinetic interaction occurred when captopril and allopurinol were administered concomitantly for 6 days .
mechanism(e1,e2)	5	7	digoxin : concomitant administration of erythromycin and digoxin has been reported to result in elevated digoxin serum levels .
None(e1,e2)	20	21	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	41	43	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	11	fifteen to 30 minutes of exposure to 1.25 mac isoflurane or enflurane had minimal effects on the duration of action of initial doses of nimbex and therefore , no adjustment to the initial dose should be necessary when nimbex is administered shortly after initiation of volatile agents .
None(e1,e2)	2	31	as most entacapone excretion is via the bile , caution should be exercised when drugs known to interfere with biliary excretion , glucuronidation , and intestinal beta-glucuronidase are given concurrently with entacapone .
None(e1,e2)	3	21	the pharmacokinetics of terfenadine and its acid metabolite and the electrocardiographic qt c interval were measured during both periods : with terfenadine alone , and with terfenadine plus dirithromycin .
mechanism(e1,e2)	29	36	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 3a4 ( cyp 3a4 ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
None(e1,e2)	66	160	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	13	40	oral contraceptive : based on auc and half-life , multiple-dose pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of tablets containing 2.5 mg of norethindrone acetate and 50 mcg of ethinyl estradiol were similar with and without coadministration of gabapentin ( 400 mg tid ;
None(e1,e2)	1	9	- anticoagulants : interaction studies in humans have shown bumetanide to have no effect on warfarin metabolism or on plasma prothrombin activity .
None(e1,e2)	76	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	25	27	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	5	21	aspirin : concomitant administration of aspirin with valdecoxib may result in an increased risk of gi ulceration and complications compared to valdecoxib alone .
None(e1,e2)	27	30	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	18	22	therefore , interactions could occur following concomitant administration of psychotropic drugs ( e.g. , narcotics , analgesics , antiemetics , sedatives , tranquilizers ) .
None(e1,e2)	23	38	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	32	40	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	7	57	dexbrompheniramine can interact with alcohol or other cns_depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	4	12	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium_channel_antagonists , angiotensin converting enzyme inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	24	40	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	0	35	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
advise(e1,e2)	10	12	if leprosy-associated inflammatory reactions develop in patients being treated with dapsone and clofazimine , it is still advisable to continue treatment with both drugs .
None(e1,e2)	57	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	16	these include probenecid , cholestyramine , and some antibiotics ( e.g . erythromycin , rifamipicin , ampicillin and chloramphenicol ) .
advise(e1,e2)	27	29	however , since aspirin , nsaids , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or nsaids with ibandronate .
None(e1,e2)	6	30	benzthiazide may interact with alcohol , blood_thinner s , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	5	49	this drug may interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine_oxidase_(_mao_)_inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	0	17	fluoxetine and its active metabolite , norfluoxe-tine , have long half-lives ( 4 to 16 days for norfluoxetine ) , that may affect strategies during conversion from one drug to the other .
None(e1,e2)	56	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	48	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	19	while all the selective serotonin reuptake inhibitors ( ssris ) , e. g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	16	25	concurrent use of butorphanol with central nervous system depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central_nervous_system_depressant effects .
None(e1,e2)	3	5	bacteriostatic antibiotics : chloramphenicol , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .
None(e1,e2)	22	39	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	3	11	the clearance of benzodiazepines metabolized by glucuronidation ( e. g. , lorazepam , oxazepam , temazepam ) is unlikely to be affected by fluvoxamine .
effect(e1,e2)	4	20	although not studied with alosetron , inhibition of n-acetyltransferase may have clinically relevant consequences for drugs such as isoniazid , procainamide , and hydralazine .
None(e1,e2)	80	84	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	11	46	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium_channel_blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide_diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
mechanism(e1,e2)	2	43	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	85	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	81	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	19	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	7	11	anticoagulants : while studies have not shown diclofenac to interact with anticoagulants_of_the_warfarin_type , caution should be exercised , nonetheless , since interactions have been seen with other nsaids .
None(e1,e2)	8	21	the gonadotropin levels may be transiently elevated by spironolactone , minimally elevated by levodopa , and suppressed by oral contraceptives and digoxin .
mechanism(e1,e2)	19	45	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	6	11	drugs with a narrow therapeutic index digoxin a single dose of eszopiclone 3 mg did not affect the pharmacokinetics of digoxin measured at steady state following dosing of 0.5 mg twice daily for one day and 0.25 mg daily for the next 6 days .
None(e1,e2)	11	13	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum_hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	0	18	macrolide_antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e_._45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	87	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	71	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	10	mao inhibitors , narcotic_analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	25	39	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	17	23	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	18	26	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf_blocking_agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	22	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	11	21	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine -containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	9	11	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine oxidase inhibitors or other antidepressants .
None(e1,e2)	2	25	amiodarone or verapamil : the risk of myopathy/rhabdomyolysis is increased when either amiodarone or verapamil is used concomitantly with a closely related member of the hmg-coa_reductase_inhibitor_class ( see warnings , myopathy/rhabdomyolysis ) .
None(e1,e2)	0	5	anesthetics /sedatives/hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
effect(e1,e2)	13	20	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic_agonists .
mechanism(e1,e2)	2	8	theophylline : ethinyl_estradiol may inhibit the metabolism of theophylline , leading to increased plasma concentrations .
None(e1,e2)	2	28	interactions for vitamin_d analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat_soluble_vitamins ;
None(e1,e2)	85	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
int(e1,e2)	11	23	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
advise(e1,e2)	4	6	although concomitant use of clozapine and carbamazepine is not recommended , it should be noted that discontinuation of concomitant carbamazepine administration may result in an increase in clozapine plasma levels .
None(e1,e2)	11	15	folic acid in large amounts may counteract the antiepileptic effect of phenobarbital , phenytoin and primidone , and increase the frequency of seizures in susceptible pediatric patients .
None(e1,e2)	6	23	human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in an eight-fold increase in the mean auc of cisapride .
None(e1,e2)	1	5	- carmustine ( e.g. , bicnu ) or
effect(e1,e2)	4	22	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
None(e1,e2)	144	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	19	psychoactive drugs : hallucinations have been reported when toradol was used in patients taking psychoactive drugs ( fluoxetine , thiothixene , alprazolam ) .
None(e1,e2)	54	76	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	4	6	analgesic/anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	13	38	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	2	6	coadministration of entecavir with lamivudine , adefovir_dipivoxil , or tenofovir disoproxil fumarate did not result in significant drug interactions .
None(e1,e2)	7	15	fenfluramine may increase slightly the effect of antihypertensive_drugs , e.g. , guanethidine , methyldopa , reserpine .
None(e1,e2)	1	14	since acetaminophen in high doses has been associated with hepatotoxicity , concomitant administration of diflunisal and acetaminophen should be used cautiously , with careful monitoring of patients .
None(e1,e2)	28	56	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	1	7	include terfenadine , astemizole , cisapride , midazolam , and triazolam .
None(e1,e2)	1	16	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	28	58	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	25	39	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	4	33	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	10	26	the effect may be mediated by the known inhibition of cimetidine on hepatic cytochrome p-450 , the enzyme system probably responsible for the first-pass metabolism of nifedipine .
int(e1,e2)	4	6	the extent to which ssri - tca interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the ssri involved .
None(e1,e2)	74	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	8	phenytoin : if acitretin is given concurrently with phenytoin , the protein binding of phenytoin may be reduced .
None(e1,e2)	28	101	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	38	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux_sodium .
None(e1,e2)	17	20	the effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide , ketoconazole , methotrexate , phenytoin , tolbutamide , and warfarin have been studied in vivo and clinically important interactions have not been found .
None(e1,e2)	4	7	dopamine antagonists : since apomorphine is a dopamine_agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	8	31	interactions may also occur with the following : anti-depressants /anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	28	30	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	35	38	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin- converting enzyme ( ace ) inhibitors , betablockers , calcium-channel blockers , diuretics , and nonsteroidal_anti-inflammatory_drugs ( nsaids ) without evidence of clinically significant adverse interactions .
None(e1,e2)	23	25	aprepitant is unlikely to interact with drugs that are substrates for the p-glycoprotein transporter , as demonstrated by the lack of interaction of aprepitant with digoxin in a clinical drug interaction study .
None(e1,e2)	11	23	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	55	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	12	central_nervous_system_depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	33	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	7	discontinuation of cimetidine in well-controlled patients receiving tricyclic_antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants .
mechanism(e1,e2)	11	14	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
None(e1,e2)	16	20	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	13	32	renal function should be carefully monitored , especially if higher dosages of the aminoglycosides are to be administered or if therapy is prolonged , because of the potential nephrotoxicity and ototoxicity of aminoglycosidic_antibiotics .
None(e1,e2)	6	46	particular caution is necessary when using romazicon in cases of mixed drug overdosage since the toxic effects ( such as convulsions and cardiac dysrhythmias ) of other drugs taken in overdose ( especially cyclic antidepressants ) may emerge with the reversal of the benzodiazepine effect by flumazenil .
None(e1,e2)	26	33	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic_antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	42	57	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	14	17	nonsteroidal anti-inflammatory agents ( nsaids ) : concomitant use of aspirin ( or other nonsteroidal_antiinflammatory_agents ) and corticosteroids increases the risk of gastrointestinal side effects .
None(e1,e2)	15	31	although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic antiretroviral_agents , including protease inhibitors , macrolide antibiotics , and azole antifungals , the effect of panretin gel on the steady-state concentrations of these drugs is not known .
None(e1,e2)	17	29	aprepitant increased the auc of midazolam by 25 % on day 4 and decreased the auc of midazolam by 19 % on day 8 relative to the dosing of aprepitant on days 1 through 3 .
None(e1,e2)	25	42	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	33	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	18	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	6	fluconazole and ketoconazole : ketoconazole and fluconazole are predominantly cyp 3a4 and 2c9 inhibitors , respectively .
None(e1,e2)	23	42	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	6	11	the co-administration of natrecor with iv vasodilators such as nitroglycerin , nitroprusside , milrinone , or iv ace inhibitors has not been evaluated ( these drugs were not co-administered with natrecor in clinical trials ) .
None(e1,e2)	81	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	26	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	19	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	44	59	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	23	25	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	2	19	cimetidine , ranitidine : in normal volunteers ( n=9 ) , pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small ( 13 % ) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine .
None(e1,e2)	0	4	digoxin : coadministration of digoxin , a p-glycoprotein substrate , with oral conivaptan resulted in a reduction in clearance and an increase in digoxin cmax and auc values .
None(e1,e2)	53	55	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	11	28	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
advise(e1,e2)	1	17	- perhexiline_hydrogen_maleate or mao-inhibitors ( with hepatotoxic potential ) must not be administered together with bezalip or bezalip_retard .
None(e1,e2)	10	20	toxicology studies of heroin-related deaths reveal frequent involvement of other central_nervous_system_depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
None(e1,e2)	51	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	18	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	9	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	3	24	the concentrations of sn38 , the active metabolite of irinotecan , were on average 33 % higher in patients receiving bolus-ifl in combination with avastin when compared with bolus-ifl alone .
None(e1,e2)	0	43	5ht3_antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	10	37	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	38	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	23	phenytoin : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenytoin with or without other enzyme- inducing aeds .
None(e1,e2)	30	57	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	39	91	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	31	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	4	fluoxetine , ocs , sertraline , diltiazem , macrolide antibiotics ( exercise caution ) .
None(e1,e2)	14	31	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	69	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	23	42	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	48	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	14	16	there have been reports of theophylline-related side effects in patients on concomitant therapy with norfloxacin and theophylline .
None(e1,e2)	2	28	combination of amiodarone with other antiarrhythmic therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to amiodarone .
mechanism(e1,e2)	15	17	ethanol : clinical evidence has shown that etretinate can be formed with concurrent ingestion of acitretin and ethanol .
None(e1,e2)	0	1	warfarin keppra ( 1000 mg twice daily ) did not influence the pharmacokinetics of r and s warfarin .
None(e1,e2)	0	3	acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16 % ( 90 % confidence interval : 8-23 % ) , decrease mean c max digoxin by 26 % ( 90 % confidence interval : 16-34 % ) and decrease mean trough concentrations of digoxin by 9 % ( 90 % confidence limit : 19 % decrease to 2 % increase ) .
None(e1,e2)	0	24	ethanol / nutrition / herb interactions : food : cns effects of caffeine may be enhanced if combination hormonal contraceptives are used concurrently with caffeine .
None(e1,e2)	5	18	pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole , resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong qt intervals .
None(e1,e2)	37	45	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal_anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	20	44	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	21	50	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	20	29	however , because bleeding has been reported when ibuprofen and other nonsteroidal anti-inflammatory agents have been administered to patients on coumarin-type_anticoagulants , the physician should be cautious when administering ibuprofen to patients on anticoagulants .
None(e1,e2)	11	30	these in vitro studies suggest that concomitant administration of zalcitabine and lamivudine in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine , which may lead to a decreased antiretroviral effect of zalcitabine .
None(e1,e2)	15	33	in a study in diabetics with microalbuminuria inspra 200 mg combined with the ace inhibitor enalapril 10 mg increased the frequency of hyperkalemia ( serum potassium 5.5 meq/l ) from 17 % on enalapril alone to 38 % .
effect(e1,e2)	3	8	digitalis glycosides : amphotericin_b -induced hypokalemia may potentiate digitalis toxicity .
None(e1,e2)	2	31	because of foscarnet s tendency to cause renal impairment , the use of foscavir should be avoided in combination with potentially nephrotoxic drugs such as aminoglycosides , amphotericin b and intravenous pentamidine unless the potential benefits outweigh the risks to the patient .
None(e1,e2)	80	147	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	23	27	in general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including anti-arrhythmic agents such as quinidine and procainamide , cardiac_glycosides and tricyclic anti-depressants .
None(e1,e2)	21	65	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	112	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	95	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	27	62	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
mechanism(e1,e2)	0	7	ketoconazole tablets may alter the metabolism of cyclosporine , tacrolimus , and methylprednisolone , resulting in elevated plasma concentrations of the latter drugs .
None(e1,e2)	34	39	this observed increase in the bioavailability of fexofenadine may be due to transport-related effects , such as p-glycoprotein . in vivo animal studies also suggest that in addition to enhancing absorption , ketoconazole decreases fexofenadine gastrointestinal secretion , while erythromycin may also decrease biliary excretion .
None(e1,e2)	10	23	if signs and symptoms suggestive of digoxin toxicity occur when enoxacin and digoxin are given concomitantly , physicians are advised to obtain serum digoxin levels and adjust digoxin doses appropriately .
None(e1,e2)	32	39	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
mechanism(e1,e2)	5	15	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	8	14	digoxin : when multiple doses of atorvastatin and digoxin were coadministered , steady-state plasma digoxin concentrations increased by approximately 20 % .
None(e1,e2)	116	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	13	25	therefore , close monitoring of prothrombin time is recommended and adjustment of the anticoagulant dose may be necessary when eulexin capsules are administered concomitantly with warfarin .
None(e1,e2)	2	4	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
advise(e1,e2)	31	49	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	35	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	94	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	31	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	51	70	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	12	21	there is limited experience with concomitant antihypertensive agents such as alpha-blockers , calcium_channel-blockers , ace inhibitors , and diuretics ( both thiazide -like and loop ) .
None(e1,e2)	5	15	compounds tested in man include warfarin , theophylline , phenytoin , diazepam , aminopyrine and antipyrine .
advise(e1,e2)	3	7	therefore , when heparin_sodium is given with dicumarol or warfarin sodium , a period of at least 5 hours after the last intravenous dose or 24 hours after the last subcutaneous dose should elapse before blood is drawn if a valid prothrombin time is to be obtained .
None(e1,e2)	0	7	cytokines ( interferon , interleukin ) : cytokines have been reported to induce both hyperthyroidism and hypothyroidism .
None(e1,e2)	55	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	34	45	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	9	12	drug-drug interactions between keppra and other antiepileptic drugs ( aeds ) phenytoin keppra ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy .
mechanism(e1,e2)	2	18	probenecid : probenecid interferes with renal tubular secretion of ciprofloxacin and produces an increase in the level of ciprofloxacin in serum .
None(e1,e2)	62	80	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin_sodium under-dosage .
None(e1,e2)	4	10	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	6	12	platelet inhibitors : drugs such as acetylsalicylic_acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	35	44	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim /sulfamethoxazole or zidovudine .
None(e1,e2)	16	31	co-administration of cyp3a4 inhibitors ( eg , ketoconazole , itraconazole , erythromycin , grapefruit juice , cimetidine ) with felodipine may lead to several- fold increases in the plasma levels of felodipine , either due to an increase in bioavailability or due to a decrease in metabolism .
None(e1,e2)	39	49	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	6	10	however , co-administration of duloxetine with aluminum - and magnesium-containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
None(e1,e2)	0	8	vitamin_a and oral retinoids : concomitant administration of vitamin_a and/or other oral retinoids with acitretin must be avoided because of the risk of hypervitaminosis a .
mechanism(e1,e2)	43	64	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	0	21	warfarin : in a short-term controlled study in 14 normal volunteers , ketoprofen did not significantly interfere with the effect of warfarin on prothrombin time .
None(e1,e2)	2	12	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	6	15	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	0	7	dicumarol : it has been reported that allopurinol prolongs the half-life of the anticoagulant , dicumarol .
None(e1,e2)	11	27	warfarin : the effect of celecoxib on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2-5 mg of warfarin .
None(e1,e2)	38	56	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	5	warfarin : the effects of warfarin and nsaids on gi bleeding are synergistic , such that users of both drugs together have a risk of serious gi bleeding higher than users of either drug alone .
None(e1,e2)	4	9	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine_derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
None(e1,e2)	6	22	concomitant use of prophylactic low dose heparin did not appear to affect safety , however , its effects on the efficacy of xigris have not been evaluated in an adequate and well-controlled clinical trial .
None(e1,e2)	0	22	antidepressants : in vitro data indicate that nefazodone inhibits the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	24	26	physiological changes resulting from smoking cessation , with or without nicotine replacement , may alter the pharmacokinetics of certain concomitant medications , such as tricyclic_antidepressants and theophylline .
None(e1,e2)	30	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	5	antacids ( aluminum - or magnesium -containing ) : concomitant administration of 300-mg cefdinir capsules with 30 ml maalox tc suspension reduces the rate ( cmax ) and extent ( auc ) of absorption by approximately 40 % .
None(e1,e2)	107	109	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	2	17	caffeine : enoxacin is a potent inhibitor of the cytochrome p-450 isozymes responsible for the metabolism of methylxanthines .
None(e1,e2)	0	3	antacid : when atorvastatin and maalox tc suspension were coadministered , plasma concentrations of atorvastatin decreased approximately 35 % .
None(e1,e2)	4	37	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
int(e1,e2)	0	26	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	15	17	dosage adjustment of strattera may be necessary when coadministered with cyp2d6 inhibitors , e.g. , paroxetine , fluoxetine , and quinidine .
None(e1,e2)	38	60	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing_compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	9	13	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	20	30	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	35	20	drugs that inhibit cyp3a4 cyp3a4 is a minor metabolic pathway for the elimination of zaleplon because the sum of desethyl zaleplon ( formed via cyp3a4 in vitro ) and its metabolites , 5-oxo-desethylzaleplon and 5-oxo-desethylzaleplon_glucuronide , account for only 9 % of the urinary recovery of a zaleplon dose .
None(e1,e2)	39	43	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	25	42	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	18	22	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	23	25	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	32	63	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic_acid .
None(e1,e2)	7	22	patients taking revia may not benefit from opioid containing medicines , such as cough and cold preparations , antidiarrheal preparations , and opioid_analgesics .
effect(e1,e2)	0	10	erythromycin use in patients who are receiving high doses of theophylline may be associated with an increase in serum theophylline levels and potential theophylline toxicity .
None(e1,e2)	1	5	- daunorubicin ( e.g. , cerubidine ) or
None(e1,e2)	9	12	certain antibiotic , cisplatin , cyclosporine , diuretic , foscarnet , and vaccines .
None(e1,e2)	40	43	also , due to the potential for additive effects such as bradycardia and av block , caution is warranted in patients receiving clonidine with agents known to affect sinus node function or av nodal conduction ( e.g. , digitalis , calcium_channel_blockers , and beta-blockers . )
None(e1,e2)	18	22	other drug interactions : no pharmacokinetic interactions were observed between vardenafil and the following drugs : glyburide , warfarin , digoxin , maalox , and ranitidine .
None(e1,e2)	0	24	anticholinergic_agents : although ipratropium bromide is minimally absorbed into the systemic circulation , there is some potential for an additive interaction with concomitantly used anticholinergic_medications .
None(e1,e2)	2	31	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
mechanism(e1,e2)	3	9	the coadministration of aspirin decreases the biologic half-life of fenoprofen because of an increase in metabolic clearance that results in a greater amount of hydroxylated fenoprofen in the urine .
None(e1,e2)	31	36	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	23	33	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	13	45	cimetidine , ranitidine : in normal volunteers ( n=9 ) , pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small ( 13 % ) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine .
int(e1,e2)	0	14	sulfapyridine may interact with any of the following : - acetaminophen ( e.g. , tylenol ) ( with long-term , high-dose use ) or
None(e1,e2)	1	15	phenytoin/ phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin_d , but may reduce endogenous plasma levels of calcitriol/ergocalcitriol by accelerating metabolism .
mechanism(e1,e2)	2	43	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	29	42	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	10	19	antiarrhythmic agents , class i ( such as flecainide , lidocaine , or quinidine ) : concurrent use with arbutamine may have a proarrhythmic effect .
advise(e1,e2)	8	48	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
mechanism(e1,e2)	23	36	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 3a4 ( cyp 3a4 ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
None(e1,e2)	59	61	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	21	25	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	13	21	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	20	30	the oral dexamethasone doses should be reduced by approximately 50 % when coadministered with aprepitant , to achieve exposures of dexamethasone similar to those obtained when it is given without aprepitant .
None(e1,e2)	56	74	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2_antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone_anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	6	30	concomitant use of agents in the tricyclic_antidepressant_class ( which includes anafranil ) with drugs that can inhibit cytochrome p450 2d6 may require lower doses than usually prescribed for either the tricyclic_antidepressant_agent or the other drug .
effect(e1,e2)	0	8	cyclopentolate may interfere with the anti-glaucoma action of carbachol or pilocarpine ;
None(e1,e2)	12	32	hormonal contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive ortho-novum produced average decreases of norethindrone and ethinyl estradiol levels of 14 % and 31 % , respectively .
None(e1,e2)	42	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	20	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	17	27	approximately 2/3 of the patients in the phase 3 study received either prophylactic low dose heparin ( unfractionated_heparin up to 15,000 units/day ) or prophylactic doses of low_molecular_weight_heparins as indicated in the prescribing information for the specific products .
None(e1,e2)	22	33	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	31	37	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	17	reported examples of this interaction include the following : antibiotics : rifampin is a potent inducer of cyp3a4 .
None(e1,e2)	0	6	tricyclic_antidepressants ( amitriptyline , imipramine , nortriptyline ) : metabolism may be inhibited by combination hormonal contraceptives , increasing plasma levels of antidepressant ;
None(e1,e2)	4	11	co-administration of warfarin and cerivastatin did not alter the pharmacokinetics of cerivastatin_sodium .
None(e1,e2)	0	13	lithium serum concentrations should be monitored closely when initiating or changing therapy with bextra in patients receiving lithium .
None(e1,e2)	0	9	vitamin_a : because of the relationship of accutane to vitamin_a , patients should be advised against taking vitamin supplements containing vitamin a to avoid additive toxic effects
None(e1,e2)	29	60	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic_hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	26	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	22	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	0	13	allegra should not be taken closely in time with aluminum and magnesium containing antacids .
None(e1,e2)	0	16	methenamine therapy : urinary excretion of amphetamines is increased , and efficacy is reduced , by acidifying_agents used in methenamine therapy .
None(e1,e2)	114	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	13	41	anticonvulsants ( phenytoin ) : steady state plasma exposure ( auc ) of valdecoxib ( 40 mg bid for 12 days ) was decreased by 27 % when co-administered with multiple doses ( 300 mg qd for 12 days ) of phenytoin ( a cyp 3a4 inducer ) .
None(e1,e2)	7	14	beta-blockers : in controlled clinical studies , adrenergic_beta-receptor_blockers have been frequently administered concomitantly with nicardipine_hcl .
None(e1,e2)	12	26	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	12	14	h2 blockers/proton pump inhibitors : long-term suppression of gastric acid secretion by h2_blockers or proton_pump_inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
None(e1,e2)	42	84	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	8	12	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	51	63	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	26	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
advise(e1,e2)	4	13	cyclosporine , tacrolimus and digoxin concentrations should be monitored at the initiation of itraconazole therapy and frequently thereafter , and the dose of these three drug products adjusted appropriately .
None(e1,e2)	85	106	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	12	ssris : weakness hyperreflexia , and incoordination have been reported rarely when 5-ht1_agonists have been co-administered with ssris ( e. g .
None(e1,e2)	94	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	16	38	although studies designed to examine drug interactions have not been done , it was noted that corticosteroid or acth treatment of relapses for periods of up to 28 days has been administered to patients ( n=180 ) receiving betaseron .
None(e1,e2)	2	9	hydrochlorothiazide ( hctz ) alone or in combination with triamterene : concomitant use of hctz alone or in combination with triamterene is contraindicated .
None(e1,e2)	5	7	in patients taking furosemide , nifedipine , diltiazem , ace inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	4	6	single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent , respectively .
None(e1,e2)	21	23	of over 3500 patients enrolled in the ibandronate osteoporosis treatment and prevention studies , 15 % used anti-peptic agents ( primarily h2_blockers and ppis ) .
None(e1,e2)	15	30	oral contraceptive : based on auc and half-life , multiple-dose pharmacokinetic profiles of norethindrone and ethinyl_estradiol following administration of tablets containing 2.5 mg of norethindrone acetate and 50 mcg of ethinyl_estradiol were similar with and without coadministration of gabapentin ( 400 mg tid ;
None(e1,e2)	102	104	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	24	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline_salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	5	7	tricyclic antidepressants ( amitriptyline , imipramine , nortriptyline ) : metabolism may be inhibited by combination hormonal contraceptives , increasing plasma levels of antidepressant ;
None(e1,e2)	26	80	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	20	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	28	40	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	0	4	diuretics : patients on diuretics , especially those with intravascular volume depletion , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with fosinopril sodium .
None(e1,e2)	17	26	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	1	5	other antiarrhythmic_drugs ( eg , quinidine , procainamide , lidocaine , propranolol ) have occasionally been used concurrently with norpace .
None(e1,e2)	3	21	concomitant use of tricyclic_antidepressants with other drugs metabolized by cytochrome p450iid6 may require lower doses than usually prescribed for either the tricyclic_antidepressant or the other drug .
None(e1,e2)	30	53	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
int(e1,e2)	3	7	diphenoxylate hcl and atropine_sulfate may interact with mao_inhibitors in studies with male rats , diphenoxylate hydrochloride was found to inhibit the hepatic microsomal enzyme system at a dose of 2 mg/kg/day .
mechanism(e1,e2)	10	31	however , a crossover study in healthy subjects receiving either tagamet 300 mg q.i.d . or 800 mg h.s . concomitantly with a 300 mg b.i.d . dosage of theophylline ( theo-dur , key pharmaceuticals , inc. ) demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg h.s . regimen , particularly in subjects aged 54 years and older .
None(e1,e2)	21	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	5	leucovorin : the concentration of 5-fluorouracil is increased and its toxicity may be enhanced by leucovorin .
advise(e1,e2)	4	6	therefore concomitant administration of itraconazole with cisapride is contraindicated .
None(e1,e2)	11	35	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
None(e1,e2)	6	18	however , co-administration of duloxetine with aluminum - and magnesium-containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
None(e1,e2)	8	29	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	26	30	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin_hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	0	4	cyclosporine : administration of nonsteroial_anti-inflammatory_drugs concomitantly with cyclosporine has been associated with an increase in cyclosporine-induced toxicity , possibly due to decreased synthesis of renal prostacyclin .
None(e1,e2)	37	44	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	14	61	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
effect(e1,e2)	6	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	59	68	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	2	21	phenobarbital or primidone : no formal pharmacokinetic studies have been performed examining the addition of tiagabine to regimens containing phenobarbital or primidone .
None(e1,e2)	34	46	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal_muscle_relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	24	34	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	14	16	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
effect(e1,e2)	28	32	in rats , simultaneous ingestion of disulfiram and nitrite in the diet for 78 weeks has been reported to cause tumors , and it has been suggested that disulfiram may react with nitrites in the rat stomach to form a nitrosamine , which is tumorigenic .
None(e1,e2)	10	20	discontinuation of cimetidine in well-controlled patients receiving tricyclic antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants .
None(e1,e2)	28	61	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	7	methotrexate : caution should be used if diflunisal is administered concomitantly with methotrexate .
None(e1,e2)	34	74	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	7	19	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	0	10	h2-receptor_antagonists : co-administration of a single dose of intravenously administered famotidine ( 20 mg ) reduced the oral absorption of a single 400 mg dose of cefditoren pivoxil administered following a meal , as evidenced by a 27 % decrease in mean cmax and a 22 % decrease in mean auc .
None(e1,e2)	55	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	28	43	in another study with intravenous administration of midazolam , aprepitant was given as 125 mg on day 1 and 80 mg/day on days 2 and 3 , and midazolam 2 mg iv was given prior to the administration of the 3-day regimen of aprepitant and on days 4 , 8 , and 15 .
effect(e1,e2)	5	21	these pharmacokinetic effects seen during diltiazem coadministration can result in increased clinical effects ( e.g. , prolonged sodation ) of both midazolam and triazolam .
None(e1,e2)	32	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	13	15	in vitro studies indicate cyp3a4 isoform and cyp1a2 isoform mediate the metabolism of levobupivacaine to desbutyl_levobupivacaine and 3-hydroxy levobupivacaine , respectively .
None(e1,e2)	42	68	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	17	24	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
advise(e1,e2)	3	13	if possible , anticholinesterase_agents should be withdrawn at least 24 hours before initiating corticosteroid therapy .
None(e1,e2)	3	5	the use of nimbex before succinylcholine to attenuate some of the side effects of succinylcholine has not been studied .
None(e1,e2)	53	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	20	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , paroxetine , and fluvoxamine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	42	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	67	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	25	29	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	14	24	micro-dosed progesterone preparations : micro-dosed progesterone preparations ( minipills that do not contain an estrogen ) may be an inadequate method of contraception during accutane therapy .
None(e1,e2)	14	20	additive depressant effect when used with general anesthetics , sedatives , antianxiety drugs , hypnotics , alcohol , and other opiate_analgesics .
advise(e1,e2)	0	12	epinephrine also should be used cautiously with other drugs ( e.g. , digitalis , glycosides ) that sensitize the myocardium to the actions of sympathomimetic drugs .
None(e1,e2)	9	22	ergot derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine contraindicated due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
None(e1,e2)	4	10	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
effect(e1,e2)	6	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	34	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	0	4	colestipol -concomitant intake of colestipol and vitamin k may reduce the absorption of vitamin k .
None(e1,e2)	12	23	although these results do not indicate a significant interaction between toradol and warfarin or heparin , the administration of toradol to patients taking anticoagulants should be done extremely cautiously , and patients should be closely monitored .
None(e1,e2)	15	19	phenobarbital or primidone : no formal pharmacokinetic studies have been performed examining the addition of tiagabine to regimens containing phenobarbital or primidone .
None(e1,e2)	4	32	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	5	11	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
None(e1,e2)	98	114	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	37	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	71	75	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone_anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	28	30	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	17	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	3	16	patients receiving other narcotic_analgesics , antipsychotics , antianxiety agents , or other cns depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
mechanism(e1,e2)	2	31	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	13	45	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	2	cholestyramine : cholestyramine may increase the clearance of corticosteroids .
None(e1,e2)	14	49	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
mechanism(e1,e2)	19	42	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	4	12	laboratory tests response to plenaxis should be monitored by measuring serum total testosterone concentrations just prior to administration on day 29 and every 8 weeks thereafter .
None(e1,e2)	29	42	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	0	23	acetaminophen : in normal volunteers , concomitant administration of diflunisal and acetaminophen resulted in an approximate 50 % increase in plasma levels of acetaminophen .
None(e1,e2)	20	38	1- nc denotes a mean change of less than 10 % 2- pediatrics 3- mean increase in adults at high trileptal doses in vivo , the plasma levels of phenytoin increased by up to 40 % , when trileptal was given at doses above 1200 mg/day .
None(e1,e2)	102	111	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	133	152	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	32	34	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	10	42	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic_drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels ) .
None(e1,e2)	15	42	the iv methylprednisolone dose should be reduced by approximately 25 % , and the oral methylprednisolone dose should be reduced by approximately 50 % when coadministered with aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without aprepitant .
None(e1,e2)	12	39	hypotension was more likely to occur if the calcium antagonist were a dihydropyridine_derivative , e.g. , nifedipine , while left ventricular failure and av conduction disturbances , including complete heart block , were more likely to occur with either verapamil or diltiazem .
effect(e1,e2)	4	9	corticosteroids and corticotropin ( acth ) : may potentiate amphotericin_b - induced hypokalemia which may predispose the patient to cardiac dysfunction .
None(e1,e2)	1	22	because cholestyramine binds bile acids , cholestyramine resin may interfere with normal fat digestion and absorption and thus may prevent absorption of fat_soluble_vitamins such as a , d , e , and k .
None(e1,e2)	20	30	in in vivo studies , 10- to 30-mg/day doses of aripiprazole had no significant effect on metabolism by cyp2d6 ( dextromethorphan ) , cyp2c9 ( warfarin ) , cyp2c19 ( omeprazole , warfarin ) , and cyp3a4 ( dextromethorphan ) substrates .
None(e1,e2)	3	7	other drug interactions cimetidine , erythromycin and dextropropoxyphene had no effect on the pharmacokinetics of mhd .
None(e1,e2)	33	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	5	17	a dose increase of lopinavir/ ritonavir to 533/133 mg twice daily with food isrecommended in combination with nevirapine .
None(e1,e2)	17	19	on the basis of the metabolism of bexarotene by cytochrome p450 3a4 , ketoconazole , itraconazole , erythromycin , gemfibrozil , grapefruit juice , and other inhibitors of cytochrome p450 3a4 would be expected to lead to an increase in plasma bexarotene concentrations .
None(e1,e2)	6	13	data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following : sertraline and paroxetine .
None(e1,e2)	29	37	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal_anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
effect(e1,e2)	2	22	triazolam : erythromycin has been reported to decrease the clearance of triazolam and , thus , may increase the pharmacologic effect of triazolam .
None(e1,e2)	2	8	antidepressants ( tricyclic ) , atropine or other anticholinergic_agents , or digitalis glycosides : concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects .
None(e1,e2)	18	23	although not studied with alosetron , inhibition of n-acetyltransferase may have clinically relevant consequences for drugs such as isoniazid , procainamide , and hydralazine .
None(e1,e2)	7	13	macrolide antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot_alkaloid_class , of which d.h.e . 45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	52	80	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	2	6	immunosuppressants : cyclosporine , tacrolimus , sirolimus
None(e1,e2)	62	64	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	31	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	13	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	38	40	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing_compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	3	22	ace inhibitors and angiotensin_ii_receptor_antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace inhibitors or angiotensin ii receptor antagonists ( acei/arb ) .
None(e1,e2)	8	21	in addition to bleeding associated with heparin and vitamin_k_antagonists , drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
None(e1,e2)	30	40	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
advise(e1,e2)	4	21	therefore , co-administration of tricyclic_antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	0	27	hiv_protease_inhibitors : indinavir ( 800 mg t.i.d . ) co-administered with vardenafil 10 mg resulted in a 16-fold increase in vardenafil auc , a 7-fold increase in vardenafil cmax and a 2-fold increase in vardenafil half-life .
effect(e1,e2)	0	10	calcium_channel_blockers may also have an additive effect when given with tenormin .
effect(e1,e2)	16	35	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1_agonists .
None(e1,e2)	5	7	protease inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination hormonal contraceptives ;
effect(e1,e2)	3	9	antidepressants , tricyclic amphetamines may enhance the activity of tricyclic_antidepressants or sympathomimetic agents ;
None(e1,e2)	0	13	dopamine_antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine_antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	7	23	antithyroid agents may decrease thyroidal uptake of sodium_iodide_i131 , a rebound in uptake may occur up to 5 days after sudden withdrawal of carbimazole .
None(e1,e2)	0	36	digoxin - in subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of citalopram and digoxin ( single dose of 1 mg ) did not significantly affect the pharmacokinetics of either citalopram or digoxin .
mechanism(e1,e2)	18	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	22	methadone levels may be decreased ; increased dosages may be required to prevent symptoms of opiate withdrawal . methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly .
None(e1,e2)	18	20	although deferasirox has a lower affinity for aluminum than for iron , exjade should not be taken with aluminum -containing antacid_preparations .
None(e1,e2)	3	10	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic agonists .
None(e1,e2)	15	17	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
effect(e1,e2)	15	24	furosemide : clinical studies , as well as post marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
None(e1,e2)	6	14	no interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa/dopa-decarboxylase inhibitor .
None(e1,e2)	25	34	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type_1c_antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	6	20	fluconazole , and the 5-ht3 antiemetics ondansetron ( zofran ) and granisetron ( kytril ) have all been used with busulfex .
None(e1,e2)	5	40	clinical trials have indicated that pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral , inhaled and/or parenteral antibiotics , bronchodilators , enzyme supplements , vitamins , oral or inhaled corticosteroids , and analgesics .
None(e1,e2)	3	5	other drug interactions cimetidine , erythromycin and dextropropoxyphene had no effect on the pharmacokinetics of mhd .
None(e1,e2)	9	18	medications can interfere with folate utilization , including : anticonvulsant_medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	29	32	while no in vivo drug-drug interaction studies were conducted between estazolam and inducers of cyp3a , compounds that are potent cyp3a inducers ( such as carbamazepine , phenytoin , rifampin , and barbiturates ) would be expected to decrease estazolam concentrations .
None(e1,e2)	46	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	57	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
effect(e1,e2)	0	10	naproxen and other nsaids can reduce the antihypertensive effect of propranolol and other beta-blockers .
advise(e1,e2)	0	7	nafazodone , fluvoxamine , cimetidine ( consider xanax dose reduction ) .
effect(e1,e2)	17	22	since the concomitant administration of these two drugs can lead to phenytoin intoxication , prior to administering disulfiram to a patient on phenytoin therapy , a baseline phenytoin serum level should be obtained .
None(e1,e2)	10	27	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	8	22	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	39	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	62	115	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
int(e1,e2)	0	24	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	7	46	midazolam : aprepitant increased the auc of midazolam , a sensitive cyp3a4 substrate , by 2.3-fold on day 1 and 3.3-fold on day 5 , when a single oral dose of midazolam 2 mg was coadministered on day 1 and day 5 of a regimen of aprepitant 125 mg on day 1 and 80 mg/day on days 2 through 5 .
mechanism(e1,e2)	46	57	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
effect(e1,e2)	4	24	the potentiating action of hydroxyzine must be considered when the drug is used in conjunction with central nervous system depressants such as narcotics , non-narcotic_analgesics and barbiturates .
None(e1,e2)	0	9	rifabutin , another rifamycin , is structurally similar to rifampin and may possibly have some of the same drug interactions as rifampin .
effect(e1,e2)	14	35	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1_agonists .
advise(e1,e2)	8	42	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	0	8	veratrum_alkaloids : amphetamines inhibit the hypotensive effect of veratrum_alkaloids .
effect(e1,e2)	14	23	furosemide : clinical studies , as well as random observations , have shown that ibuprofen can reduce the natriuretic effect of furosemide and thiazides in some patients .
None(e1,e2)	0	17	rifampin : following concomitant administration of a single dose of arava to subjects receiving multiple doses of rifampin , m1 peak levels were increased ( ~40 % ) over those seen when arava was given alone .
None(e1,e2)	29	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
mechanism(e1,e2)	2	14	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
None(e1,e2)	24	36	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline_salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline_salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	0	19	phenytoin : in a single ( 400 mg ) and multiple dose ( 400 mg tid ) study of neurontin in epileptic patients ( n=8 ) maintained on phenytoin monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics .
None(e1,e2)	7	34	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium_hydroxide s ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	26	33	the following agents may increase certain actions or side effects of anticholinergic drugs . amantadine antiarrhythmic agents of class ( e.g . quinidine ) , antihistamines antipsychotic_agents ( e.g . phenothiazines ) , benzodiazepines .
None(e1,e2)	7	10	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
effect(e1,e2)	0	13	naproxen and other nsaids can reduce the antihypertensive effect of propranolol and other beta-blockers .
None(e1,e2)	8	27	antiretroviral agents : no drug interactions with other antiretroviral_medications have been identified that would warrant alteration of either the enfuvirtide dose or the dose of the other antiretroviral_medication .
None(e1,e2)	49	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	28	40	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	39	64	aspirin/acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
None(e1,e2)	29	43	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	4	24	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
effect(e1,e2)	5	10	pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole , resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong qt intervals .
None(e1,e2)	0	6	glyburide : the concomitant administration of ciprofloxacin with the sulfonylurea glyburide has , on rare occasions , resulted in severe hypoglycemia .
None(e1,e2)	0	13	cholestyramine -concomitant intake of cholestyramine and vitamin k may reduce the absorption of vitamin_k .
None(e1,e2)	25	39	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic_antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	1	47	although glucocorticoids have been shown to reduce proleukin-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
None(e1,e2)	100	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	25	39	in addition , studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics or pharmacodynamics of warfarin , or the pharmacokinetics of propranolol ( 40 mg twice daily ) , phenytoin , theophylline , or oral contraceptives .
None(e1,e2)	30	32	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	30	32	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	20	22	agents with increased levels in the presence of carbamazepine : equetrotm increases the plasma levels of the following agents : clomipramine_hcl , phenytoin ( 6 ) , and primidone thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with equetrotm , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .
None(e1,e2)	47	62	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic_acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	2	15	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
None(e1,e2)	66	101	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	33	37	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns_depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
None(e1,e2)	5	16	in patients taking furosemide , nifedipine , diltiazem , ace inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	32	37	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
effect(e1,e2)	0	21	cyclopropane or halogenated hydrocarbon anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines , such as dopamine .
None(e1,e2)	10	38	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	28	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	0	7	methotrexate - there is one report that methotrexate may decrease the possible effectiveness of supplemental l-glutamine for chemotherapy-induced mucositis .
mechanism(e1,e2)	18	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	11	potassium-sparing_diuretics such as spironolactone , triamterene , or amiloride , or potassium supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
None(e1,e2)	15	34	in order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with taxol should be premedicated with corticosteroids ( such as dexamethasone ) , diphen-hydramine and h2 antagonists ( such as cimetidine or ranitidine ) .
None(e1,e2)	5	12	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	19	25	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic_agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	8	10	other significant inhibitors of cyp2d6 , such as fluoxetine or paroxetine , would be expected to have similar effects and , therefore , should be accompanied by similar dose reductions .
None(e1,e2)	13	24	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type 1c antiarrhythmics propafenone and flecainide ) .
None(e1,e2)	2	15	interactions with mixed_agonist/antagonist_opioid_analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
advise(e1,e2)	7	14	for adult-onset diabetics , dosage adjustment of hypoglycemic_medications may be necessary during and after thiazide_diuretic therapy ;
None(e1,e2)	94	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	4	23	although not studied with alosetron , inhibition of n-acetyltransferase may have clinically relevant consequences for drugs such as isoniazid , procainamide , and hydralazine .
None(e1,e2)	18	76	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	35	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	21	coadministration of esomeprazole 30 mg and diazepam , a cyp2c19 substrate , resulted in a 45 % decrease in clearance of diazepam .
None(e1,e2)	3	47	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone , decreased the auc of ethinyl estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
None(e1,e2)	10	14	compounds that have been tested in man include antipyrine , digoxin , propranolol , theophylline , and warfarin and no clinically meaningful interactions were found .
None(e1,e2)	92	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	33	42	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	4	25	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	5	15	probenecid : as with other b-lactams , the renal excretion of cephalexin is inhibited by probenecid .
mechanism(e1,e2)	0	22	bosentan is also expected to reduce plasma concentrations of other statins that have significant metabolism by cyp3a4 , such as lovastatin and atorvastatin .
effect(e1,e2)	4	6	the concomitant use of beta-adrenergic_blocking_agents with digitalis and calcium antagonists may have additive effects on prolonging atrioventricular conduction time .
None(e1,e2)	0	2	furosemide : toradol iv/im reduced the diuretic response to furosemide in normovolemic healthy subjects by approximately 20 % ( mean sodium and urinary output decreased 17 % ) .
None(e1,e2)	3	11	grapefruit juice increases ethinyl_estradiol concentrations and would be expected to increase progesterone serum levels as well ;
None(e1,e2)	28	43	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	2	selegiline - l-phenylalanine and the selective mao inhibitor selegiline may have synergistic antidepressant activity if used concomitantly .
None(e1,e2)	124	148	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	44	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	22	29	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
advise(e1,e2)	2	5	patients taking coumarin-derivative_anticoagulants concomitantly with capecitabine should be monitored regularly for alterations in their coagulation parameters ( pt or inr ) .
None(e1,e2)	5	22	oral contraceptives multiple doses of cefditoren_pivoxil had no effect on the pharmacokinetics of ethinyl estradiol , the estrogenic component in most oral contraceptives .
None(e1,e2)	44	110	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	26	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	15	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns-depressive effect of alcohol , barbiturates or other sedating drugs .
None(e1,e2)	0	20	lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of lithium toxicity .
None(e1,e2)	87	134	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	11	co-administration of warfarin and cerivastatin did not alter the pharmacokinetics of cerivastatin_sodium .
mechanism(e1,e2)	11	36	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	0	11	theophylline : grepafloxacin is a competitive inhibitor of the metabolism of theophylline .
None(e1,e2)	0	6	vasopressors , such as dopamine and isoproterenol ;
effect(e1,e2)	9	28	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	0	8	meperidine : amphetamines potentiate the analgesic effect of meperidine .
effect(e1,e2)	10	16	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
None(e1,e2)	12	13	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
advise(e1,e2)	2	21	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	11	13	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	129	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	32	49	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	15	17	allopurinol : in a study of healthy male volunteers no significant pharmacokinetic interaction occurred when captopril and allopurinol were administered concomitantly for 6 days .
None(e1,e2)	19	23	erythromycin use in patients who are receiving high doses of theophylline may be associated with an increase in serum theophylline levels and potential theophylline toxicity .
None(e1,e2)	15	17	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium carbonate , and terbutaline .
None(e1,e2)	65	67	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	4	9	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ace inhibitors during therapy with lithium .
None(e1,e2)	30	54	diltiazem : in patients with mild to moderate hypertension , administration of aprepitant once daily , as a tablet formulation comparable to 230 mg of the capsule formulation , with diltiazem 120 mg 3 times daily for 5 days , resulted in a 2-fold increase of aprepitant auc and a simultaneous 1.7-fold increase of diltiazem auc .
None(e1,e2)	24	38	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux_sodium .
None(e1,e2)	100	112	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	28	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	38	48	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	36	54	cancidas reduced the blood auc0-12 of tacrolimus by approximately 20 % , peak blood concentration ( cmax ) by 16 % , and 12-hour blood concentration ( c12hr ) by 26 % in healthy subjects when tacrolimus ( 2 doses of 0.1 mg/kg 12 hours apart ) was administered on the 10th day of cancidas 70 mg daily , as compared to results from a control period in which tacrolimus was administered alone .
None(e1,e2)	22	32	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac_tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	12	22	human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in a mean eight-fold increase in auc of cisapride .
mechanism(e1,e2)	0	5	cimetidine reduces the clearance of alfenta .
None(e1,e2)	0	40	valproate : available data suggest that there is no significant effect of valproate on the clearance of felbatol at steady state , therefore , the addition of valproate is not expected to cause a clinically important effect on felbatol ( felbamate ) plasma concentrations .
None(e1,e2)	8	15	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	2	4	magnesium- and aluminum -containing antacids , administered concomitantly with lomefloxacin , significantly decreased the bioavailability ( 48 % ) of lomefloxacin .
None(e1,e2)	15	19	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	76	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	31	39	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	4	12	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	3	5	include terfenadine , astemizole , cisapride , midazolam , and triazolam .
None(e1,e2)	94	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	41	43	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	63	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	20	29	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	18	47	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	18	40	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic_products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin_analog ( e.g. , octreotide ) , sulfonamide antibiotics .
effect(e1,e2)	4	12	the therapeutic efficacy of tricyclic_antidepressants may be compromised in these patients when cimetidine is discontinued .
None(e1,e2)	17	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
effect(e1,e2)	2	12	when a diuretic is added to the therapy of a patient receiving prinivil , an additional antihypertensive effect is usually observed .
None(e1,e2)	10	31	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	14	20	therefore , interactions could occur following concomitant administration of psychotropic drugs ( e.g. , narcotics , analgesics , antiemetics , sedatives , tranquilizers ) .
None(e1,e2)	7	9	in a study with concomitant administration of aspirin and fosinopril_sodium , the bioavailability of unbound fosinoprilat was not altered .
None(e1,e2)	78	115	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	72	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	19	35	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	18	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	5	in the warfarin study , vardenafil had no effect on the prothrombin time or other pharmacodynamic parameters .
None(e1,e2)	28	35	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	8	10	oral neomycin sulfate may enhance the effect of coumarin in anticoagulants by decreasing vitamin k availability .
None(e1,e2)	25	27	while no in vivo drug-drug interaction studies were conducted between estazolam and inducers of cyp3a , compounds that are potent cyp3a inducers ( such as carbamazepine , phenytoin , rifampin , and barbiturates ) would be expected to decrease estazolam concentrations .
None(e1,e2)	15	25	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
effect(e1,e2)	4	16	the potentiating action of hydroxyzine must be considered when the drug is used in conjunction with central_nervous_system_depressants such as narcotics , non-narcotic analgesics and barbiturates .
effect(e1,e2)	0	15	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	13	23	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	5	22	phenytoin , nicotine , and rifampin may decrease clozapine plasma levels , resulting in a decrease in effectiveness of a previously effective clozapine dose .
None(e1,e2)	14	19	in addition , certain drugs that are metabolized by this isoenzyme , including many antidepressants ( tricyclic antidepressants , selective_serotonin_reuptake_inhibitors , and others ) , may inhibit the activity of this isoenzyme , and thus may make normal metab-olizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system , leading to drug interactions .
None(e1,e2)	27	29	however , in a well-controlled study of patients with lymphoma on combination therapy , allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide , doxorubicin , bleomycin , procarbazine and/or mechlorethamine .
mechanism(e1,e2)	4	13	hiv protease inhibitors : indinavir ( 800 mg t.i.d . ) co-administered with vardenafil 10 mg resulted in a 16-fold increase in vardenafil auc , a 7-fold increase in vardenafil cmax and a 2-fold increase in vardenafil half-life .
None(e1,e2)	23	44	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	102	115	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	60	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	2	antacids ( aluminum - or magnesium-containing ) : concomitant administration of 300-mg cefdinir capsules with 30 ml maalox tc suspension reduces the rate ( cmax ) and extent ( auc ) of absorption by approximately 40 % .
None(e1,e2)	33	44	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin_g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	6	12	data from a randomized trial of hexalen and cisplatin plus or minus pyridoxine in ovarian cancer indicated that pyridoxine significantly reduced neurotoxicity ;
None(e1,e2)	81	106	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	8	20	no interaction was noted with the mao-b inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa /dopa decarboxylase inhibitor ( n=29 ) .
None(e1,e2)	9	20	additionally , paroxetine did not alter the pharmacokinetics of sonata , reflecting the absence of a role of cyp2d6 in zaleplon s metabolism .
None(e1,e2)	12	19	although deferasirox has a lower affinity for aluminum than for iron , exjade should not be taken with aluminum-containing antacid_preparations .
None(e1,e2)	40	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	20	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
None(e1,e2)	17	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	31	34	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	17	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
mechanism(e1,e2)	0	12	quinidine at 648 mg bid decreased the bioavailability ( auc ) of nisoldipine by 26 % , but not the peak concentration .
None(e1,e2)	4	21	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	15	35	a pharmacokinetic study evaluating the administration of a single dose of inspra 100 mg with ketoconazole 200 mg bid , a potent inhibitor of the cyp3a4 pathway , showed a 1.7-fold increase in cmax of eplerenone and a 5.4-fold increase in auc of eplerenone .
None(e1,e2)	19	37	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	20	23	glibenclamide : in a study of 7 healthy male volunteers , acitretin treatment potentiated the blood glucose lowering effect of glibenclamide ( a sulfonylurea similar to chlorpropamide ) in 3 of the 7 subjects .
None(e1,e2)	12	18	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	2	4	when other antiplatelet_agents or anticoagulants are used concomitantly , there is the potential for flolan to increase the risk of bleeding .
advise(e1,e2)	0	7	auranofin should not be used together with penicillamine ( depen , cuprimine ) , another arthritis medication .
advise(e1,e2)	3	5	therefore , when inspra and nsaids are used concomitantly , patients should be observed to determine whether the desired effect on blood pressure is obtained .
mechanism(e1,e2)	17	20	there have been greater than 2-fold increases in previously stable plasma levels of other antidepressants , including nortriptyline , when fluoxetine_hydrochloride has been administered in combination with these agents .
None(e1,e2)	12	38	valproate : available data suggest that there is no significant effect of valproate on the clearance of felbatol at steady state , therefore , the addition of valproate is not expected to cause a clinically important effect on felbatol ( felbamate ) plasma concentrations .
None(e1,e2)	43	75	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone_anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	21	31	however , there are limited in vivo data suggesting a modest cyp2d6 inhibitory effect for escitalopram , i.e. , coadministration of escitalopram ( 20 mg/day for 21 days ) with the tricyclic_antidepressant desipramine ( single dose of 50 mg ) , a substrate for cyp2d6 , resulted in a 40 % increase in cmax and a 100 % increase in auc of desipramine .
None(e1,e2)	21	73	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	9	14	additive depressant effect when used with general anesthetics , sedatives , antianxiety drugs , hypnotics , alcohol , and other opiate analgesics .
mechanism(e1,e2)	2	12	administration of cmi has been reported to increase the plasma levels of phenobarbital , if given concomitantly .
None(e1,e2)	9	21	co-administration of tikosyn with verapamil resulted in increases in dofetilide peak plasma levels of 42 % , although overall exposure to dofetilide was not significantly increased .
None(e1,e2)	10	15	analgesic/anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	30	43	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
effect(e1,e2)	6	23	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	5	14	oral contraceptives : coadministration of atorvastatin and an oral contraceptive increased auc values for norethindrone and ethinyl estradiol by approximately 30 % and 20 % .
None(e1,e2)	43	54	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	6	25	may interact with the following : beta-adrenergic_blocking_agents ( these medicines may make your condition worse and prevent the adrenergic bronchodilators from working properly ) and disopyramide , quinidine , phenothiazines , and procainamide ( these medicines may increase the risk of heart problems ) .
None(e1,e2)	16	25	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	30	36	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
mechanism(e1,e2)	2	7	atorvastatin : atorvastatin increases the auc for norethindrone and ethinyl estradiol .
effect(e1,e2)	4	13	- the action of sulphonylureas and insulin may be enhanced by bezalip or bezalip_retard .
None(e1,e2)	4	6	when taken orally , imidazole_compounds like ketoconazole may enhance the anticoagulant effect of coumarin-like drugs .
None(e1,e2)	21	27	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	107	113	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	87	115	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	33	in addition , studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics or pharmacodynamics of warfarin , or the pharmacokinetics of propranolol ( 40 mg twice daily ) , phenytoin , theophylline , or oral contraceptives .
None(e1,e2)	59	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	9	antacids containing magnesium trisilicate , when administered concomitantly with nitrofurantoin , reduce both the rate and extent of absorption .
None(e1,e2)	15	28	approximately 2/3 of the patients in the phase 3 study received either prophylactic low dose heparin ( unfractionated heparin up to 15,000 units/day ) or prophylactic doses of low_molecular_weight_heparins as indicated in the prescribing information for the specific products .
None(e1,e2)	1	7	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	66	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	11	38	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	26	31	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	11	15	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	4	19	fluconazole , and the 5-ht3_antiemetics ondansetron ( zofran ) and granisetron ( kytril ) have all been used with busulfex .
None(e1,e2)	19	72	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	30	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	5	20	concurrent administration of hexalen and antidepressants_of_the_mao_inhibitor_class may cause severe orthostatic hypotension.cimetidine , an inhibitor of microsomal drug metabolism , increased altretamine s half-life and toxicity in a rat model .
None(e1,e2)	37	42	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	71	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	27	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	26	28	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	78	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	12	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin sodium .
None(e1,e2)	14	19	dose adjustment is not recommended.levetiracetam had no effect on plasma concentrations of carbamazepine , valproate , topiramate , or lamotrigine .
None(e1,e2)	22	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	7	37	although glucocorticoids have been shown to reduce proleukin -induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
None(e1,e2)	16	22	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	10	26	in a single-dose crossover study examining lansoprazole 30 mg and omeprazole 20 mg each administered alone and concomitantly with sucralfate 1 gram , absorption of the proton_pump_inhibitors was delayed and their bioavailability was reduced by 17 % and 16 % , respectively , when administered concomitantly with sucralfate .
None(e1,e2)	41	70	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	19	24	effect of clonazepam on the pharmacokinetics of other drugs : clonazepam does not appear to alter the pharmacokinetics of phenytoin , carbamazepine , or phenobarbital .
None(e1,e2)	3	12	all subjects received glipizide alone and following treatment with 100 mg of fluconazole as a single daily oral dose for seven days .
None(e1,e2)	11	26	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	10	14	sulfapyridine may interact with any of the following : - acetaminophen ( e.g. , tylenol ) ( with long-term , high-dose use ) or
None(e1,e2)	24	32	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	21	24	in addition to the interactions noted above , chronic ( 2 weeks ) oral cordarone administration impairs metabolism of phenytoin , dextromethorphan , and methotrexate .
None(e1,e2)	6	16	other potentially important drug interactions : benzodiazepines : benzodiazepines metabolized by hepatic oxidation ( e.g. , alprazolam , midazolam , triazolam elc . ) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine .
None(e1,e2)	3	5	coadministration of oral contraceptives , diazepam , phenytoin , or quinidine did not seem to change the pharmacokinetic profile of esomeprazole .
None(e1,e2)	24	45	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	27	47	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic_acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel_blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	59	80	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	11	13	folic acid in large amounts may counteract the antiepileptic effect of phenobarbital , phenytoin and primidone , and increase the frequency of seizures in susceptible pediatric patients .
None(e1,e2)	5	16	when ertapenem is co-administered with probenecid ( 500 mg p.o . every 6 hours ) , probenecid competes for active tubular secretion and reduces the renal clearance of ertapenem .
advise(e1,e2)	36	43	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	3	31	blood levels of hydrodolasetron increased 24 % when dolasetron was coadministered with cimetidine ( nonselective inhibitor of cytochrome p-450 ) for 7 days , and decreased 28 % with coadministration of rifampin ( potent inducer of cytochrome p-450 ) for 7 days .
None(e1,e2)	21	34	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	26	37	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	0	15	heparin : since heparin is contraindicated in patients with heparin-induced thrombocytopenia , the co-administration of argatroban and heparin is unlikely for this indication .
None(e1,e2)	6	9	antacid : the effect of an aluminum_hydroxide - and magnesium_hydroxide -containing antacid ( maalox ) * on the pharmacokinetics of capecitabine was investigated in 12 cancer patients .
None(e1,e2)	17	41	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central_nervous_system_depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
advise(e1,e2)	2	7	nafazodone , fluvoxamine , cimetidine ( consider xanax dose reduction ) .
None(e1,e2)	8	10	diltiazem plasma levels were not significantly affected by lovastatin or pravastatin .
advise(e1,e2)	7	17	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	7	16	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
None(e1,e2)	19	24	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	34	66	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting_enzyme_(_ace_)_inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	7	9	the pressor effects of catecholamines such as dopamine or norepinephrine are enhanced by bretylium tosylate .
None(e1,e2)	12	16	in addition , under the influence of sympatholytic medicinal products such as beta-blockers , clonidine , guanethidine , and reserpine , the signs of hypoglycemia may be reduced or absent .
None(e1,e2)	14	22	results of studies in multiple sclerosis patients taking tysabri and concomitant interferon beta-1a ( avonex 30 mcg im once weekly ) or glatiramer_acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate .
None(e1,e2)	21	62	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
effect(e1,e2)	10	29	other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
effect(e1,e2)	1	8	if desipramine_hydrochloride is to be combined with other psychotropic_agents such as tranquilizers or sedative/hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	25	32	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle_relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	4	18	these six volunteers received terfenadine alone ( 60 mg twice daily ) for 8 days , followed by terfenadine in combination with dirithromycin ( 500 mg once daily ) for 10 days .
None(e1,e2)	10	21	potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( phenytoin , valproate , oral contraceptive , digoxin , warfarin , probenecid ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .
None(e1,e2)	0	17	curariform_muscle_relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
None(e1,e2)	21	26	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	10	15	potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( phenytoin , valproate , oral contraceptive , digoxin , warfarin , probenecid ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .
None(e1,e2)	8	33	effects of erythromycin on felbatol the coadministration of erythromycin ( 1000 mg/day ) for 10 days did not alter the pharmacokinetic parameters of cmax , cmin , auc , ci/kg or tmax at felbamate daily doses of 3000 or 3600 mg/day in 10 otherwise healthy subjects with epilepsy .
None(e1,e2)	5	18	thus , when nsaids and lithium are administered concurrently , subjects should be observed carefully for signs of lithium toxicity .
None(e1,e2)	5	35	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1_agonists .
None(e1,e2)	20	26	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	23	41	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	15	the similarity of the tysabri -associated adverse event profile between study 1 ( without co-administered avonex ) and study 2 ( with co-administered avonex ) indicates that this alteration in clearance does not necessitate reduction of the tysabri dose to maintain safety , general ) .
effect(e1,e2)	8	14	psychoactive drugs : hallucinations have been reported when toradol was used in patients taking psychoactive_drugs ( fluoxetine , thiothixene , alprazolam ) .
advise(e1,e2)	30	43	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	26	67	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	3	5	h2 blockers and proton_pump_inhibitors ( ppis )
None(e1,e2)	42	45	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
mechanism(e1,e2)	7	13	erythromycin and clarithromycin ( and possibly other macrolide_antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
advise(e1,e2)	0	21	ibandronate should be taken at least 60 minutes before any oral medications containing multivalent cations ( including antacids , supplements or vitamins ) .
None(e1,e2)	6	9	diphenhydramine hydrochloride has additive effects with alcohol and other cns_depressants ( hypnotics , sedatives , tranquilizers , etc ) .
None(e1,e2)	69	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	8	17	nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside antibiotics or potent diuretics such as furosemide .
None(e1,e2)	20	22	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as acetylsalicylic_acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
effect(e1,e2)	0	12	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
None(e1,e2)	69	114	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	22	28	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns_depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
effect(e1,e2)	7	13	while the effects of chronic phenytoin or carbamazepine therapy on the action of nimbex are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .
effect(e1,e2)	7	15	resistance to the neuromuscular blocking action of nondepolarizing_neuromuscular_blocking_agents has been demonstrated in patients chronically administered phenytoin or carbamazepine .
None(e1,e2)	31	42	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	28	62	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
advise(e1,e2)	10	14	caution is warranted and therapeutic concentration monitoring is recommended for antiarrhythmics when coadministered with crixivan .
None(e1,e2)	2	5	amantadine , tricyclic_antidepressants , and maois may increase anticholinergic effect of clidinium .
None(e1,e2)	18	23	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim /sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	16	34	digitalis : immediate release capsules : since there have been isolated reports of patients with elevated digoxin levels , and there is a possible interaction between digoxin and nifedipine , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over- or under-digitalization .
None(e1,e2)	2	29	effects of antacids on felbatol the rate and extent of absorption of a 2400 mg dose of felbatol as monotherapy given as tablets was not affected when coadministered with antacids .
None(e1,e2)	0	19	phenobarbital ( primidone ) : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenobarbital ( primidone ) with or without other enzyme-inducing aeds .
None(e1,e2)	15	18	consequently , drugs with a low therapeutic margin , such as vitamin k antagonists , phenytoin , and theophylline , could have a delayed elimination and increases in their serum half-life leading to a toxic level .
None(e1,e2)	22	37	the following drug interactions have been identified involving nizoral tablets and other drugs metabolized by the cytochrome p450 3a4 enzyme system : ketoconazole tablets inhibit the metabolism of terfenadine , resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite .
None(e1,e2)	6	10	antihypertensive medications , other , especially diazoxide , or pre anesthetic and anesthetic agents used in surgery or skeletal-muscle relaxants , nondepolarizing , used in surgery
None(e1,e2)	17	31	plasma exposure of diazepam ( 10 mg bid ) was increased by 28 % following administration of valdecoxib ( 40 mg bid ) for 12 days , while plasma exposure of valdecoxib ( 40 mg bid ) was not substantially increased following administration of diazepam ( 10 mg bid ) for 12 days .
None(e1,e2)	38	50	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	26	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	30	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	2	7	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	4	8	pyrantel ( e.g. , antiminth ) - taking piperazine and pyrantel together may decrease the effects of piperazine .
effect(e1,e2)	0	2	warfarin : meclofenamate_sodium enhances the effect of warfarin .
int(e1,e2)	0	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	10	26	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	0	6	amantadine , tricyclic antidepressants , and maois may increase anticholinergic effect of clidinium .
None(e1,e2)	44	66	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	51	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	3	antidepressants , tricyclic amphetamines may enhance the activity of tricyclic antidepressants or sympathomimetic agents ;
None(e1,e2)	8	12	in patients with chronic hepatitis c treated with pegasys in combination with copegus , pegasys treatment did not affect ribavirin distribution or clearance .
None(e1,e2)	44	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	29	35	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	28	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	18	22	preliminary clinical data suggest that the incidence of nephrolithiasis is higher in patients receiving indinavir in combination with ritonavir than those receiving crixivan 800 mg q8h .
None(e1,e2)	66	77	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	17	36	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal_anti-inflammatory_agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	23	32	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium_polystyrene_sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	15	23	the similarity of the tysabri -associated adverse event profile between study 1 ( without co-administered avonex ) and study 2 ( with co-administered avonex ) indicates that this alteration in clearance does not necessitate reduction of the tysabri dose to maintain safety , general ) .
mechanism(e1,e2)	6	8	sulindac : the concomitant administration of diflunisal and sulindac in normal volunteers resulted in lowering of the plasma levels of the active sulindac sulfide metabolite by approximately one-third .
effect(e1,e2)	4	13	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine oxidase inhibitors or other antidepressants .
None(e1,e2)	8	19	although the occurrence has not been reported with cefizox , nephrotoxicity has been reported following concomitant administration of other cephalosporins and aminoglycosides .
None(e1,e2)	0	24	furosemide : clinical studies , as well as post marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
None(e1,e2)	9	21	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
effect(e1,e2)	10	14	in clinical trials in patients undergoing ptca/pci , co-administration of angiomax with heparin , warfarin , thrombolytics or glycoprotein iib/iiia inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications .
effect(e1,e2)	3	5	concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
None(e1,e2)	16	27	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan kerastick for topical solution .
None(e1,e2)	35	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	16	tolbutamide : in diabetic patients receiving diflunisal and tolbutamide , no significant effects were seen on tolbutamide plasma levels or fasting blood glucose .
None(e1,e2)	74	78	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	21	23	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .
None(e1,e2)	22	49	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	67	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	14	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
effect(e1,e2)	0	18	dopamine_d2_receptor_antagonists ( e.g. , phenothiazines , butyrophenones , risperidone ) and isoniazid may reduce the therapeutic effects of levodopa .
mechanism(e1,e2)	16	40	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	13	37	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	94	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	8	68	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	10	13	therefore , administration of quinolones with antacids containing calcium , magnesium , or aluminum ;
None(e1,e2)	7	52	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	24	31	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	12	14	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	55	83	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	4	25	the daily dose of enablex should not exceed 7.5 mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
None(e1,e2)	9	45	there have been postmarketing reports of drug interactions when erythromycin is coadministered with cisapride , resulting in qt prolongation , cardiac arrythmias , ventricular tachycardia , ventricular fibrulation , and torsades de pointes , most like due to inhibition of hepatic metabolism of cisapride by erythromycin .
None(e1,e2)	4	34	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	14	25	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine_antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
effect(e1,e2)	0	11	phospholine_iodide potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and carbamate_insecticide s .
effect(e1,e2)	3	18	the use of codeine may result in additive cns depressant effects when coadministered with alcohol , antihistamines , psychotropics or other drugs that produce cns depression .
None(e1,e2)	12	35	the ecg changes and/or hypokalemia that may result from the administration of non-potassium_sparing_diuretics ( such as loop or thiazide diuretics ) can be acutely worsened by beta-agonists , especially when the recommended dose of the beta-agonist is exceeded .
None(e1,e2)	4	6	the concomitant intake of alcohol and acamprosate does not affect the pharmacokinetics of either alcohol or acamprosate .
None(e1,e2)	12	37	valdecoxib caused a statistically significant increase in plasma exposures of r-warfarin and s-warfarin ( 12 % and 15 % , respectively ) , and in the pharmacodynamic effects ( prothrombin time , measured as inr ) of warfarin .
None(e1,e2)	4	28	grapefruit juice co-administration of felodipine with grapefruit juice resulted in more than 2-fold increase in the auc and cmax , but no prolongation in the half- life of felodipine .
None(e1,e2)	26	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	15	22	drug-drug interactions given the primary cns effects of aripiprazole , caution should be used when abilify is taken in combination with other centrally_acting_drugs and alcohol .
None(e1,e2)	20	43	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	0	20	antihypertensive_medication s and vasodilators : the following adverse events were experienced more commonly in patients receiving concomitant antihypertensive medications or vasodilators ( n = 94 ) compared to patients not receiving these concomitant drugs ( n = 456 ) : hypotension 10 % vs 4 % , myocardial infarction 3 % vs 1 % , serious pneumonia 5 % vs 3 % , serious falls 9 % vs 3 % , and bone and joint injuries 6 % vs 2 % .
None(e1,e2)	7	29	in em individuals treated with paroxetine or fluoxetine , the auc of atomoxetine is approximately 6- to 8-fold and css , max is about 3- to 4-fold greater than atomoxetine alone .
advise(e1,e2)	0	14	isuprel should be used with caution , if at all , when potent inhalational anesthetics such as halothane are employed because of potential to sensitize the myocardium to effects of sympathomimetic amines .
None(e1,e2)	9	12	reported examples of this interaction include the following : immunosuppressive s : cyclosporine ( cyp3a4 substrate ) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine , despite reduction in dose of cyclosporine .
None(e1,e2)	7	17	zebeta should be used with care when myocardial_depressants or inhibitors of av conduction , such as certain calcium_antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	0	26	acidifying_agents : gastrointestinal acidifying agents ( guanethidine , reserpine , glutamic acid hcl , ascorbic acid , fruit juices , etc . ) lower absorption of amphetamines .
None(e1,e2)	32	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	16	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	0	9	dolasetron_mesylate did not inhibit the antitumor activity of four chemotherapeutic_agents ( cisplatin , 5-fluorouracil , doxorubicin , cyclophosphamide ) in four murine models .
None(e1,e2)	4	9	other depressasnts such as alcohol , barbiturates , and maois may enhance cns depression when administered with ethchlorvynol .
mechanism(e1,e2)	0	9	bile_acid_binding_resins may also interfere with the absorption of oral phosphate supplements and hydrocortisone .
advise(e1,e2)	4	21	drug-drug interactions albuterol - strattera should be administered with caution to patients being treated with systemically-administered ( oral or intravenous ) albuterol ( or other beta2 agonists ) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure .
None(e1,e2)	11	25	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	37	44	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	8	calcium_channel_blockers , dihydropyridine : e.g. , felodipine , nifedipine , nicardipine
None(e1,e2)	5	24	therefore , when chlorothiazide and non-steroidal_anti-inflammatory_agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained
None(e1,e2)	2	19	phenobarbital ( primidone ) : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenobarbital ( primidone ) with or without other enzyme-inducing aeds .
None(e1,e2)	16	23	toxicology studies of heroin-related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
None(e1,e2)	70	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	10	12	calcium channel blockers , dihydropyridine : e.g. , felodipine , nifedipine , nicardipine
None(e1,e2)	13	38	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	15	23	because tetracyclines have been shown to depress plasma prothrombin activity , patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage .
None(e1,e2)	11	25	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	38	45	alprazolam : when fluvoxamine maleate ( 100 mg qd ) and alprazolam ( 1 mg q.d . were co-administered to steady state , plasma concentration and other pharmacokinetics parameters ( auc , cmax , t1/2 , ) of alprazolam were approximately twice those observed when alprazolam was administered alone ;
None(e1,e2)	15	43	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta_blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium_sparing_diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
effect(e1,e2)	15	28	the concurrent use of two or more drugs with anticholinergic activity -- such as an antipsychotic_drug ( eg , chlorpromazine ) , an antiparkinsonian drug ( eg , trihexyphenidyl ) , and/or a tricyclic antidepressant ( eg , amitriptyline ) -- commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
None(e1,e2)	1	5	include terfenadine , astemizole , cisapride , midazolam , and triazolam .
None(e1,e2)	4	9	maalox * coadministration of maalox_tc had no effect on nicardipine_hcl absorption .
None(e1,e2)	83	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	10	uricosuric_agents : aspirin may decrease the effects of probenecid , sulfinpyrazone , and phenylbutazone .
None(e1,e2)	24	30	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
effect(e1,e2)	10	18	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
None(e1,e2)	51	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	4	antacids containing aluminum_hydroxide and magnesium_hydroxide reduce the oral absorption of enoxacin by 75 % .
mechanism(e1,e2)	7	14	cyclosporine : modest increases in mean trough cyclosporine concentrations were observed following initiation of carvedilol treatment in 21 renal transplant patients suffering from chronic vascular rejection .
mechanism(e1,e2)	2	10	chlorpropamide : chlorpropamide s plasma half-life may be prolonged by allopurinol , since allopurinol and chlorpropamide may compete for excretion in the renal tubule .
None(e1,e2)	12	24	it is recommended that if casodex is started in patients already receiving coumarin_anticoagulants , prothrombin times should be closely monitored and adjustment of the anticoagulant dose may be necessary .
None(e1,e2)	0	2	antacids containing aluminum_hydroxide and magnesium hydroxide reduce the oral absorption of enoxacin by 75 % .
None(e1,e2)	2	21	administration of diltiazem_hydrochloride concomitantly with propranolol in five normal volunteers resulted in increased propranolol levels in all subjects and bioavailability of propranolol was increased approximately 50 % .
None(e1,e2)	6	20	naproxen : the concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen , but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite .
None(e1,e2)	102	148	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	16	probenecid : the oral combination of probenecid before intramuscular injection of pipracil produces an increase in piperacillin peak serum level of about 30 % .
None(e1,e2)	17	31	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
int(e1,e2)	5	8	a possible drug interaction of foscavir and intravenous pentamidine has been described .
None(e1,e2)	0	22	anticoagulants : coagulation parameters should be tested more frequently and monitored regularly during simultaneous administration of high doses of heparin , oral anticoagulants , or other drugs that may affect the blood coagulation system or the thrombocyte function .
None(e1,e2)	19	33	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
mechanism(e1,e2)	5	10	isoflurane , enflurane , and halothane decrease the ed50 of nuromax by 30 % to 45 % .
None(e1,e2)	17	21	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	48	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	15	theophylline serum levels should be monitored and appropriate dose adjustments considered for patients given both theophylline and pegasys .
None(e1,e2)	16	35	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	24	28	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	16	44	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	10	32	paroxetine ( 20 mg qd ) increased the concentration of duloxetine ( 40 mg qd ) by about 60 % , and greater degrees of inhibition are expected with higher doses of paroxetine .
None(e1,e2)	2	4	sumatriptan and d.h.e_._45 ( dihydroergotamine_mesylate ) injection , usp should not be taken within 24 hours of each other..
None(e1,e2)	0	4	mineral_oil -concomitant intake of mineral_oil and vitamin k may reduce the absorption of vitamin k .
None(e1,e2)	27	40	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	95	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	9	other nephrotoxic medications : agents such as aminoglycosides , cyclosporine , and pentamidine may enhance the potential for drug-induced renal toxicity , and should be used concomitantly only with great caution .
None(e1,e2)	15	32	the iv methylprednisolone dose should be reduced by approximately 25 % , and the oral methylprednisolone dose should be reduced by approximately 50 % when coadministered with aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without aprepitant .
None(e1,e2)	46	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	21	23	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
mechanism(e1,e2)	10	12	in a study in normal volunteers , concomitant administration of buspirone_hcl and haloperidol resulted in increased serum haloperidol concentrations .
None(e1,e2)	44	46	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
effect(e1,e2)	11	23	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns depressants such as anesthetics , opiates , and alcohol .
None(e1,e2)	20	22	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
None(e1,e2)	7	34	this observed increase in the bioavailability of fexofenadine may be due to transport-related effects , such as p-glycoprotein . in vivo animal studies also suggest that in addition to enhancing absorption , ketoconazole decreases fexofenadine gastrointestinal secretion , while erythromycin may also decrease biliary excretion .
None(e1,e2)	16	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	21	38	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	2	16	therefore smaller alfenta doses will be required with prolonged administration and the duration of action of alfenta my be extended .
None(e1,e2)	1	3	- indomethacin : indomethacin blunts the increases in urine volume and sodium excretion seen during bumetanide treatment and inhibits the bumetanide-induced increase in plasma renin activity .
None(e1,e2)	24	43	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting_enzyme_inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal_anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	34	52	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	0	20	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	1	9	plasma valproate concentration should be monitored when isoniazid and valproate are co administered , and appropriate dosage adjustments of valproate should be made .
None(e1,e2)	30	44	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	35	49	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	7	mineral_oil -concomitant intake of mineral oil and vitamin_k may reduce the absorption of vitamin k .
None(e1,e2)	13	35	cimetidine : in a study in healthy volunteers , a one-week course of cimetidine at 400 mg b.i.d . with a single 5 mg dose of isradipine on the sixth day showed an increase in isradipine mean peak plasma concentrations ( 36 % ) and significant increase in area under the curve ( 50 % ) .
None(e1,e2)	0	6	metoprolol - administration of 20 mg/day lexapro for 21 days in healthy volunteers resulted in a 50 % increase in cmax and 82 % increase in auc of the beta-adrenergic blocker metoprolol ( given in a single dose of 100 mg ) .
None(e1,e2)	0	6	carbamazepine - combined administration of racemic citalopram ( 40 mg/day for 14 days ) and carbamazepine ( titrated to 400 mg/day for 35 days ) did not significantly affect the pharmacokinetics of carbamazepine , a cyp3a4 substrate .
effect(e1,e2)	14	16	there have been reports of theophylline-related side effects in patients on concomitant therapy with quinolones and theophylline .
effect(e1,e2)	11	46	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal_muscle_relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	3	5	the effect of gabapentin on cimetidine was not evaluated .
None(e1,e2)	0	21	dopamine_antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	0	13	uricosuric_agents : aspirin may decrease the effects of probenecid , sulfinpyrazone , and phenylbutazone .
None(e1,e2)	61	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	24	30	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	1	15	anesthetics/ sedatives /hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	12	17	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
effect(e1,e2)	12	35	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1_agonists .
None(e1,e2)	21	26	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	4	6	urinary acidifying agents ( ammonium_chloride , sodium_acid_phosphate , etc . ) increase the concentration of the ionized species of the amphetamine molecule , thereby increasing urinary excretion .
None(e1,e2)	2	6	anticonvulsants : carbamazepine , phenobarbital , phenytoin
None(e1,e2)	26	44	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	30	34	use lowest possible dose of atorvastatin with careful monitoring , or consider hmg-coa reductase inhibitors that are not primarily metabolized by cyp3a4 , such as pravastatin , fluvastatin , or rosuvastatin in combination with crixivan .
None(e1,e2)	28	42	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
advise(e1,e2)	2	24	if additional adrenergic_drugs are to be administered by any route , they should be used with caution because the pharmacologically predictable sympathetic effects of brovana may be potentiated .
None(e1,e2)	12	15	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	20	32	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	0	9	prednisolone : ethinyl estradiol may inhibit the metabolism of prednisolone , leading to increased plasma concentrations .
None(e1,e2)	45	71	this drug may interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	7	13	cardiac effects of dopamine are antagonized by beta-adrenergic_blocking_agents , such as propranolol and metoprolol .
None(e1,e2)	44	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	27	37	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
advise(e1,e2)	22	28	because both of these drugs have negative inotropic properties and the effects of coadministration with tambocor are unknown , neither disopyramide nor verapamil should be administered concurrently with tambocor unless , in the judgment of the physician , the benefits of this combination outweigh the risks .
None(e1,e2)	17	36	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	16	30	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium_hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	8	10	oral anticoagulant agents : pharmacokinetic drug-drug interactions between argatroban and warfarin ( 7.5 mg single oral dose ) have not been demonstrated .
None(e1,e2)	13	23	the clearance of benzodiazepines metabolized by glucuronidation ( e. g. , lorazepam , oxazepam , temazepam ) is unlikely to be affected by fluvoxamine .
None(e1,e2)	19	28	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
effect(e1,e2)	4	8	olanzapine : coadministration of eszopiclone 3 mg and olanzapine 10 mg produced a decrease in dsst scores .
None(e1,e2)	6	31	the possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril ( captopril tablets , usp ) or initiating therapy with small doses ( 6.25 or 12.5 mg ) .
None(e1,e2)	14	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	11	13	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	9	19	because cyp 3a4 inhibitors may increase plasma concentrations of buprenorphine , patients already on cyp 3a4 inhibitors such as azole_antifungals ( e.g .
effect(e1,e2)	9	32	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	48	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	25	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	32	43	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	32	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	9	11	may interact with cefamandole naftate , cephalothin sodium , magnesium_sulfate , prednisolone_sodium_succinate , and prochlorperazine edisylate .
None(e1,e2)	30	45	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or h1-blocking agents , tricyclic_antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	0	32	carbamazepine - combined administration of racemic citalopram ( 40 mg/day for 14 days ) and carbamazepine ( titrated to 400 mg/day for 35 days ) did not significantly affect the pharmacokinetics of carbamazepine , a cyp3a4 substrate .
None(e1,e2)	3	28	therefore , if theophylline is co-administered with fluvoxamine maleate , its dose should be reduced to one third of the usual daily maintenance dose and plasma concentrations of theophylline should to monitored .
None(e1,e2)	8	10	it may also interact with amantadine or other anticholinergic_drugs or maois , which may intensify the anticholinergic action .
mechanism(e1,e2)	6	28	plasma levels of several closely related tricyclic_antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
None(e1,e2)	79	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	7	antacids , sucralfate , metal cations , multivitamins quinolones form chelates with alkaline earth and transition metal cations .
None(e1,e2)	22	26	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	0	14	amiodarone taken concomitantly with procainamide for less than seven days increases plasma concentrations of procainamide and n-acetyl procainamide by 55 % and 33 % , respectively .
None(e1,e2)	10	26	in vitro data suggest that itraconazole , when compared to ketoconazole , has a less pronounced effect on the biotransformation system responsible for the metabolism of astemizole .
None(e1,e2)	2	39	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	59	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	20	28	agents with increased levels in the presence of carbamazepine : equetrotm increases the plasma levels of the following agents : clomipramine_hcl , phenytoin ( 6 ) , and primidone thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with equetrotm , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .
None(e1,e2)	10	15	there is limited experience with concomitant antihypertensive agents such as alpha-blockers , calcium channel-blockers , ace_inhibitors , and diuretics ( both thiazide-like and loop ) .
None(e1,e2)	10	12	valdecoxib caused a statistically significant increase in plasma exposures of r-warfarin and s-warfarin ( 12 % and 15 % , respectively ) , and in the pharmacodynamic effects ( prothrombin time , measured as inr ) of warfarin .
mechanism(e1,e2)	13	22	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine_sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
mechanism(e1,e2)	5	11	another oral azole antifungal , ketoconazole , inhibits the metabolism of astemizole , resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong qt intervals .
None(e1,e2)	33	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	70	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	20	39	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	4	18	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co-administered with other psychotropic medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
None(e1,e2)	102	128	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	23	29	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	8	10	in clinical trials , the concomitant administration of sulfadoxine and pyrimethamine did not alter the adverse reaction profile .
None(e1,e2)	1	3	- isoniazid ( nydrazid ) ;
None(e1,e2)	6	12	clinical interaction studies with cimetidine and warfarin indicated that the coadministration of femara with these drugs does not result in clinically- significant drug interactions .
None(e1,e2)	12	53	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	22	24	serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of crohn s disease including corticosteroids , antibiotics ( metronidazole or ciprofloxacin ) and aminosalicylates .
None(e1,e2)	0	21	furosemide : in normal volunteers , the concomitant administration of diflunisal and furosemide had no effect on the diuretic activity of furosemide .
None(e1,e2)	2	32	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on day 1 , and aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on days 2 through 5 , increased the auc of dexamethasone , a cyp3a4 substrate by 2.2-fold , on days 1 and 5 .
effect(e1,e2)	14	17	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	10	30	in another drug interaction study , co-administration of orally inhaled ciclesonide and oral ketoconazole , a potent inhibitor of cytochrome p450 3a4 , increased the exposure ( auc ) of des-ciclesonide by approximately 3.6-fold at steady state , while levels of ciclesonide remained unchanged .
None(e1,e2)	25	34	beta blockers : although the results of a clinical study did not indicate a safe problem associated with the administration of d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp to subjects already receiving propranolol , there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine .
None(e1,e2)	6	60	clinical experience with concomitant administration of bosentan and warfarin in patients with pulmonary arterial hypertension did not show clinically relevant changes in inr or warfarin dose ( baseline vs. end of the clinical studies ) , and the need to change the warfarin dose during the trials due to changes in inr or due to adverse events was similar among bosentan - and placebo-treated patients .
None(e1,e2)	18	25	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium_antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
effect(e1,e2)	5	9	similarly , the effects of phenytoin on phenobarbital , valproic_acid and sodium plasma valproate concentrations are unpredictable
None(e1,e2)	1	9	- methyldopa ( e.g. , aldomet ) use of methyldopa with sulfapyridine may increase the chance of side effects affecting the liver and/or the blood
None(e1,e2)	4	14	other reported interactions with amiodarone : fentanyl ( cyp3a4 substrate ) in combination with amiodarone may cause hypotension , bradycardia , and decreased cardiac output .
None(e1,e2)	37	41	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	23	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	14	30	although it has not been established that there is an interaction between clozapine and benzodiazepines or other psychotropics , caution is advised when clozapine is initiated in patients taking a benzodiazepine or any other psychotropic drug .
None(e1,e2)	2	10	- a monoamine_oxidase_inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	18	36	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac_glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	17	20	the effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis drug rifampin .
None(e1,e2)	2	9	coadministration of digoxin did not influence the pharmacokinetics of levetiracetam .
None(e1,e2)	44	56	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	26	59	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	18	26	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin /flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	9	13	lotensin has been used concomitantly with beta-adrenergic-blocking agents , calcium-channel-blocking_agents , diuretics , digoxin , and hydralazine , without evidence of clinically important adverse interactions .
None(e1,e2)	2	21	digoxin : rofecoxib 75 mg once daily for 11 days does not alter the plasma concentration profile or renal elimination of digoxin after a single 0.5 mg oral dose .
None(e1,e2)	0	11	triazolam : erythromycin has been reported to decrease the clearance of triazolam and , thus , may increase the pharmacologic effect of triazolam .
None(e1,e2)	0	9	sildenafil_citrate - theoretically , l-arginine supplements taken concomitantly with sildenafil_citrate , may potentiate the effects of the drug .
None(e1,e2)	9	22	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium channel blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	15	24	this effect may be mediated by the known inhibition of hepatic cytochrome p- 450 by cimetidine , which could decrease first pass metabolism of nimodipine .
None(e1,e2)	16	33	toxicology studies of heroin-related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
None(e1,e2)	10	35	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
